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The Greater Pittsburgh Area is famous for its three rivers: the Allegheny, Monongahela, and 
Ohio Rivers.  These rivers have a history of being polluted by decades of mine runoff and 
chemicals released by industrial sites.  N ew problems, such as pollution from endocrine 
disrupting compounds and xenoestrogens, have recently been discovered in this well known 
aquatic environment and are suspected to be caused by the failing sewer system.  Personal care 
products, pharmaceuticals and plasticizers all have the potential to enter the water supply though 
both treated and untreated sewage.  Many of these compounds are known or suspected endocrine 
disruptors. 
Estrogenic potential of fish extracts from flesh/fat tissue captured from Freeport and Ford 
City was studied via the E-Screen Assay on MCF-7, T47D and BT-20 human breast cancer cell 
lines.  Results showed weak estrogenic responses in both MCF-7 and T47D cell lines, with no 
significant differences for fish gender, weight, or sample location. 
Estrogenic potential of extracts from fish brain tissue was tested via Bromodeoxyuridine 
MCF-7 Analysis and paired with High Performance Liquid Chromatography-Mass Spectrometry 
to investigate the presence of specific xenoestrogens in the fish extracts. Fifty eight fish were 
sampled from rivers in the Greater Pittsburgh Area.  All samples were non-detectable for methyl, 
ethyl, propyl and butyl parabens.  Bisphenol A (BPA) was detected in 44 of the 58 samples, with 
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a range from non-detectable to 120 pg/gram.  The Harmarville sample location had higher results 
for all analyses when compared to all other sample sites. 
In summary, this dissertation supported all previous available literature leading to the 
conclusion that parabens are safe to remain on the market and are not a significant environmental 
concern. In particular, there does not seem to be any need for concern over paraben levels 
detected in the Greater Pittsburgh Area river system and water supply.  The BPA portion of this 
research was in agreement with previous literature as to its bioconcentration tendencies; 
however, new implications regarding the public health significance of the effects from BPA in 
brain tissue may require some re-evaluation of concerns about BPA transport and fate in the 
environment around Pittsburgh and elsewhere. 
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1.0 INTRODUCTION 
1.1 PUBLIC HEALTH SIGNIFICANCE 
Endocrine Disrupting Compounds (EDCs) and xenoestrogens, such as Bisphenol A (BPA) and 
parabens, are a public health concern.  M any prevalent diseases, potentially caused by a 
disruption of the endocrine system, are elevated in different societies throughout the world.  
Diabetes, a disorder of the endocrine system causing a build-up of glucose in the system due to a 
lack of or misuse of insulin, has had an increase in incidence rates, or new cases, for the last 20 
years [1].  Additionally, reproductive cancers and sexual malformation disorders are prevalent 
across the globe. It is time to look at our efforts in determining the causes of such disorders.  
Environmental pollution from EDCs may be a contributing factor or a direct cause of these 
public health issues.  Research on EDCs did not begin until the mid 1900s when it was 
discovered that diethylstilbestrol (DES), a pharmaceutical administered to prevent miscarriages, 
caused harsh health effects in the offspring of expectant mothers [2].  However, research interest 
was engendered in the 1990s when environmental studies discovered reptiles, specifically 
alligators in Florida and fish in the United Kingdom, with sexual malformations [3-5].  This 
discovery led researchers to begin the hunt for the cause of this environmental debacle.  Since 
that time, academic and industrial researchers have been attempting to narrow down the growing 
problem of endocrine disruption.  However, controversial studies, inconsistent results and the 
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ever expanding chemical market have bewildered the research community causing policy and 
legislation in the area of endocrine disruption to become quite contentious. 
1.2 INTRODUCTION TO ENDOCRINE DISRUPTING COMPOUNDS 
There has been a growing concern about the effects of man-made chemicals on the endocrine 
system in both humans and animals.  The study of EDCs started decades ago, but slow progress 
has been made for many reasons: (1) the vast number of chemicals available on the market, (2) 
the difficulty in isolating risks from individual EDCs or those in combinations, and (3) the 
impact of confounding factors from natural hormones and phytoestrogens on any particular 
biological system.  Although it is a widely accepted hypothesis that EDCs can cause detrimental 
changes to human endocrine systems, toxicological and risk assessment data have been unable to 
prove or disprove the potential for human health effects from a myriad of chemicals [6].  A great 
cause for environmental concern is the rapidly increasing amount of pharmaceutical and personal 
care products entering the consumer market.  Most of these chemicals have not been thoroughly 
evaluated for endocrine activity.  Although it is generally accepted that market products are safe, 
and some have research to support their claims, there are reasons to believe that products may 
have environmental endocrine effects.  Some products have the sole purpose of altering the 
hormonal state of the user (e.g. contraceptives) and therefore may have involuntary effects to 
other humans and/or possible detrimental effects to organisms at lower doses [7].  Substances 
may also react with other environmental pollutants to form new endocrine active substances, and 
drugs may be metabolized to different unstudied forms and then excreted to the environment [7].  
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There may also be additive, synergistic or antagonistic effects of EDCs when present together in 
the environment [8].   
The general public is exposed to these chemicals through various sources.  It begins with 
the direct consumer, assume a f emale, applying hygiene products directly onto the skin and 
ingesting pharmaceutical contraceptives.  Waste is disposed of down the drain and excreted into 
the sewer system.  S ewer systems may treat water in a Wastewater Treatment Plant (WWTP) 
which may possibly remove some of the chemicals, while discharging the rest into the nearest 
body of water.  Or, during high rain events, sewer systems may bypass treatment and dump 
untreated wastewater directly into the nearest body of water via Sanitary Sewer Overflows 
(SSOs) and Combined Sewer Overflows (CSOs).  Surface water is generally used for the public 
drinking water supply and now contains low levels of hygiene products containing suspected 
EDCs and low levels of pharmaceutical contraceptives.  These doses may or may not be harmful 
to the aquatic environment, and these chemicals may possibly be increasingly harmful in 
combination with other EDCs.  Two new exposure pathways (via ingestion of the water and 
bathing in the water) are created for unsuspecting individuals, including men and children, two 
groups that should not be exposed to pharmaceutical contraceptives.   
In endocrine disruption research, most attention has been directed towards aquatic 
species, primarily because the aquatic environment receives most of the pollutants released to the 
environment, either by direct point source discharges from industry and wastewater treatment 
facilities or indirect sources such as spills, pesticide application over large areas, runoff and 
deposition [5].  Generally, potential EDCs can get into the environment through various ways: 
disposal in landfills or into household drains, urination/sewage pathways, washing/bathing with 
hygiene products, or simply by direct use of the individual.  Landfill disposal causes leachate 
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concerns which may transport potential EDCs to the local ground and surface waters.  Sewer 
disposal allows for partial cleanup in WWTPs, if the sewage system is operating at its optimum 
potential.  H owever, many sewer systems do not possess the ability to process all of the 
community sewage, and will dump untreated waste directly into receiving bodies of water during 
times of high flow and/or rain events.  This is especially the case in Pittsburgh, Pennsylvania, 
and its surrounding areas which are known for the unusually high volumes of SSOs and CSOs 
[9]. 
The National Institute of Environmental Health Sciences (NIEHS) is a United States 
government entity that is appointed with the task of reducing the burden of human illness caused 
by environmental influences [10].  NIEHS defines endocrine disruptors as “naturally occurring 
compounds or man-made chemicals that may interfere with the production or activity of 
hormones of the endocrine system leading to adverse health effects” [11].  These chemicals can 
be found in many common household products that are used regularly, such as plastic bottles, 
detergents, food packaging, hygiene products and others [11, 12].  Research has proven that 
exogenous chemicals can alter the endocrine system in multiple ways: (1) chemicals can adhere 
to sites where natural hormones are expected to react, thus mimicking their effects and causing 
over stimulation of the hormone receptors with false messages;  (2) chemicals compete with the 
endogenous hormones by blocking receptor sites and therefore prevent true signals from 
occurring; or (3) chemicals may breakdown natural hormones or prevent hormone synthesis [11, 
13].  Sometimes the effects of a chemical are understood, but the methods of disruption are not 
[11, 13].   
Several types of endocrine disruption can theoretically occur.  E strogenic chemicals, 
(termed ‘xenoestrogens’) cause the feminization of species, which has been demonstrated in 
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alligators from Florida lakes and fish from English rivers [5]. Xenoestrogens are also suspected 
to cause the proliferation of breast cancer cells [14].  T he most strongly suspected estrogenic 
chemicals are the natural steroids 17B-estradiol (E2) and estrone (E1), and the synthetic active 
ingredient for contraceptive pharmaceuticals, ethinyl estradiol (EE2) [5].  Androgenic chemicals, 
in turn would masculinize species, which has been seen in fish downstream of paper and pulp 
mill effluents. The causative chemical has yet to be determined [5].  A known androgenic 
chemical that is suspected of having environmental consequences is 17B-trenbolone (TB), which 
is a metabolite of a growth steroid given to cattle [5].  It is theorized that chemicals may contain 
anti-estrogenic and/or anti-androgenic effects, and it is likely that there are chemicals which may 
have adverse effects on progesterone and/or the various thyroid hormones as well [5].  A specific 
concern is that possible EDCs may have additive effects when present together.  Eight weak 
estrogenic chemicals were tested for additive effects at levels below all individual No Observed 
Effect Concentrations (NOECs) and it was concluded that there is a definitive additive estrogenic 
effect [15].  This poses a problem for studying individual EDCs as they are rarely present in the 
environment in such discrete manners. 
The International Union of Pure and Applied Chemistry (IUPAC) is an international 
scientific committee dedicated to the study of global issues involving chemical sciences [16].  In 
2003, they published a Special Topic Issue in their journal on t he implications of endocrine 
active substances in humans and wildlife [17].  This special topic was a compilation of current 
research performed on e ndocrine active substances.  T he IUPAC developed some guidelines, 
such as the use of fish in endocrine disruptor research.  They suggest using a full life-cycle test 
of fish for locations with a constant discharge of estrogenic chemicals, a fish partial life-cycle 
development/reproductive test when studying non-bioaccumulative pesticides, and short-term 
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assays for rapid screening of potential endocrine activity [18]. When screening for endocrine 
activity, three vital biomarker endpoints should be used: vitellogenin, gonado-somatic index 
(GSI) and gonad histopathology.  B ecause it is well known that early life-stages in fish are 
sensitive to endocrine active substances, developmental tests, such as the Medaka developmental 
test, are useful.  T he Medaka developmental test is utilized by exposing fish, in prelarva to 
hatchling stages, to a suspected endocrine active substance, and monitoring the sex 
characteristics that develop.  I n this sex-reversal test, the natural sex-linked colors will not 
change, but the gonad histology and sexual characteristics can change when endocrine disruption 
is present [18].  Full life-cycle tests involve exposing newly fertilized embryos to a ch emical 
until they reach adulthood, and breeding randomly selected pairs. The outcomes of spawning 
frequency, number of eggs produced, current generation fertility, viability of embryos, hatching 
success and growth/development of the second generation are all monitored [18].   
Endocrine disruption research has some very critical problems.  There are three main 
concerns about endocrine disruptors in the environment: very low doses can have profound 
effects on exposed species; mixtures of chemicals can have additive, synergistic or antagonistic 
effects; and health effects can be dependent upon the timing of exposure relative to the life cycle 
of a particular species (i.e. exposure at certain phases of growth and development may be more 
important than the amount of exposure) [13].  EDCs do not  follow conventional scientific 
paradigms and do not follow conventional dose-response curves [13].  Dose-response curves for 
EDCs tend to yield results at extremely low doses and exhibit different behaviors over dose 
ranges, sometimes causing U-shaped or upside-down U-shaped dose response curves.  Therefore, 
traditional linear dose response curves are not satisfactory prediction models.  The mechanisms 
causing this are still unknown, but it is theorized that they are influenced by contrasting forces 
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acting concurrently within the biological system.  T herefore, high dose studies cannot be fair 
predictors of the occurrence of health effects from low dose exposures and vice versa.  N on-
monotonic dose response curves are a fairly recent concept and many research study designs do 
not plan for such occurrences [13].  Embryos and fetuses tend to be extremely sensitive to EDCs, 
while adults are typically not.  This challenges the concept of high dose animal studies being 
relevant to human exposure predictions. Human studies are more difficult to use for determining 
the effects of potential endocrine disruptors for a few reasons.  There cannot be a true control 
group because the general population is already exposed to the chemical and conducting 
controlled endocrine disruption experiments on humans is unethical. Finally, it is also difficult to 
determine a cau sal relationship between a ch emical and its potential effect because of the 
inevitability of confounding factors.  Many chemicals are suspected of being EDCs. Few have 
been proven as such, and many have never been tested for their potential to disrupt the endocrine 
system. 
Although advances have been made in the areas of endocrine disruption and its potential 
human health consequences, more research is needed to understand the intricacies of this field.  
Complicated research due to the ever increasing market for new chemical products, 
sophistication of the endocrine system itself and the likelihood for confounding factors, e.g. 
natural hormones and additive/synergistic effects, make advancement in this field challenging. 
1.3 WASTE WATER TREATMENT PLANTS 
Wastewater Treatment Plants (WWTPs) are a centralized way to remove household sewage and 
liquid wastes from communities.  T he use of a sewage collection system brings wastes to the 
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influent of the WWTP, where waste is then processed with intentions to separate harmful 
contaminants from the water in order to recycle the water back to receiving surface waters.  
Initial sewage collection systems were intended to remove rainwater from communities to 
prevent flooding.  Later, the idea of household waste removal was developed and homes were 
tied in to this existing system.  The mixture of water and sewage is called a combined sewer.  
The Greater Pittsburgh Area has problems with combined sewer overflow because these systems 
were historically combined [9].  As the population increased, most combined sewer systems 
were overburdened, causing CSOs to dump excess water directly to the receiving surface waters 
in times of high flow (i.e. during rainfall), resulting in large quantities of chemical pollutants and 
biological pathogens to enter our environment without the benefit of treatment.  In newer 
communities, sanitary sewer systems were developed to prevent the mixing of wastes with 
rainwater.  These areas have less potential to overflow pollutants into the environment, but still 
have the design capacity for SSOs to dump into surface waters during high flow events in order 
to prevent sewage line backups. 
When wastewater actually reaches the WWTP, the pollutant potencies are drastically 
reduced.  T his is done though use of preliminary, primary, secondary and tertiary treatment 
processes [19].  Preliminary treatment employs the use of screens to remove coarse solids and 
floating objects from the influent.  S ometimes a comminutor, a machine that grinds solids, is 
used to shred heavy material that may make it in to the WWTP influent.  P rimary treatment 
involves the influent entering a grit chamber where sand and small stones may be allowed to 
settle to the bottom for removal to a landfill to prevent damage to the WWTP equipment.  
Wastewater then flows to a sedimentation tank which slows the flow rate to allow for organic 
and inorganic suspended solids to settle out and form primary sludge.  P rimary sludge will be 
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removed from the system.  S econdary treatment employs the use of biological treatment 
processes to remove up to 90% of organic matter, using either attached growth processes 
(microbiological growth occurs on a surface which the wastewater runs across) or suspended 
growth processes (microbiological growth is suspended in an aerated tank) in WWTPs, usually 
followed by a secondary clarifier settling tank. Another type of secondary treatment utilized 
might be a lagoon, which works similarly to the microbiological growth processes but in a more 
natural manner.  Finally, the tertiary treatment process step disinfects the water to make it safe 
for reuse by using chlorine, ozone, and/or ultraviolet radiation.  Land Treatment (irrigating of 
crops with wastewater and allowing the soil to filter the sludge) and Constructed Wetlands are 
alternative methods to mechanical WWTPs [19]. 
Problems with current wastewater processing are numerous.  These include, but are not 
limited to, the age of WWTP systems in use, the cost of replacing municipal WWTPs with newer 
models, the vast amounts of chemicals in household wastes and their individual properties for 
removal concerns, the increasing amount of waste caused by population growth, farm runoff and 
urban wastes that are not all collected by WWTPs, and the use of non-centralized septic systems 
[19].  
While WWTP processes have developed over the last few decades, from primarily 
removing Biological Oxygen Demand (BOD) to current models for enhanced biological 
phosphorous removal, there is still much lacking in the ability to remove chemicals [20]. Any 
decomposition usually occurs as a first-order reaction [20].  However, the fate and transport of 
metabolites is of major relevance in the study of EDCs.  Just because a chemical is broken down 
by bacteria does not guarantee that the metabolite becomes less potent; it may continue to have 
endocrine disrupting effects. 
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Some better methods of decomposition are available for use, but require a cost-benefit 
analysis. Although it is known that longer retention times help bacteria to develop methods to 
metabolize new chemicals, neither the United States nor the European Union operate with 
retention times long enough to satisfy this efficient decomposition.  T he solution would be to 
upgrade plants to allow for an increased retention time and therefore a longer sludge age of at 
least 12-15 days [20].  When WWTP effluents with little or no surface water dilution are to be 
used for irrigation purposes, ozonation should be considered.  When only 5-10 g/m3 of ozone are 
used, pharmaceutical concentrations can be reduced to below detectable limits, and the cost is 
minimal [20]. However, the required kilo-watt hours required for the WWTP process are 
significantly increased, leading to diminished cost-effectiveness, and the byproducts of ozonation 
have not been thoroughly investigated [20].  Two other expensive options for cleanup of 
effluents are nanofiltration and activated carbon adsorption. 
Some methods of prevention may be useful to stop chemicals from entering the WWTP 
processes.  They are, however, difficult to implement and will required much political support, 
encouragement and funding.  The use of separate WWTPs for high pharmaceutical loads, such as 
hospitals and/or residential treatment facilities, would reduce public loading and could be 
specialized to meet the specific chemical demand rather than using expensive treatment 
processes on all water [20]. Discussion of environmental risks and labeling personal care 
products and pharmaceuticals packaging would help doctors and consumers to pick a more 
environmentally friendly product [20].  Special methods of disposal for products with 
environmental risks could be developed to keep dangers out of our water supply.   F inally, a 
separate waste system for urine would contain the chemical load [20]. 
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There are many things known about the transport and fate of generic environmental 
agents as they undergo the WWTP process.  Personal care products tend to adsorb onto sludge 
and sediments because of their elevated lipophilicity [20].  As sludge age increases, biological 
decomposition becomes more effective most likely because slow growing bacteria have time to 
develop adequate numbers and/or diversified metabolism is developed to make use of new 
energy sources [20]. 
WWTPs are able to reduce the estrogenicity and androgenicity of human sewage.  
Estrogenicity of WWTP effluents has been proven by multiple methods, both in vivo and in 
vitro, using endpoints of induced vitellogenin (an egg yolk precursor protein found in female 
fish) production and shifted sex ratios of offspring [21].  In general, as wastewater moves 
through the sewage treatment process, estrogenic and androgenic activity decreases [22].  Plants 
with secondary and tertiary treatments tend to lower androgenic chemicals better than estrogenic 
compounds [23].  A test for androgenic potential was performed on the inlet water and outlet 
effluents of a WWTP in India.  By performing the Hershberger assay, Kumar et. al. showed that 
outlet WWTP effluents, as well as the untreated influents, contained androgenic properties [24].  
By using High Performance Liquid Chromatography (HPLC), twenty chemicals were found in 
the influent waters, and only five of the chemicals were found intact in the outlet samples [24]. 
Through Gas Chromatography-Mass Spectrometry methods (GC-MS), the effluent was found to 
contain four known androgenic compounds that were not removed by normal wastewater 
processing: nonylphenol, hexachlorobenzene, and two testosterone equivalents,  isoandrosterone 
and dehydroepiandrosterone [24].  In a study of five WWTP designs in the United Kingdom, 
overall estrogenic activity was removed between 70 - 100% and androgenic activity was 
removed between 93 - 100% in 4 out  of the 5 de signs [22].  M ost of the estrogenic and 
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androgenic activity was removed during biological/secondary treatment processes [22].  Of the 
secondary treatment types available, aerated sludge secondary treatment was more effective at 
removing estrogenic activity than slag or plastic filtration [22].   
1.4 RESEARCH REVIEW FOR BISPHENOL A (BPA) 
1.4.1 Chemical Properties 
Bisphenol A (BPA) or 4',4'-dihydroxy-2,2-diphenylpropane (CAS no. 8 0-05-7) is an organic 
compound containing two phenol functional groups.  BPA has been classified as a suspected 
endocrine disruptor [12, 25].  Figure 1, Chemical Structure of Bisphenol A, shows its chemical 
structure.  Table 1, Chemical Properties of Bisphenol A, lists known chemical properties of BPA.   
 
 
Figure 1. Chemical Structure of Bisphenol A 
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Table 1. Chemical Properties of Bisphenol A 
Chemical Information  Value 
CAS no. [26, 27] 80-05-7 
Molecular Formula [26, 27] C15H16O2 
Molecular Weight [26, 27] 228.29 
Melting Point in deg C [26] 158 – 159 
Solubility @ 20-25 deg C [27] 1000 mg/L 
Vapor Pressure @ 20-25 deg C [27] 7.25e-7 mmHg 
Henry’s Law Constant @ 25 deg C [27] 2.18e-10 
Sorption Coefficient Koc [27] 2.74  
Octanol-Water Partition Coefficient [26, 27] 3.32 
Diffusion Coefficient in air [27] 0.05 cm2/s 
Diffusion Coefficient in water [27] 5.89 cm2/s 
Oral Reference Dose [27] 0.05 mg/kg/day 
Inhalation Reference Concentration [27] 0.08 mg/m3 
Dermal Adsorption Fraction [27] 0.1 
Gastrointestinal Adsorption Fraction [27] 0.5 
 
 
1.4.2 Transportation and Fate of BPA in the Environment  
BPA is used in polycarbonate plastics and epoxy resins for food packaging, plastic baby bottles, 
dental fillings, and in many other household products.  BPA is known to enter the human body 
through oral exposure.  It is partially excreted through human urine as free BPA and a conjugate 
form from liver enzymes [28].  BPA enters the environment from human urine and improperly 
disposed garbage when it leaches from plastics as they degrade.  BPA may be processed by 
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WWTPs with a documented 73-93% removal efficiency [29].  It may also be directly deposited 
into the surface water system through untreated CSOs and SSOs or into groundwater from septic 
tank leachate. 
The transport and fate of BPA in the environment has been studied to a great extent.  The 
matrix in which BPA is studied can have a profound influence on the research results.  BPA acts 
differently in deionized water compared to tertiary treated wastewater when exposed to hydroxyl 
radicals [30].  BPA exhibits a half-life of 3-5 days in river water and up to 30 days in seawater 
[31, 32].  BPA has a sediment adsorption coefficient (Koc) of 1524, indicating that concentrations 
of BPA will be adsorbed onto sediments in concentrations higher than that of surface waters 
[33].  T his adsorption is affected by many variables:  a dsorption to sediment is increased in 
higher salinity waters from decreasing solubility of BPA, competition with Dissolved Organic 
Matter results in a decrease to the amount of BPA adsorbed, and sediment conditions like 
temperature and pH can affect adsorption [33].  Li et. al. came to three conclusions: (1) 
manganese oxides can inhibit the adsorption of BPA onto sediment media in surface waters, (2) 
iron oxides and organic materials can encourage binding of BPA to sediments and (3) natural 
surface coatings samples contribute more to the pollution levels of surface waters than surficial 
sediments [34].  BPA has an Octanol-Water Partition Coefficient (Kow) of 3.32, indicating that 
its lipophilicity will allow it to bioconcentrate in fatty tissues [33].  Fish bioconcentrate BPA via 
oral and gill exposure routes and have the potential to cause the bioaccumulation of BPA 
throughout the food chain.   
Methods to remove BPA from the environment are being researched. BPA is broken 
down by photolysis according to the first-order reaction model and the use of diatomite-TiO2 
composites rather than pure TiO2 powders seems to encourage this process [35].  P an et. al. 
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discovered that carbon nanomaterials adsorb large amounts of BPA quickly and retain BPA due 
to a strong affinity.  B PA pollution could be greatly altered in the presence of carbon 
nanomaterials and therefore this may be used as an environmental or WWTP clean-up method in 
the future [36]. 
1.4.3 Exposure to Bisphenol A  
BPA is a large environmental contributor because of its high volume of production (over 6 
billion pounds produced yearly and over 100 tons released into the atmosphere by yearly 
production) [13].  It is used extensively in the production of polycarbonate plastics, for canning 
and bottling industries.  This allows for oral exposure through food and drink consumption.  
Plastic has become one of the fastest growing environmental waste concerns in the United States.  
BPA is a chemical used in the production of polycarbonate plastic and will leach out of the 
plastic after continued use, repeated washings, exposure to high temperatures and contact with 
acidic/basic substances [25]. 
BPA has been thoroughly studied in surface water systems across the world.  BPA has 
been detected in Taiwan surface waters at ranges between 0.037 µg/L (limit of detection) to 4.23 
µg/L in 59% of samples tested [37].  Surface waters analyzed in Spain and other Mediterranean 
areas discovered BPA in the µg/L range for all samples collected.  United States waters ranged 
between <1.0 to 8.0 µg/L for BPA concentrations [38, 39].  BPA in Germany waters ranged from 
0.0005 to 0.776 µg/L [39-44]. In Japan, levels varied from <0.005 to 1.9 µg/L [39, 45-50]. In 
China, BPA levels ranged from 0.03 to 0.083 µg/L and in the Netherlands, concentrations were 
found to be between <0.012 and 1 µg/L [39, 51-53]. 
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Waterworks treatment methods for preparing public drinking water, using sand, ozone, 
and carbon filtrations, did reduce concentrations of BPA dramatically, but not completely [54].  
BPA was also found in groundwater samples at low µg/L ranges, suggesting that degradation is 
slow in groundwater media [54].  B PA was detected in 51% of surface waters sampled in 
Portugal with analytical methods using solid phase extraction and Gas-Chromatography-Mass 
Spectrometry (GC-MS) in the range of 0.07- 4.0 µg/L [55].  B PA was detected in sewage 
treatment plant influents and effluents in the United Kingdom and Spain, with ranges of 884.7-
1105.2 ng/L and 13.3-19.2 ng/L, respectively [56].  In Germany, WWTP effluents have BPA 
concentrations in the 18-33 ng/L ranges, and a surface water sample from the Czech Republic 
was 28 ng/L [57].  There has recently been new evidence published that previous aquatic hazard 
assessments of BPA may not be sufficiently conservative for all species [39].  A new weight of 
evidence approach was used to calculate a Predicted No Effect Concentration (PNEC) by 
nonparametric methods, and it determined that aquatic effects on mortality, growth, development 
and reproduction can occur between the concentrations of 0.0483 µg/L and 2280 µg/L with a 
PNEC of 0.06 µg/L [39].  Much of the published literature on BPA surface water concentrations 
exceeds this PNEC [37, 39, 55]. 
 BPA has been detected in indoor and outdoor air samples, dusts and soils [13].  Many 
EDCs have been detected in indoor air and house dust.  A study performed in the United States 
found 89 i dentified EDCs in 120 sampled homes, with chemicals from various classes of 
plasticizers, emulsifiers, disinfectants, adhesives, pesticides, personal care products and flame 
retardants [58].  From the samples, BPA was found above detection limits in 86% of the dust 
samples, ranging from below detectable limits to a maximum of 17.6 µg/g [58].   
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BPA has also been previously quantified in food products [13].  Milk samples purchased 
from markets in China had BPA concentrations in the range of 0.45-0.94 µg/L or approximately 
0.41-0.85 x10-3 mg/kg relative to milk density, which is well below the European Union’s legal 
limit of 0.6 mg/kg [59].  Market seafood from Singapore was tested for concentrations of BPA.  
Basheer et. al. found BPA in prawn, crab, blood cockle, white clam, squid and fish in the range 
of 13.3 – 213.1 ng/g w/w, with the highest concentration found in crab and the lowest in the 
white clam [60].  The daily human oral intake of BPA has been estimated at less than 1 µg/kg 
bw/day [31].  E stimated oral exposure of children is in the range of 52-74 ng/kg bw/day and 
inhalation exposure at 0.24-0.41 ng/kg bw/day [61].   
1.4.4 Analytical Methods 
Analytical methods to determine the concentrations of BPA are available for many different 
matrixes.  Table 2, Analytical Methods for Bisphenol A, provides a list of these matrixes and 
also describes the associated detection limits.  HPLC with dansyl chloride derivatization has 
been successfully used to analyze for 4-nonylphenol and BPA in a sewage sludge matrix.  Figure 
2, Chemical Structure of 5-(Dimethylamino)naphthalene-1-Sulphonyl Chloride (Dansyl 
Chloride), shows the chemical structure of dansyl chloride.  Dansyl chloride derivatization 
enhances the specificity of the determination of xenoestrogens because dansyl chloride easily 
reacts with phenolic hydroxyl and amino groups, which tend to be present in most suspected 
endocrine disrupting chemicals.  Interference from other compounds decreases when detection is 
specified for the dansyl derivatives [62].  Derivatization with dansyl chloride has been used in 
the past with liquid chromatography methods to allow for greater sensitivity and selectivity of  
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Figure 2. Chemical Structure of 5-(Dimethylamino)naphthalene-1-Sulphonyl Chloride (Dansyl Chloride) 
 
 
Table 2. Analytical Methods for Bisphenol A 
Matrix Method Detection 
Limits 
Reference 
Water C18 solid phase extraction and LC-MS 0.1 ng/L Pedersen, et. el. 1999 [63] 
Water Solid phase extraction with bamboo 
charcoal followed by HPLC 
0.17-0.37 µg/L Zhao, et. al. 2009 [64] 
Surface water Solid phase microextraction using OASIS 
cartridges followed by  GC-MS 
0.002 µg/L Azevedo, et. al. 2001 [55] 
Surface Water Solid and/or liquid phase extraction and 
derivatization with N-methyl-N-(tert.-
butyldimethyltrifluoroacetamide followed 
by  GC-MS 
4-6 ng/L Mol, et. al. 2000 [65] 
River water/Wine Solid phase extraction with cryogel 
followed by HPLC 
10 ng/L Baggiani, et. al. 2010 [66] 
Water/Milk Solid phase extraction using magnetic 
molecularly imprinted polymer  followed 
by HPLC and UV detection 
Water = 14 ng/L 
Milk = 0.16 µg/L 
Ji, et. al. 2009 [59] 
Urine (humans) Online solid phase extraction for HPLC-
MS/MS 
0.4 ng/mL Ye, et. al. 2007[28] 
Sewage sludge Derivatization with dansyl chloride 
followed by HPLC 
0.1 ng Naassner, et. al 2002 [62] 
Fish bile Enzymatic hydrolysis  and solid phase 
extraction using OASIS HLB cartridges 
followed by GC-MS/MS 
0.1-0.7 ng/mL Fenlon, et. al. 2010 [67] 
Fish tissue 
(liver and muscle) 
Microwave-assisted solvent extraction and 
solid phase extraction LC-MS 
50 ng/g Pedersen, et. el. 1999 [63] 
Dust Extraction and GC-MS 0.2 µg/g Rudel, et. al. 2003 [58] 
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alkylphenols [68].  O ther methods of derivatization are also available with gas or liquid 
chromatography [56, 65].   
New methods to increase the efficiency and decrease the expense for performing solid 
phase extraction on environmental water samples are being developed, specifically to study the 
use of bamboo charcoal or molecularly imprinted polymer/cryogel composites for the extractant, 
both of which tend to yield promising results [64, 66].  T he main drawbacks to currently 
available solid phase extraction cartridges is the low selectivity of the retention mechanism and 
the high likelihood for clogging when extracting from large volumes and/or dirty samples [66]. 
Analytical methods for testing fish tissue have been available since the 1990s, however, 
they have mostly focused on t he edible tissues of fish, leaning towards a method to quantify 
exposure [63].  A method to test for bioconcentrated chemicals in fish bile was developed using 
solid phase extraction with gas-liquid chromatography-tandem mass spectrometry, however, the 
reference fish indicated laboratory contamination of BPA [67].  There is a need to further study 
the bioconcentration properties of BPA in fish and to develop methods for analyzing fish tissue. 
1.4.5 In Vitro Studies 
The effects of BPA have been studied in vitro.  BPA is known to bind to the Estrogen Receptor 
(ER) and has an affinity towards ERβ that is 10 times greater than its affinity for ERα [13].  It is 
also known to bind to the thyroid hormone receptor and the aryl hydrocarbon receptor (AhR), 
and exhibits antiandrogenic properties [13].  Although BPA is approximately 10,000 t imes 
weaker than estradiol at exhibiting estrogenic effects, there is a great cause for concern to 
determine its other endocrine disrupting abilities [13].  BPA is known to mimic estrogen at low 
doses [25].  At higher doses, BPA impedes the binding of testosterone and thyroid hormone to 
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their associated receptors.  Thus, BPA is classified as an endocrine disruptor [25].  BPA is also 
known to bind to persistent organic pollutants, such as dioxin and polychlorinated biphenyls 
(PCBs) causing longer exposures to BPA and increasing the environmental risk [25].  BPA tends 
to exhibit non-monotonic model dose response curves when studied over a wide range of doses 
[13].  Therefore, high dose studies cannot predict the occurrence of health effects at low doses 
and vice versa.  Non-monotonic dose response curves are a fairly recent concept and many 
research study designs do not plan for such occurrences [13].  Low nanomolar exposure 
(equivalent to environmental levels) to BPA can antagonize the cytotoxic effects of anticancer 
chemotherapy drugs in both ERα-positive and –negative breast cancer cells, therefore, 
implicating that BPA interacts through an unknown method unrelated to the estrogen receptors 
ERα and ERβ [69].  Brominated BPA analogues are agonists of both ERα and ERβ estrogen 
receptors and stimulate ER-mediated luciferase induction in vitro [70].  BPA exposure at doses 
as low as 10 µg/L after a four week exposure period caused gene expression of cloned amino 
acid sequences and significantly increased mRNA levels in the testes of Nile tilapias [71].  
Because of the massive influx of new chemicals available to the market every year, it is  
necessary to develop computer models to quickly screen chemicals for their endocrine disrupting 
potential.  A Quantitative Structure – Activity Relationship (QSAR) model for androgen receptor 
antagonism has been developed with a sensitivity of 64%, a specificity of 84%, and a 
concordance of 76% [72]. The model was tested satisfactorily with 176103 chemicals; 47% were 
within the domain of the model, and of them, 8% were predicted to be AR antagonists, while 
BPA tested negative [72].     
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1.4.6 In Vivo Studies 
Mammalian studies have shown that BPA has potential to cause many health effects.  Exposure 
in female mice during pregnancy by oral ingestion of spiked drinking water at concentrations of 
10 µg/mL caused allergic sensitization and bronchial inflammation in offspring [73].  Oral 
exposure of 2 and 20 µg/kg/day administered to pregnant mice in another study caused increases 
in prostate weight in male offspring [74].  BPA induced a significant uterotrophic response in 
prepubertal rats after oral exposure to doses of 200 m g/kg within three days. However, this 
response required doses 13,000 times higher than needed for ethinyl estradiol to induce the same 
response [75].  There are reports that BPA can advance the onset of puberty in female mice at 
doses as low as 2.4 µg/kg/day, although it is believed that differences in endogenous hormone 
levels from intrauterine positions, which may influence sensitivity to exogenous hormones, may 
have also affected the results [13, 76].  Subcutaneous injections of 5-10 mg/kg/day of BPA in the 
days following birth altered plasma levels of prolactin, a hormone involved in the regulation of 
lactation, and developmental patterns of prolactin in both male and female rats [77].  M eiotic 
aneuploidy, a condition that occurs during cell division in the egg causing daughter cells to 
receive the wrong number of chromosomes, has been proven to occur in female mice after 
exposure to BPA in environmental doses as low as 0.02-0.04 mg/kg/day [78].  Recent research 
on rats has proven that maternal exposure to BPA during lactation can cause decreased time to 
tumor latency and an increased amount of dimethylbenzanthracene-induced mammary tumors in 
female offspring [79].  BPA is known to cause molecular and morphological alterations in the 
uterus and vagina of rats in the microgram levels of exposure [80].  Low level exposure to BPA 
can bind to and activate the androgen receptor causing increased proliferation and tumor growth 
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in the presence of anti-cancer drug therapies when studying prostate cancer in vivo [81].  This 
indicates a very likely concern that certain groups, such as prostate cancer patients, might be 
significantly more susceptible to health effects from exposure to BPA, and impacts to sensitive 
groups need to be studied thoroughly.   
Non-mammalian species are also susceptible to affects from BPA exposure.  Insects are 
just one of these groups.  R ankin and Grosjean found that when the ring-legged earwig is 
exposed by injection to 0.12 µg, the following significant effects occurred: males experience 
reduced weight gain, increased testis and increased seminal vesicle size; and females experience 
enhanced clutch size.  However, higher doses did not always produce a dose-response effect, 
implying that there is a biological method to degrade BPA when detected by the body [82].  BPA 
displays genotoxic effects by causing DNA strand breaks after exposure to 0.3-30 µg/L for 
freshwater crustaceans and 5-500 µg/L for aquatic midge [83].  Male isopods exposed to soil 
concentrations of BPA of 10-1000 mg/kg soil for 10 weeks had a earlier molting period.  
Exposed juveniles experienced an altered sex ratio of one male per two females, while an equal 
gender distribution was observed in the controls [84].  BPA in the nanogram per liter ranges can 
cause superfeminization of freshwater snails, a condition characterized by the formation of 
excess female organs leading to increased female mortality.  This in known to occur through the 
estrogen receptor, due to observed antagonism in experiments involving tamoxifen [85].  In vivo 
studies on turbot blood showed a 6.7-fold increase of micronuclei after exposure to 50 ppb of  
BPA, indicating the potential for genotoxic effects [86]. 
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1.4.7 Human Studies 
Korean studies on breast cancer have not shown a significant risk from BPA exposure measured 
through blood serum levels.  BPA, however, was detected in the blood serum levels in 50.8% of 
the subjects, at concentrations ranging from 0-13.87 µg/L [87].   H uman exposure has been 
quantified through blood serum levels of up to 20 ng/mL of serum [13].  BPA has been found to 
cross the maternal-fetal placental barrier [13]. Human exposure has also been quantified by 
detection in urine [13].  Ye et. al. tested urinary concentrations of 15 male and female volunteers 
with no doc umented occupational exposure to BPA and found positive results for BPA in all 
samples [28].  Concentrations were detected with a mean of 2.4 ng/mL, with a detection limit of 
0.4 ng/mL.  Acute oral exposure studies performed on human adults have shown that BPA levels 
in urine exhibit a half-life of approximately five hours in the body [88-90].  With this evidence, 
and the generally accepted assumption that most exposure to BPA is through the oral route 
primarily from food intake, it would be expected that BPA levels in a population would be 
inversely related to fasting times.  Analysis of urinary data collected from the National Health 
and Nutrition Examination Survey (NHANES) showed that (1) the relationship between fasting 
time and BPA urine concentrations was weak, suggesting that the biological half-life determined 
from the above mentioned acute exposure studies is wrong; (2) accumulation of BPA in bodily 
tissues releases BPA slowly; (3) there is substantial chronic exposure to BPA that is not currently 
being addressed by the research; or (4) some combination of the three [91].  Another study using 
NHANES data documented positive associations between urinary concentrations of BPA and the 
prevalence of diabetes, heart disease and liver toxicity. However, it cannot be determined that the 
relationship is causal [13, 92].  Other studies have also associated BPA blood levels with obesity, 
endometrial hyperplasia, recurrent miscarriages, sterility and polycystic ovarian syndrome [13].  
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An occupational cohort study performed in China among workers in factories which manufacture 
BPA and epoxy resins observed a higher risk of self-reported sexual dysfunction than in 
unexposed workers.  Exposed works noted significant changes in reduced sexual desire, erectile 
difficulty, ejaculation difficulty and reduced satisfaction with sex life after only one year of 
occupational exposure [93].   
Premature infants in neonatal intensive care units are exposed to BPA.  A  study by 
Calafat et. al. shows levels of conjugated BPA in the infants’ urine ranging from 1.6 – 946 µg/L, 
proving that infants have at least some capacity to metabolize the chemical and thereby refuting 
any claims to contaminated samples or analyses.  BPA exposure was associated with the specific 
hospital location, but not the length of stay, method of feeding (i.e. breast-feed versus formula) 
or gender.  Urinary concentrations were higher for lower gestational ages than for older infants 
[94]. 
1.4.8 Regulatory Actions 
Although BPA is a hot topic for debate among regulatory agencies, little action has yet to be 
taken to remove BPA from the market.  The maximum tolerated dose of BPA was determined to 
be 1000 mg/kg bw/day and the EPA calculated reference dose is 50 µg/kg/day.  A No-Observed-
Adverse-Effect-Level (NOAEL) has yet to be found because adverse responses have always 
been detected in even the lowest administered doses [13].  In 2008, t he National Toxicology 
Program reported a subpanel critique of the data available on BPA exposure and potential low-
dose health effects.  They concluded that there is credible evidence available to show that low 
doses of BPA  can  cause specific effects, but that these effects have not been established as 
reproducible findings [95].  In the United States, though, most product withdraws have been 
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market driven, meaning that companies have voluntarily phased out BPA containing products in 
order to promote positive customer relations [96].  S ome local and state governments have 
started to propose regulations and enforce them, but as of yet, nothing has been legislated on a 
federal government level.  Canadian government officials have chosen to withdraw products 
containing BPA from their market.  Prior to this decision, the Canadian governments respected 
limits for BPA of 0.1 mg/L for drinking water resulting from contact with BPA containing 
packaging [97].  A Provisional Tolerable Daily Uptake (PTDU) for BPA from food was 
established to be 25 µg/kg bw/day [97].  T he European Scientific Committee on F ood set its 
tolerable daily intake to 50 µg/kg bw/day in 2006 and exposure to BPA from migration out of 
food packaging was set at 0.6 mg/kg [97].  
1.4.9 Problems with Research on BPA 
Problems researching BPA vary greatly.  The mechanism(s) for low dose effects from BPA is 
unknown.  BPA has been referred to as a weak environmental estrogen, but it ma y still be a 
strong endocrine disruptor through another endocrine mechanism (i.e. thyroid hormone 
receptors) [13].  In vitro research methods do not account for the way a chemical reacts in a true 
biological system or at altered developmental stages. Furthermore, the same chemical can have 
different effects in different cell types or different organ tissues.   In vivo research methods are 
complicated and it is unknown if animal mechanisms will be adequate to predict human health 
effects.  W ith endocrine disruptor research, there will always be confounding factors, such as 
exposure to other environmental chemicals which may or may not be endocrine disruptors 
themselves or exposure to natural and endogenous hormones.  Problems arise when dealing with 
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concerns for sensitive populations, such as prostate cancer patients, because BPA has been 
suggested through in vivo studies to alter the effects of anti-cancer drugs [81]. 
BPA is still considered safe for use at the current human exposure levels despite the 
substantial amount of research literature which concludes otherwise.  T he United States 
regulatory agencies involved in the decision to keep BPA in market products made the judgment 
based on a  few industry-funded research studies employing Good Laboratory Practices (GLP).  
GLP is the government mandated method of research to ensure commercial industry does not 
falsify data for monetary benefit [98].  N on-industry funded researchers, some from National 
Institutes of Health (NIH) funded studies, rallied together to document their opposition to the 
lack of government regulation of BPA, stating that studies employing GLP are not necessarily 
superior to other research and GLP does not guarantee the use of appropriate protocols or the use 
of the most current and sensitive assays [98]. 
1.5 RESEARCH REVIEW FOR PARABENS 
1.5.1 Chemical Properties 
After initial introduction of their IUPAC names in the following figures, all parabens will be 
referred to in this document by their common names.  Figure 3, Chemical Structure of Methyl 4-
Hydroxybenzoate (Methyl Paraben), shows the chemical structure of methyl paraben.  Figure 4, 
Chemical Structure of Ethyl 4-Hydroxybenzoate (Ethyl Paraben), Figure 5, Chemical Structure 
of Propyl 4-Hydroxybenzoate (Propyl Paraben), and Figure 6, Chemical Structure of Butyl 4-
Hydroxybenzoate (Butyl Paraben), show the chemical structures of ethyl, propyl and butyl 
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paraben, respectively.  Figure 7, Chemical Structure of 4-Hydroxybenzoic Acid, shows the 
chemical structure of 4-hydroxybenzoic acid.  Table 3, Chemical Properties of Various Parabens, 
shows chemical properties of methyl, ethyl, propyl and butyl paraben, as well as 4-
hydroxybenzoic acid. 
 
 
 
 
Figure 3. Chemical Structure of Methyl 4-Hydroxybenzoate (Methyl Paraben) 
 
 
 
 
Figure 4. Chemical Structure of Ethyl 4-Hydroxybenzoate (Ethyl Paraben) 
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Figure 5. Chemical Structure of Propyl 4-Hydroxybenzoate (Propyl Paraben) 
 
 
 
Figure 6. Chemical Structure of Butyl 4-Hydroxybenzoate (Butyl Paraben) 
 
 
 
Figure 7. Chemical Structure of 4-Hydroxybenzoic Acid 
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Table 3. Chemical Properties of Various Parabens 
Chemical 
Information 
Methyl 
Paraben 
Ethyl 
Paraben 
Propyl 
Paraben 
Butyl 
Paraben 
4-
Hydroxybenzoic 
Acid 
CAS no. [99-103] 99-76-3 120-47-8 94-13-3 94-26-8 99-96-7 
Molecular Formula 
[99-103] 
 
C8H8O3 C9H10O3 C10H12O3 C11H14O3 C7H6O3 
Molecular Weight 
[104] 152.15 
 
166.17 
 
180.20 
 
194.23 
 
138.12 
 
pKa [105] 8.87 8.90 8.87 8.79  
Solubility @ 25 deg 
C (g/100mL) [104] 
0.25 
 
0.17 
 
0.05 
 
0.02 
 
0.6 
 
Melting Point deg 
C [99-103] 125 - 128 114 – 117 95 – 98 67 - 70 213 - 217 
Vapor Pressure Pa 
@ 100 deg C [106]     3.9x10
-3 
Octanol-Water 
Partition 
Coefficient    [104, 
105, 107, 108] 
1.87 - 1.96 2.34 - 2.51 2.90 - 3.04 3.46 - 3.57 1.56 
Gibbs free energy 
∆Gsub (kJ/mol) 
[109] 
42.2 
 
43.4 
 
 
46.7 
 
 
45.0 
 
 
Sublimation 
Enthalpy 
∆Hsub(kJ/mol) [109] 
98.8 + 0.8 
 
100.9 + 0.7 
 
 
123.7 + 0.6 
 
 
108.4 + 0.8 
 
 
Entropy ∆Ssub 
(J/mol-K) [109] 
190 + 2 
 
192 + 2 
 
258 + 2 
 
212 + 3 
 
 
Entropy 
∆Sfus(J/mol-K) 
[109] 
63 + 2 
 
68 + 2 
 
74 + 2 
 
78 + 2 
 
 
Heat of Fusion 
∆Hfus(kJ/mol) [109] 
25.3 + 0.7 
26.4 + 0.8 
 
27.2 + 0.8 
 
26.6 + 0.8 
 
 
Heat of 
Vaporization 
∆Hvap(kJ/mol) [109] 
73.5 
74.5 
 
96.5 
 
81.8 
 
 
Oral LD50- mouse 
(mg/kg)  [99-102, 
106] 
>8000 3000 6332 13,200 2200 
NOAEL-rat 
(mg/kg/day) [106]     1000 
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1.5.2 Transportation and Fate of Parabens in the Environment 
Less is known about the transport and fate of parabens in the environment than BPA.  Although 
it is generally believed that parabens do not persist for long periods of time, this may not be true.  
Any potential endocrine disrupting effects will most likely come from direct exposure from 
market products containing parabens.  Wastewater treatment processes have been shown to 
adequately reduce paraben concentrations.  C anosa et. al. showed influent concentrations of 
methyl paraben in two sets of samples were reduced from 2.92 ng/mL  to less than detectable in 
the effluent [108].  Ethyl, propyl and butyl parabens were reduced to non-detectable as well, with 
benzyl paraben not being present in the influent [108].  With these removal efficiencies, it is not 
expected that parabens would be present in surface waters unless the body of water receives 
direct discharges of non-treated sewage water, which is a known problem in the Greater 
Pittsburgh Area  [9, 108]. 
1.5.3 Exposure to Parabens 
There is widespread exposure to parabens around the world.  Parabens are used as food 
preservatives because of their antifungal properties and are therefore present in the edible 
coatings used on produce to extend the shelf life of these agricultural products.  Parabens, 
however, only reduce the incidence and severity of citrus postharvest diseases caused by blue 
and green molds by less than 20%, with no synergistic effects noted for combinations of 
parabens [110, 111].  T he poor inhibitory activity is suspected to be caused by the chemical 
characteristics of the coating and/or the fruit itself, suggesting that not all preservatives will be 
effective or should be used universally [110].  This method of exposure may be unnecessary if 
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the intended benefit is not satisfactory.  While developing analytical methods, Zhang et. al. tested 
six food products: orange juice, soy sauce, pickle, strawberry jam, vinegar and soda.  Methyl and 
ethyl parabens were found only in the soy sauce, at concentrations of 2.7 µg/g and 2.5 µg/g, 
respectively [112].   
In Sweden, investigation of eleven paraben-containing compounds found the total 
paraben concentrations to be within the range of 0.43%-0.79% w/w for skin care products, 
0.07%-0.44% for hair products, and 0.30%-0.52% for soaps, with all products containing methyl 
paraben and about 90% containing propyl paraben [107].  Two hundred and fifteen different 
cosmetic products found on the Danish market in the 1990s were analyzed by HPLC for paraben 
content.  O f these, 93% were found to contain paraben(s), with a range of 0.01-0.59% w/w. 
Positive detection was found in 77% of rinse-off products, with a range of 0.01-0.50% w/w, and 
99% in leave-on products, with a range of 0.01-0.59% w/w.  O nly one sunscreen had a 
concentration of 0.87% w/w which is higher than the limit of 0.80% w/w for mixtures set by the 
European Economic Community (EEC) [113].   
Eriksson et. al. performed a substance flow analysis of parabens for Denmark based on 
data from 2004 [114].  Table 4, Summary of Eriksson’s Results, describes a summary of the 
product analysis performed in Denmark.  T otal inflow was approximately 154 t onnes of pure 
chemicals and 7.2-73 tonnes via various commodities which correspond to an average 
wastewater concentration of 640-900 µg/L when excluding biodegradation, metabolism and 
sinks.  Of personal care products on the Danish market, 272 out of 751 contained parabens 
(36%), with methyl and propyl parabens the most commonly used.  U sing the Households 
Products Database in the USA (over 6000 consumer brands) and the SkinDeep Personal Care  
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Table 4. Summary of Eriksson’s Results 
Commodity  
 
(Note: Reference 
[114] for the entire 
table) 
Concentrations 
found in Products 
Estimated 
Amounts on 
the Market 
Estimated Usage or 
Theoretical Consumption  
Annual Contribution in 
tonnes (unless otherwise 
noted) 
Personal Care 
Products 
0.024-0.8% 36% Hair Conditioner = 12-39 
Deodorant = 11-26 
Hand Soaps = 10-16 
Oral hygiene products = 5-14 
Shampoo = 0-10 
Skin care products = 1-6 
(g/person/week) 
4.0-132 (import) 
2.0-68 (export) 
0.16-5.2 (national 
consumption) 
Pet Care Products 0.1-0.2% 15%   
Pharmaceuticals 0.3-3.16 mg/g 3.2%  0.26-0.91 (2004) 
 
Herbal Medicines  4.9%   
Vitamins and 
Mineral 
Supplements 
n/a 0%   
Veterinary Medicine  0.1 – 2.6 mg/g 7.9%  0.109 (MP and PP for 
2005) 
Filled Chocolate 
Candies 
7.9-180 mg/kg  8.9%   Filled chocolates:    <0.1 – 
0.19 imported, <0.1-0.13 
exported, <0.1-0.18 for 
domestic industry usage 
 
Snacks, Nuts, and 
Candy 
300 mg/kg (max. 
allowable) 
Estimate 2% 4 g of snacks/day (adult) 
9 g of snacks/day (child) 
0.2 (imported 2004)  0.3 
(exported 2004) 
Meat Products 1000 mg/kg 
(max. allowable) 
Estimate 2%  0.095-0.74 kg  imported 
0.35-0.96 kg exported 
Soy Sauces 33.4-250 mg/L 26%  0.010-0.077 (imported 
2004) 
Food Supplements 2000 mg/kg 
(max. allowable) 
Estimate 2%  0.3 tonnes imported 
 0.1 tonnes exported  
0.2 national consumption  
 
Household Cleaners 0.2% singles; 0.7% 
mixture 
Estimate 11%  9-33 (imported 2004); 26-
92 (exported 2004); 9-32 
(natl’ production 2004)  
Spray Paints <0.1% 0.007% 150-170 tonnes/year <1.2 kg 
Water-based Paints 0.27-0.6% Estimate 2%  1 (import 2004) 
1.3 (export 2004) 
3.1 (internal consumption 
2004) 
Children’s toys (i.e. 
finger paint, 
modeling clay, and 
sticky toys) 
0.27%   0.3 
Artificial Blood 0.2% MP 500 units 
(2005) 
 <1kg 
Kitchen Rolls (made 
of virgin fibre) 
2.9-3.1 mg/kg PP 18% 13 kg/year per person 37-40 kg 
Industry    0.09-3.3  
 
 
 33 
Product Safety Guide (over 14835 products), it was found that methyl paraben was present in 
40% of personal care products, ethyl in 9%, propyl in 33%, butyl in 10%, and isobutyl in 10%.  
Personal care products containing parabens are considered to be stable for a period of 12 months 
after opened.  For pharmaceuticals, liquid solutions generally have a shorter shelf-life than 
tablets.  Digested pharmaceuticals are known to be excreted through human urine as either the 
paraben itself or the metabolite 4-hydroxybenzoic acid  [114].  Eriksson et. al. estimated that 
105-865 kg (digested waste from human urine), 44-104 kg (digested wastes from dog urine), and 
3.4 tonnes (from garbage containing residual paraben products) will end up i n solid waste.  
Using the assumptions that the daily consumption of water is 127 L/person with the estimated 
usage of 74% for grey wastewaters and 37% for personal hygiene, they also estimated 0.8-2.6 
tonnes from bathroom grey wastewater-wastewater without toilets and 3.7-5.4 tonnes from point 
source emissions from industry to enter the wastewater stream [114]. 
Other studies have analyzed cosmetic products in the ranges of 35-977 mg/kg for methyl 
paraben, 14-735 mg/kg for ethyl paraben, 41-209 mg/kg for propyl paraben, and 300-466 mg/kg 
for butyl paraben [115].  Claver et. al. tested cleaning mousse and cleaning towels when 
developing new analytical methods and found concentrations of parabens in the range of 0.14-
0.73 mg/g [105].  Wash-off cosmetic products were also tested and the results discovered Avon 
products with methyl paraben concentrations of approximately 1040 µg/g, Adidas products with 
propyl paraben at concentrations of 334 µg/g, and Clean & Clear products with methyl, ethyl, 
propyl and butyl parabens in the range of 114-317 µg/g  [112]. 
EDCs have been detected in indoor air and house dust.  A study performed in the United 
States found 89 i dentified EDCs in 120 s ampled homes, with chemicals from classes of 
plasticizers, emulsifiers, disinfectants, adhesives, pesticides, personal care products and flame 
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retardants [58].  From the samples, methyl, ethyl and butyl parabens were present, with methyl 
paraben being found above detection limits in 67% of the air samples and 90% of the dust 
samples [58].  
Cosmetic products get washed off and end up i n WWTPs.  In a Spanish test of three 
sewage sludge samples, methyl, propyl and benzyl parabens were found at concentrations 
between 5 and 202 µg/kg [116].  Due to the universal use of parabens in personal care products, 
especially those used for bathing, exposure is complicated by the development of by-products.  
Under experimental conditions, parabens will decay by pseudo-first-order-kinetics to one of two 
by-products (relative to each parent paraben compound) involving chlorination of the aromatic 
ring associated with a carbon in the ortho-positions relative to the hydroxyl group [117].  These 
Spanish researchers detected the formation of three new halogenated transformation products 
(for each parent paraben) when parabens were exposed to chlorinated tap water, making a total 
of five by-products for each parent paraben.  They were identified as bromo- and bromochloro-
parabens, because of the traces of bromine also found in tap water [117].  According to the study, 
this formation takes place within minutes, allowing dermal and possibly ingestion routes of 
exposure to be realistic while bathing.  Formation of brominated by-products occurred when 
bromine was present in the tap water in only minimal amounts.  This research group also found 
the presence of di-chlorinated forms of methyl and propyl parabens in raw sewage for the first 
time [117].  These by-products could be instrumental in the process of determining any dangers 
of using parabens, possibly more so that the endocrine disrupting potential of the parent parabens 
themselves. 
After being processed in WWTPs, parabens are not expected to be persistent in the 
environment, but are being found in detectable levels in surface water samples.  I n a 2009 
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Spanish study, methyl paraben was detected in tap and surface water at 0.040 ng/mL and 0.037 
ng/mL, respectively.  Ethyl, propyl, butyl and benzyl parabens were all below the limits of 
quantification or non-detectable [118].  In a 2010 study of the same area (Northwest Spain), all 
parabens were present in levels ranging from 0.8 – 105 ng/L, with methyl paraben at 54 ng/L, 
ethyl paraben at 29 ng/L, and derivations of propyl paraben as the high and low values [119].  
These two studies imply that there may be some seasonal effects on the transport and fate of this 
family of chemicals.  Methyl paraben is also being detected in Spanish tap water in 
concentrations of 17 ng/L [120]. 
1.5.4 Analytical Methods 
Some methods have been established to determine the concentrations of parabens in 
environmental matrices [121].  S urface water, WWTP influent and effluent, indoor air, and 
house dusts are the established analytical matrices for determination of methyl, ethyl, propyl, 
butyl and benzyl parabens [121].  D etection limits reported for GC/MS and LC/MS/MS are 
below 10 ng/L (ppt) [121]. Table 5, Summary of Analytical Methods for Parabens, provides a 
summary of analytical methods and the associated detection limits. 
1.5.5 In Vitro Studies 
Parabens have been studied extensively in vitro to determine their endocrine disrupting potential.  
It has been proposed that the mechanism for the estrogenicity of parabens is inhibition of 
sulfotransferase (SULT) activity [122].  Sulfotransferases are responsible for the metabolism of 
estrogen in the liver, skin and other organs.  By inhibiting the SULT function, estrogens are not 
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metabolized to their inactive forms, leading to prolonged exposure from chronic topical 
application of parabens [122].  Prusakiewicz et. al. discovered SULT activity of skin cytosol to 
be inhibited by parabens, with potency increasing by ester chain length.  The metabolite,  
 
Table 5. Summary of Analytical Methods for Parabens 
 
Matrix Analytes Method Detection 
Limits 
Reference 
Surface water; 
sewage influent and 
effluent 
 
MP, EP, PP, BuP, 
BzP 
Solid-phase 
microextraction fibre 
for GC-MS/MS 
0.001 – 0.025 ng/mL Canosa, et. al. 2006 
[108] 
Surface water; 
sewage influent and 
effluent 
MP, EP, PP, BzP Solid-phase 
extraction and ultra-
high performance 
liquid 
chromatography-
electrospray 
ionisation-tandem 
mass spectrometry 
1-5 ng/L Pedrouzo, et. al. 
2009 [123] 
Urine (humans) MP, EP, PP, n-BuP, 
iso-BuP,  BzP 
Online Solid-phase 
extraction for 
HPLC-isotope 
dilution tandem 
mass spectrometry 
0.2 ng/mL Ye, et. al. 2006 
[124] 
Sewage sludge MP, EP, PP, BzP Pressurized liquid 
extraction and ultra 
HPLC-tandem mass 
spectrometry 
8 µg/kg Nieto, et. al. 2009 
[116] 
Wash-off cosmetic 
products and food 
MP, EP, PP, BuP HPLC with 
chemiluminescence 
MP = 1.9e-9 g/mL 
EP = 2.7e-9 g/mL 
PP = 3.9e-9 g/mL 
BuP = 5.3e-9 g/mL 
Zhang, et. al. 2005 
[112] 
Cosmetic products MP, EP, PP, BuP Supercritical fluid 
extraction with LC-
MS 
MP = 4.7 ng/g 
EP = 13.5 ng/g 
PP = 13.4 ng/g 
BuP = 19.3 ng/g 
Lee, et. al. 2006 
[115] 
Cosmetic products MP, EP, PP, BuP LPLC with 
monolithic column 
and 
chemiluminescence 
MP = 1.9e-8 M 
EP = 2.8e-8 M 
PP = 2.3e-8 M 
BuP =4.2e-8 M 
Claver, et. al. 2009 
[105] 
Indoor Air MP, EP, BuP Extraction and 
GC/MS 
MP = 1 ng/m3  
EP = 1 ng/m3  
BuP =4 ng/m3  
Rudel, et. al. 2003 
[58] 
Dust MP, EP, PP, BuP Extraction and 
GC/MS 
MP = 0.3µg/g 
EP  = 0.2µg/g 
BuP = 0.2µg/g 
Rudel, et. al. 2003 
[58] 
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4-hydroxybenzoic acid, did not inhibit SULT activity [122].  Butyl paraben exhibited the most 
potent inhibitory effects, achieving complete inhibition at 1 mM, while propyl paraben could 
only achieve 50% inhibition, and methyl and ethyl only inhibited to a minor extent [122].  When 
tested in liver cytosol, the results were the same for butyl paraben, but methyl, ethyl and propyl 
parabens all achieved 50% inhibition [122]. When tested in normal human epidermal 
keratinocytes, butyl paraben potency for SULT inhibition increased three-fold, indicating that 
this phenomenon may be more potent in a cellular system than shown in vitro [122].  The MMT 
cell proliferation assay utilized human embryonic kidney cells to determine the antiandrogenic 
properties of parabens.  Me thyl, propyl and butyl parabens significantly inhibited the 
transcriptional activity of testosterone at a concentration of 10 µM, while 4-hydroxybenzoic acid 
did not [125]. 
Van Meeuwen et. al. investigated the effects of parabens and their metabolites on human 
breast cancer cells using a MCF-7 cell proliferation assay.  Each test compound was analyzed 
multiple times in the concentration range of 1nM - 10 mM, and three mixed compounds 
(containing combinations of parabens) were tested for an additive effect as well [126]. Parabens 
did not show cytotoxic effects up to a level of 1 mM [126].  Full concentration-response curves 
(relative to 17β-estradiol) from the MCF-7 proliferation assay were produced for all parabens 
tested except methyl paraben and 4-methoxybenzoic acid (this included ethyl, propyl, butyl, 
benzyl, isopropyl and isobutyl parabens).  EC50 values ranged from 0.5 – 10 µM [126]. Estrogen 
equivalency factors (EEF) were derived from the EC50s and determined to be around 10
-5 for 
butyl, benzyl, isopropyl and isobutyl parabens and 10-6 for ethyl and propyl parabens [126].  
EEFs for methyl paraben and 4-methoxybenzoic acid were derived from their EC5 and EC10 
values to be more accurate, as they did not produce a full curve equivalent to 17β-estradiol.  The 
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values produced from EC5 for methyl paraben and 4-methoxybenzoic acid were 7x10
-7  and 
1x10-7, respectively [126].   Results of the paraben mixtures demonstrate there is no interaction 
between ethyl and propyl parabens, but that there is an additive effect between 17β-estradiol and 
different parabens [126].   The second part of this study investigated the effects of parabens on 
aromatase using human placental microsomes (from one placenta sample to maintain 
background control) with a tritium water release assay.  Compounds were tested in triplicate at a 
range of 100 nM – 100 µM, based on literature findings.  This study confirmed with statistically 
significant results that aromatase activity was inhibited up to 55% by parabens at levels as low as 
10 µM [126].  Metabolites of parabens did not inhibit aromatase activity [126].  Inhibition of 
aromatase is considered an anti-estrogenic effect because it is responsible for the conversion of 
androgens into estrogens.  Inhibition occurs within one magnitude of the determined magnified 
estrogenic effects, so it is likely to see that these mechanisms are counteracting each other [126].  
Van Meeuwen et. al. concluded that because effective concentrations determined in this study 
are orders of magnitude lower than actual concentrations found in human samples, it is unlikely 
that parabens would contribute greatly to the overall estrogenic burden, and that more research 
should focus on the additive effects of potential endocrine disrupting compounds [126]. 
Using the yeast screen assay, methyl, ethyl, propyl and butyl paraben were found to be 
estrogenic, but the main metabolite, 4-hydroxybenzoic acid, was not estrogenic [127].  T he 
magnitude of response increased with alkyl group size, showing the following results compared 
to 17β-estradiol: methyl paraben was approximately 2,500,000-fold less; ethyl paraben was 
approximately 150,000-fold less; propyl paraben was approximately 30,000-fold less; and butyl 
paraben was approximately 10,000-fold less [127].  This means propyl paraben is equivalent in 
potency to 4-nonylphenol and butyl paraben was three-fold more potent [127].  To prove that this 
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mechanism was through the estrogen receptor, antiestrogenic 4-hydroxytamoxifen was used as 
an inhibitor, which effectively inhibited all parabens that had responded in a dose dependant 
manner [127].   
1.5.6 In Vivo Studies 
Parabens have been studied in mammalian species.  Methyl paraben is known to activate TRPA1 
channels in mice and cause pain sensations at an EC50 value of 4.4 mM.  This concentration is 
well within the allowable range of 0.1 - 0.8% w/w which corresponds to 6.6 – 52.6 mM [128].  
TRPA1 channels are members of the transient receptor potential (TRP) super family, and this 
particular channel has attracted attention for its role in nociception, or the neural processes of 
detecting stimuli which may cause damage to tissue [128].  Jewell et. al. compared the hydrolysis 
of parabens in human skin to the skin of minipigs.  Parabens are hydrolyzed in tissue by 
carboxylesterases to the metabolite 4-hydroxybenzoic acid, however studies had not previously 
been evaluated using the skin [104].  The results showed that parabens are similarly absorbed 
through human and minipig skin, with minipig skin having a higher ability to hydrolyze more 
lipophilic esters than human skin [104].  It was also suggested that parabens with small alcohol 
leaving groups and low lipophilicity (such as methyl paraben) would be better used for 
pharmaceuticals needing quick systemic circulation, while esters with larger leaving groups and 
high lipophilicity (such as benzyl paraben) would be more efficient for pharmaceuticals which 
target the skin, due to the ability to be retained on the skin [104].  Butyl paraben competes with 
3H-estradiol for binding to the estrogen receptor in the uteri of immature rats five orders of 
magnitude lower than diethylstilbestrol and approximately two orders of magnitude less than 4-
nonylphenol when tested via a competitive binding assay [127].  Methyl and butyl paraben (the 
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least and most potent from previous in vitro studies) were given to rats by oral and subcutaneous 
routes.  Oral exposure to parabens did not produce an increase in uterus weights of immature rats 
[127].  The subcutaneous route did not show any significant results for methyl paraben, but butyl 
paraben significantly increased uterus weights at doses between 400 a nd 800 m g/kg/day.  A  
butyl paraben dose of 1200 mg/kg/day increased the uterus wet weights by 170% above controls 
[127].   The lowest butyl paraben dose producing significant results was 200 mg/kg/day [127].   
1.5.7 Human Studies 
Systemic uptake of parabens has been studied in humans.  In 2007, Janjua et. al. demonstrated 
that butyl paraben could be systemically absorbed through human skin after whole-body topical 
application of 2 mg/cm2 basic cream formulation (mean cream amount of 40 grams) made up of 
2% w/w compound.  This provides an average exposure of 10 m g/kg bw/day.  Blood sample 
serum levels of butyl paraben were found to increase rapidly, peak at a mean (SEM) level 135 
µg/L three hours after the application, drop to 18 µg/L after 24 hours, and not return to baseline 
during the one week long testing period.  A lthough butyl paraben was present, it did have a 
short-term effect on reproductive and thyroid hormone levels.  W hen testing levels of 
testosterone, follicle stimulating hormone, sex hormone-binding globulin and T3 no significant 
changes were found.  S ome significant variations were reported for inhibin B, TSH, FT4 and 
estradiol levels.  However, the authors concluded that the results of this study were caused by 
chance [129].  Janjua et. al. performed the same study methodology one year later but tested 
urinary concentrations, rather than blood.  T he results determined that the majority of butyl 
paraben was excreted 8-12 hours after whole-body topical application with the mean urine 
concentration found to be 2596 + 136 µg [130].  The mean recovery rate for unmetabolized butyl 
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paraben was 0.32% [130]. This is expected to represent a huge underestimation of the amount 
actually absorbed as the metabolic change to 4-hydroxybenzoic acid was not analyzed because it 
is not specific to butyl paraben [130].  In a study of 22 demographically diverse adult volunteers 
with no known occupational exposure, Ye et. al. found parabens in all urinary samples [124].  
Concentrations were detected as high as 41.4 ng /mL for methyl paraben and 10.2 ng /mL for 
propyl paraben, with a detection limit of 2 ng/mL [124]. 
Premature infants in neonatal intensive care units are exposed to parabens.  A study by 
Calafat et. al. found that paraben concentrations were higher in the infants than adult 
concentrations from previously reported studies, and appeared to have correlated concentrations 
suggesting that methyl and propyl paraben exposure for premature infants was through the same 
route [94]. 
Cosmetics have had a suspected association with cancerous tumors for a long time.  In, 
2003, Darbre published a plea for more research involving the use of underarm cosmetics and 
breast cancer.  Darbre suspected an association between the two because of supporting evidence 
that breast cancer occurs disproportionately in the upper outer quadrant (both in male and female 
cases) where deodorant/antiperspirant is applied, and because of the vast amounts of chemicals 
used in deodorant/antiperspirants, which include metal salts, antimicrobial agents and 
preservatives, among others [131].  Darbre, et. al. reported parabens accumulated in human 
breast tumours [132].  Eighteen out of twenty tumour extracts showed positive results (mean 
value of 20.6 ng/g) with methyl paraben present at the highest levels [132].  Benzyl paraben was 
not detected.  This study is highly controversial and was greatly criticized.  Peer-reviewers have 
concerns with the method of sample collection: (1) there was no data on patient use of paraben 
containing personal care products or paraben containing cancer treatment products; (2) no 
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control tissues were utilized; and (3) parabens were found in the analytical blanks leading to 
suspicion of contaminated equipment, although, according to Darbre, this was corrected for 
during the analysis [132-134].  Regardless of the controversy, Darbre’s study showed that 
parabens can at least be accumulated in breast cancer tumors.  Darbre suggests that the in vitro 
estrogenic activity of parabens may be stimulating growth of estrogen-dependent human breast 
cancer cells, but does not theorize a specific mechanism [131]. 
1.5.8 Other Studies 
Because of the massive influx of new chemicals available to the market every year, it is  
necessary to develop computer models to quickly screen chemicals for their endocrine disrupting 
potential.  A Quantitative Structure – Activity Relationship (QSAR) model for androgen receptor 
antagonism has been developed with a sensitivity of 64%, a specificity of 84%, and a 
concordance of 76% [72]. The model was tested satisfactorily with 176103 chemicals; 47% were 
within the domain of the model, and of them, 8% were predicted to be AR antagonists, while 
methyl, ethyl, propyl and butyl parabens and 4-hydroxybenzoic acid tested negative [72].  
Guadarrama et. al. developed a simplified theoretical model using computers and mathematics to 
simulate the estrogenic activities of parabens.  Th eir results showed that methyl paraben is 
theorized to be the most active (of all parabens tested, namely n-butyl, benzyl and isobutyl 
paraben) with fragments of the estrogen receptor [135].  The claim is that methyl paraben is the 
most estrogenic and the best antibacterial agent among other parabens [135]. 
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1.5.9 Regulatory Actions 
The European Commission (EEC) is a college of commissioners comprised of a member from 
each European Country.  Its primary purpose is to simplify and improve the regulatory 
environment by proposing legislation to the European Parliament and the Council of Ministers to 
adopt [136].  In 1999, the EEC published Directive 76/768 on cosmetic legislation.  In Annex VI, 
the EEC placed restrictions on parabens for the use of preservatives: products are not to exceed 
0.4% w/w for one ester and 0.8% for mixtures of esters.  These concentrations are not applicable 
if the use of parabens in the product is for something other than as a preservative [137].  In 2005 
and 2006, the EEC published three documents written by scientific committees that explain their 
position on the potential dangers of parabens.  One of the 2005 documents specifically addressed 
whether or not there was sufficient information to support a link between parabens and breast 
cancer, and determined that there is a lack of evidence [138].  The other document published in 
2005 is a safety evaluation of parabens, and it summarized that the current literature supports the 
following:  
• Acute toxicity is only seen at high doses. 
• There is no evidence of mutagenicity, carcinogenicity, genotoxicity, teratogenicity. 
• Research on developmental and reproductive effects is inadequate. 
• There is efficient hydrolysis of parabens to the 4-hydroxybenzoic acid metabolite. 
• There is no accumulation of either the parent or metabolites in tissues. 
• Parabens are able to bind to the estrogen receptor but potential estrogenic potency is 1000 
to 1,000,000 times lower than the potency of 17β-estradiol or testosterone. 
• There are no interactions, additive, or synergistic effects of parabens [139]. 
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Dietary administration studies in vivo calculated a NOAEL for methyl and ethyl paraben at 1000 
mg/kg bw/day and a Lowest-Observed-Adverse-Effect-Level (LOAEL) of 10 mg/kg bw/day for 
propyl paraben [139]. Toxicological data has led the EU Scientific Committee on Food to 
establish an Acceptable Daily Intake (ADI) for total parabens at 10 mg/kg bw/day [139].  The 
opinion that methyl and ethyl parabens can be safely used up to maximum concentrations of 
0.4% w/w remains unchanged, but more data was requested for propyl, butyl and isobutyl 
parabens [139]. The 2006 doc ument was an extensive to-date literature review supporting the 
opinion of their earlier documents [140]. In the United States, the FDA has limited the use of 
heptyl paraben to a maximum level of 12 ppm  in fermented malt beverages and 20 ppm  in 
noncarbonated soft drinks and fruit-based beverages [141].  No other paraben derivatives have 
restricted uses in the United States. 
1.5.10 Problems with Research on Parabens 
Research on the endocrine disruptive effects of parabens has been controversial.  Darbre’s 
significant finding of paraben accumulation in breast cancer tissue has ignited the need for 
research on parabens, but due to its controversial nature, it has been highly criticized  [132-134].  
Issues with method of sample collections, confounding effects of other natural and 
xenoestrogens with proven higher potencies, paraben contamination issues and lack of adequate 
controls have been reoccurring problems in the study of potential health effects caused by 
paraben exposure. 
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1.6 SUMMARY 
It is known that BPA can cause endocrine disruption in mammals and aquatic animals, and its 
endocrine disrupting effects have been proven in vitro.  It is not unreasonable to suspect that 
BPA is causing health problems in humans as well.  W ith the large exposure to BPA, it is 
necessary to thoroughly understand the effects of this chemical on the human endocrine system, 
which is determined by understanding its chemical and physical properties through in vivo and in 
vitro studies. 
Parabens are known to cause endocrine disruption in vitro through their estrogenic 
properties, however they are not suspected to be a significant problem in biological systems.  
Parabens may still be a public health concern because of the wide exposure to high 
concentrations and volumes of parabens, caused by applying paraben containing products 
directly onto skin and on food products as preservatives.  Little is known at this time about the 
transport and fate of parabens in the environment and they have not been thoroughly studied in 
the United States. 
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2.0  ESTROGENICITY OF EXTRACTS FROM ALEWIFE (ALOSA 
PSEUDOHARENGUS) AND SHAD (ALOSA SAPIDISSIMA) CAPTURED IN THE 
GREATER PITTSBURGH AREA 
The Greater Pittsburgh Area is famous for its three rivers: the Allegheny, Monongahela, and 
Ohio Rivers.  These rivers have a long history of being polluted by decades of mine runoff and 
chemicals released by industrial sites such as steel mills.  New problems, such as pollution from 
Endocrine Disrupting Compounds (EDCs) and xenoestrogens, have recently been discovered in 
this well known aquatic environment and are suspected to be caused by the failing sewer system.  
The Greater Pittsburgh Area has a very old sewer system with approximately 317 documented 
Combined Sewer Overflows (CSOs) and Sanitary Sewer Overflows (SSOs) [142].  During wet 
weather conditions,  CSOs and SSOs are known to discharge over 16 billion gallons per year of 
untreated wastewater into the Pittsburgh area rivers [9].  U ntreated wastewater pollutes local 
surface waters with infectious organisms and EDCs.  Newer research interests have questioned 
the use of personal care products (i.e. hygiene products and pharmaceuticals) and their effects on 
the environment.  Both sewage treatment plant effluents and untreated sewage exhibit strong 
estrogenic activity in both in vitro and in vivo studies [22, 143-146].  R esearch in the United 
Kingdom has shown correlations between estrogenic substances found in sewage effluents and 
feminization of wild fish [147].  While this new research initiative was being pursued, efforts 
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were employed to standardized methods to utilize MCF-7 breast cancer cell lines for the 
screening of estrogenic compounds  [14]. 
In 2007, T he University of Pittsburgh’s Center for Healthy Environments and 
Communities (CHEC), the School of Medicine and the Veterans Research Foundation of the 
Pittsburgh Veterans Healthcare System participated in a study to detect the estrogenic potential 
of extracts derived from flesh, fat and skin sampled from channel catfish using the E-Screen 
Assay described by Soto et. al [14].  In this study, extracts derived from fish captured in the 
Pittsburgh lock and dam pool were compared to fish caught from up-river areas on the Allegheny 
River that were less impacted by CSO outfalls.  The study found that extracts derived from fish 
caught in areas with higher CSO densities had significantly higher estrogenic potential than those 
less impacted by sewage effluent [148, 149].  This finding led CHEC, in conjunction with the 
Allegheny River Stewardship Project (ARSP), to continue research away from the city, into a 
small town model. 
2.1 OBJECTIVE 
The objective of this study was to investigate the presence of estrogenic compounds in extracts 
derived from the flesh, fat and skin taken from alewife (Alosa pseudoharengus) and shad (Alosa 
sapidissima) captured in the Greater Pittsburgh Area.  Fish were caught in the Allegheny River 
from locations near both Freeport and Ford City, Pennsylvania.  Estrogenic potential of extracts 
was tested utilizing the E-Screen Assay with human breast cancer cell lines MCF-7, T47D and 
BT-20. 
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2.2 MATERIAL AND METHODS 
2.2.1 Sampling Locations 
Ford City, Pennsylvania is located in Armstrong County on the Allegheny River approximately 
40 miles northeast of the city of Pittsburgh and approximately four miles south of Kittanning.  
Ford City has one permitted Wastewater Treatment Plant (WWTP) and three permitted CSOs, as 
determined by Pennsylvania Department of Environmental Protection (PA DEP) data file 
searches.  Fish samples were taken near Ford City, downstream of the area’s WWTP and CSO 
outfalls.  The nearest CSO discharge is approximately 1.8 miles and the furthest is approximately 
2.9 miles, both upstream from the sample point.  The sample point is the confluence of the 
Crooked Creek with the Allegheny River. 
Freeport, Pennsylvania is located in Armstrong County on t he Allegheny River 
approximately 28 miles northeast of Pittsburgh.  Freeport has one permitted WWTP and a total 
of five permitted CSOs, as determined by PA DEP data file searches.  Two of the CSOs and the 
WWTP discharge into Buffalo Creek, less than 0.5 miles from where the creek flows into the 
Allegheny River.  The other three CSOs discharge directly into the Allegheny River, with the 
nearest discharge approximately 0.6 m iles up-river of the Freeport sample point.  A ll of the 
Freeport discharges are within one mile of the sample point.   
The Freeport sample location is in the vicinity of two more CSOs than the Ford City 
location and is in closer proximity to the outfalls as well.  It was suspected that extracts from the 
fish captured in the Freeport area would have higher estrogenicity levels than the ones from Ford 
City because of the higher number of CSOs in the Freeport area and because the sampling 
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location at Freeport is in closer vicinity to CSOs and WWTP effluent discharges than the Ford 
City sample location. 
Figure 8, Map of Freeport and Ford City Fish Sample Locations with WWTP and CSO 
Outfalls, shows the two locations of fish sampling, the relative locations of WWTPs and CSO 
overflows and barriers of fish movement offered by lock and dam systems. Additionally, 
although fish are free to generally move within a specific lock and dam system, the fish sampled 
from these two locations are independent of one another.  T wo lock and dam facilities exist 
along the Allegheny River between the sample locations making it very unlikely that the fish 
would travel across both dams to reach the other location [150]. 
 
Figure 8. Map of Freeport and Ford City Fish Sample Locations with WWTP and CSO Outfalls 
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2.2.2 Sampling Methods 
Fish were caught using rod and reel method by anglers on the shore of the river as well as boats 
provided by the research team of the ARSP and volunteers. All regulations of the Pennsylvania 
Fish and Boat Commission were followed, including ensuring that all anglers connected with this 
project held valid fishing licenses and that the ARSP obtained necessary scientific collection 
permits.  Sample collection information consisting of river location, date and time of catch, GPS 
coordinates of catch, sampler’s name and initial categorization of the fish species were recorded 
for each fish.  T he fish were then euthanized by pithing (protocol #0711563); the methods of 
capture and euthanasia have been approved by the Institutional Animal Care And Use 
Committee (IACUC) of the University of Pittsburgh.  Each fish was then immediately packed on 
ice and transported to the laboratory for dissection.   
Prior to dissection, each fish was assigned an identification number based on the date of 
catch, species and sample location.  The gender and weight of the fish were recorded, and digital 
pictures were taken prior to dissection.  The flesh/fat sample from each fish was standardized at 
approximately 200 grams.  The multiple organs were removed and archived for future research.  
The organs and fillets were placed on dry ice until delivered to the laboratory where they were 
stored at -80OC. 
2.2.3 Composite Preparation 
This study utilized a screening method of composites rather than individual fish samples due to 
cost-benefit evaluation between statistical power and analytical costs.  Fish were composited 
according to sample location, gender and weight range. Each composite was comprised of two or 
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three fish. The fillet pieces used to construct each composite were allowed to thaw on ice and 
when pliable, each fillet was roughly minced using scissors.  T hese explants were frozen in 
liquid nitrogen and pulverized into a fine powder using a cyropulvizer (Biospec Products Inc).  
The powder was collected into glass vials (Fisher Scientific) and stored under nitrogen at -80OC. 
2.2.4 Extraction of Fish Flesh 
A one gram (±5%) sample of the composite powder was homogenized in normal saline using a 
Polytron homogenizer (Brinkmann Instruments) and extracted using a chloroform/methanol (9:1) 
extraction process.  The resulting organic phase was evaporated using nitrogen.  The remaining 
residue was stored under nitrogen at -20OC in 15 x 45 mm threaded glass vials with rubber lined 
caps (Gerresheimer). 
2.2.5 Cell Culture 
The human breast cancer cell lines MCF-7 (ERα-positive), T47D (ERβ-positive) and BT-20 
(ER-negative) were obtained from the American Type Cell Collection.  T hese cell lines were 
maintained in a humidified 37OC, 5% CO2 incubator.  T he cells were grown in T-75 vented 
flasks (Greiner Bio-One).  T he growth medium consisted of RPMI 1640 with L-glutamine 
(Mediatech), supplemented with 10% Fetal Bovine Serum (FBS; Atlanta Biologicals), penicillin 
(50 units/mL; Invitrogen) and streptomycin (50 µg/mL; Invitrogen). Cell lines were passed once 
a week, and the growth medium was changed twice a week. 
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2.2.6 E-Screen Assay 
The E-Screen Assay was performed as previously described in the literature [14, 151].  
Seventy-two hours prior to performing the assay, a T-75 flask of each cell line had its growth 
medium removed, was rinsed with phenol-red free Hank’s Balanced Salt Solution (HBSS; 
Mediatech), and the growth medium replaced with steroid-free medium consisting of RPMI 1640 
with L-glutamine and without phenol red (Invitrogen), supplemented with 5% charcoal-dextran 
stripped FBS (Gemini Bio-Products), penicillin (50 units/mL) and streptomycin (50 µg/mL).  
After incubating for 72 hours, the steroid-free medium was removed and the monolayer rinsed 
with HBSS. Two mL of trypsin (0.25% trypsin, 2.21 nM  EDTA in HBSS without sodium 
bicarbonate, calcium, and magnesium; Invitrogen) was added to the flask to detach the cells.  
The cells were resuspended in steroid-free medium and removed from the flask.  The cell 
number was determined using a hemocytometer and the concentration of the cell suspension was 
adjusted to 50,000 cells per mL.    
The E-Screen Assay was performed using 96-well plates (Greiner Bio-One).  Each plate 
consisted of treated (steroid-free medium, cells, and fish extract), background control 
(steroid-free medium, fish extract and no cells), negative control (steroid-free medium, cells, and 
no fish extract) and positive control (steroid-free medium, cells, no fish extract, and 1 nM  
17β-estradiol [Steraloids]) wells.  O ne hundred µL of cell suspension was added to each 
treatment, negative control, and positive control well.  The plates were returned to the incubator, 
and the cells allowed to adhere to the plate overnight.   
The next morning, the composite fish extract residues to be tested were resuspended in 
one mL of ethanol:glycerol (70:30), kept at room temperature and shielded from light.  T he 
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resuspended residue was vortexed for one minute to ensure uniform distribution of fish extract.  
This suspension was used to make the stock solution of each fish extract.  The stock solution was 
filtered using a 0.2 micron filter (Costar) to remove bacterial contamination.  This stock solution 
was used to make eight dilutions of fish extract, with final concentrations of 1/4000, 1/3000, 
1/2000, 1/1500, 1/1000, 1/500, 1/200, and 1/100 of composite extract diluted in steroid-free 
medium.   
The plates were treated with 100 µL of eight dilutions of fish extract in the absence and 
presence of 1 nM estradiol (E2) and 10 nM hydroxytamoxifen.  Each analysis was performed on 
five individual wells.  The plates were returned to the incubator and allowed to incubate for 72 
hours.   
At the end of this period, the cell density per well was estimated following the procedure 
described by Soto et. al. [14, 151].  The medium was removed and the cells were fixed for one 
hour using a 10% trichloroacetic acid solution.  The plate was then rinsed five times using tap 
water. The cells were stained using 0.4% w/v Sulforhodamine (SRB) in 1% acetic acid.  After 30 
minutes, the plates were rinsed with 1% acetic acid to remove unbound SRB and allowed to air 
dry.  T he protein-bound dye was solubilized with 10 mM Tris base per well.  T he plate was 
placed on a gyratory shaker for 10 minutes to homogenize the dye solution.  The absorbance of 
each well was determined at a wave length of 564 nm using a Synergy HT plate reader (BioTek) 
with KC4 software (version 3.0) installed. 
2.2.7 Proliferation Index (PI) and Estrogen Response Profile (ERP) 
Raw absorbance values were collected for each well.  These values converted to z-scores used to 
identify outliers.  A z-score greater than 1.96 was considered to be an outlier and the well was 
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excluded from further analysis. The mean absorbance of the background control wells was 
calculated for each column and subtracted from the absorbance value of each well in that 
column.  These background corrected absorbance values were used to calculate the Proliferation 
Index (PI) for each well.  The PI is calculated according to the following equation: 
 
PI = (background-corrected absorbance value of each well) / (mean absorbance of the 
negative control wells) 
Where: 
 background-corrected absorbance value of each well = ab sorbance value of the 
background control (steroid-free medium, fish extract and no cells) subtracted from 
the raw absorbance value of the treated well 
 mean absorbance of the negative control wells = av erage of the raw absorbance 
values for the negative controls (steroid-free medium, cells, and no fish extract) 
The PI is used to evaluate the data of each composite compared to its estradiol control.  The PI 
for the negative control wells is not an assigned value, but was calculated in the same manner as 
the other conditions of the experiment.  Once the PIs were calculated for each well, the mean and 
95% Confidence Interval (CI) was calculated for each fish extract dilution, negative control and 
positive control. These data were plotted to compare their dose response curves against known 
responses of estradiol (positive estrogen responsive) and hydroxytamoxifen (anti-estrogen 
responsive) added extracts.  E ach analysis was graphed for the composite, the composite in 
combination with estradiol and the composite in combination with hydroxytamoxifen over the 
range of the eight dilutions for the MCF-7, T47D and BT-20 cell lines.  In order to determine the 
receptor response, estradiol and hydroxytamoxifen were added to the extracts and thus compared 
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to expected estrogen and anti-estrogen receptor responses.  BT-20 cells are ER-negative lines, 
therefore positive results would indicate that proliferation is occurring via an unknown 
mechanism that is not utilizing the estrogen receptor.  The MCF-7 cell line is primarily ERα-
positive and T47D are primarily ERβ-positive.  Studying how the same sample reacts under all 
three conditions may give an indication to the type of mechanism causing any proliferation that 
may be observed in these experiments. 
The Estrogen Response Profile (ERP) plots the mean and 95% CIs of the negative and 
positive controls, as well as the eight dilutions of fish extract along the X-axis.  The Y-axis is a 
numeric scale of PI values.  The 95% CIs of the negative and positive controls are used to define 
five response regions of the ERP.  T he 95% CI of the negative control establishes the non-
estrogenic response range of the ERP.  The 95% CI of the positive control defines the region of 
estrogenic response.  The weak and moderate estrogenic responses are respectively defined as 
the midrange between the upper limit of the 95% CI of the negative control and the lower limit 
of the positive (E2) control range.  A response above the upper limit of the 95% CI of the 
positive control represents a strong estrogenic response. 
2.2.8 Estrogenicity Index (EI) 
The data was analyzed by determining the Estrogenicity Index of each composite.  T he 
Estrogenicity Index (EI) is defined as the calculated value based on the proliferation of exposed 
cells after normalizing to the cell plate positive and negative control wells.  The Proliferation 
Index is converted into the Estrogenicity Index according to following equation:  
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EI = (PI - mean of negative control wells) / (mean of positive control wells – the 
mean of negative control wells) 
 Where: 
 PI  (Proliferation Index) =  (background-corrected absorbance value of each well) 
/ (mean absorbance of the negative control wells) 
 negative control wells = a blank matrix comprised of steroid-free medium, cells 
and no fish extract or any hormones 
 positive control wells = a quality control comprised of steroid-free medium, cells, 
no fish extract, and 1nM 17β-estradiol 
2.2.9 Statistical Analyses 
This study design allowed for the creation of 440 analytical data points (5 runs * 8 dilutions * 11 
composites = 440) which required a repeated measures statistical model.  A Subject Specific 
Random Effects Model, a mixed model with fixed and random effects, was utilized to analyze 
the data.  T he fish are the random effect because they were randomly sampled, and the 
composites are fixed effects because they were assigned based on the fixed effects gender, 
weight range and location.  T his model does not assume normality of the sample population.  
The models were created in Stata using the xtreg command. The Estrogenicity Index (for both 
MCF-7 and T47D) was modeled as a function of location, gender or weight class, using the 
Subject Specific Random Effects Model.    Spearman Rank Correlation testing was performed to 
determine the relationship between the MCF-7 and T47D analyses.  
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2.3 RESULTS AND DISCUSSION 
2.3.1 Proliferation Index 
Table 6, MCF-7 Proliferation Index Data Summary (Mean with SD and Range), displays the 
results of the Mean Proliferation Index with standard deviations and ranges for all eleven 
composites in each dilution range for the MCF-7 analysis, including extracts with estradiol or 
hydroxytamoxifen present.  Table 7, T47D Proliferation Index Data Summary (Mean with SD 
and Range) displays the same results for the T47D analysis.  BT-20 data is not shown because 
there was no effect. 
2.3.2 Descriptive Results from ERP 
Descriptive results for the three cell lines are described in Table 8, Summary of the Estrogen 
Response Profile (ERP) for Cell Proliferation Assays by Composite.  Because BT-20 cell lines 
do not have estrogen receptors, the negative results seen in these cells give strength to the 
concept that all responses seen in the MCF-7 and T47D cell lines are due to the presence of 
estrogen receptors.  S even out of eleven of the MCF-7 analyses showed a w eak estrogenic 
response.  The other four showed no estrogenic response.  There do not appear to be any obvious 
associations for fish weight, gender or location in these responses. Seven out of eleven of the 
T47D analyses showed a weak estrogenic response.  Two out of eleven showed an estrogenic 
response and two out of eleven showed no estrogenic response.  The two composites which 
showed no estrogenic response in the T47D analysis were both from Freeport (Composites 3 and 
11).  The two composites which showed estrogenic response in the T47D analysis were both  
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Table 6. MCF-7 Proliferation Index Data Summary (Mean with SD and Range) 
Neg Ctl Pos Ctr Tam Tam + E2 1/4000 1/3000 1/2000 1/1500 1/1000 1/500 1/200 1/100
1.00 + 0.08 2.03 + 0.22 - - 1.16 + 0.05 1.14 + 0.04 1.06 + 0.06 1.02 + 0.08 1.09 + 0.10 1.15 + 0.05 1.11 + 0.09 1.24 + 0.11
0.90 - 1.16 1.85 - 2.58 - - 1.12 - 1.25 1.10 - 1.19 0.94 - 1.10 0.92 - 1.14 1.00 - 1.25 1.08 - 1.22 1.05 - 1.26 1.10 - 1.39
1.00 + 0.05 2.21 + 0.17 - - 2.14 + 0.13 2.05 + 0.18 2.23 + 0.19 2.46 + 0.36 2.26 + 0.11 2.27 + 0.09 2.01 + 0.11 1.82 + 0.17
0.94 - 1.08 1.86 - 2.47 - - 1.96 - 2.26 1.82 - 2.31 2.02 - 2.48 2.05 - 2.88 2.17 - 2.44 2.13 - 2.37 1.92 - 2.17 1.65 - 2.08
1.00 + 0.06 2.17 + 0.14 0.97 + 0.03 1.93 + 0.05 - - 1.05 + 0.07 1.11 + 0.06 1.11 + 0.08 1.13 + 0.02 1.10 + 0.11 1.04 + 0.05
0.89 - 1.11 2.00 - 2.38 0.93 - 1.00 1.86 - 1.99 - - 0.97 - 1.13 1.06 - 1.21 1.01 - 1.23 1.11 - 1.16 1.00 - 1.29 0.97 - 1.10
1.00 + 0.04 2.84 + 0.28 - - 1.21 + 0.14 1.05 + 0.06 1.15 + 0.08 1.22 + 0.08 1.19 + 0.10 1.20 + 0.09 1.33 + 0.09 1.42 + 0.07
0.94 - 1.06 2.43 - 3.39 - - 1.12 - 1.45 0.95 - 1.09 1.06 - 1.28 1.12 - 1.31 1.07 - 1.29 1.08 - 1.30 1.26 - 1.48 1.32 - 1.47
1.00 + 0.13 2.52 + 0.27 - - 2.72 + 0.14 2.83 + 0.14 2.72 + 0.12 2.77 + 0.09 2.74 + 0.10 2.52 + 0.11 2.48 + 0.09 2.32 + 0.11
0.71 - 1.19 2.22 - 3.07 - - 2.50 - 2.91 2.70 - 2.98 2.62 - 2.91 2.66 - 2.89 2.62 - 2.84 2.38 - 2.64 2.36 - 2.60 2.16 - 2.42
1.00 + 0.06 2.39 + 0.10 1.13 + 0.08 2.17 + 0.09 - - 1.20 + 0.08 1.23 + 0.06 1.12 + 0.04 1.17 + 0.05 1.17 + 0.08 1.13 + 0.06
0.91 - 1.10 2.19 - 2.52 1.07 - 1.27 2.09 - 2.32 - - 1.09 - 1.30 1.16 - 1.31 1.08 - 1.18 1.10 - 1.24 1.03 - 1.22 1.05 -1.20
1.00 + 0.04 2.12 + 0.10 - - 1.11 + 0.09 1.00 + 0.09 0.99 + 0.06 1.00 + 0.04 0.99 + 0.05 1.04 + 0.05 1.06 + 0.06 1.08 + 0.05
0.95 - 1.07 1.98 - 2.32 - - 0.99 - 1.24 0.93 - 1.14 0.94 - 1.09 0.95 - 1.05 0.92 -1.04 0.97 - 1.08 1.01 - 1.14 1.00 - 1.14
1.00 + 0.06 1.92 + 0.08 - - 1.91 + 0.14 1.92 + 0.09 1.89 + 0.08 1.81 + 0.06 1.85 + 0.07 1.84 + 0.09 1.74 + 0.07 1.66 + 0.05
0.90 - 1.11 1.82 - 2.06 - - 1.76 - 2.05  1.77 - 2.00 1.79 - 1.99 1.74 - 1.91 1.77 - 1.96 1.77 - 2.00 1.67 - 1.81 1.59 - 1.73
1.00 + 0.10 2.07 + 0.09 1.04 + 0.04 2.18 + 0.07 - - 1.04 + 0.04 1.02 + 0.06 1.05 + 0.04 1.04 + 0.07 0.95 + 0.06 0.94 + 0.04
0.85 - 1.19 1.87 - 2.17 1.01 - 1.09 2.07 - 2.24 - - 1.00 - 1.09 0.93 - 1.08 1.00 - 1.11 0.97 - 1.15 0.86 - 1.01 0.89 - 0.98
1.00 + 0.09 1.87 + 0.09 - - 1.15 + 0.06 1.20 + 0.07 1.20 + 0.04 1.19 + 0.08 1.34 + 0.11 1.41 + 0.09 1.41 + 0.09 1.35 + 0.06
0.91 - 1.19 1.75 - 2.03 - - 1.06 - 1.21 1.13 - 1.27 1.13 - 1.24 1.10 - 1.29 1.19 - 1.43 1.30 - 1.52 1.30 - 1.55 1.26 - 1.43
1.00 + 0.05 2.07 + 0.13 - - 2.12 + 0.13 2.11 + 0.09 2.12 + 0.13 2.08 + 0.11 2.12 + 0.14 2.06 + 0.05 1.98 + 0.07 1.74 + 0.10
0.93 - 1.09 1.85 - 2.28 - - 1.97 - 2.33 1.99 - 2.21 2.02 - 2.34 1.98 - 2.21 1.96 - 2.29 2.01 - 2.13 1.87 - 2.05 1.67 - 1.91
1.00 + 0.08 2.10 + 0.18 0.91 + 0.03 1.79 + 0.09 - - 0.93 + 0.04 1.09 + 0.00 1.05 + 0.05 1.05 + 0.11 1.07 + 0.08 1.02 + 0.04
0.92 - 1.17 1.70 - 2.28 0.88 - 0.96 1.72 - 1.95 - - 0.86 - 0.98 1.09 - 1.10 0.99 - 1.12 0.90 - 1.19 0.96 - 1.18 0.97 - 1.08
1.00 + 0.07 2.11 + 0.10 - - 1.00 + 0.08 1.04 + 0.07 1.04 + 0.07 0.98 + 0.05 0.98 + 0.02 1.01 + 0.04 1.13 + 0.03 1.15 + 0.06
0.87 - 1.10 1.97 - 2.29 - - 0.90 - 1.11 0.96 - 1.14 0.96 - 1.12 0.92 - 1.04 0.95 - 1.01 0.97 - 1.08 1.10 - 1.18 1.08 - 1.23
1.00 + 0.06 2.25 + 0.18 - - 2.09 + 0.06 2.09 + 0.19 2.03 + 0.05 2.11 + 0.19 2.09 + 0.13 2.02 + 0.12 1.98 + 0.14 2.07 + 0.19
0.86 - 1.11 2.02 - 2.60 - - 2.01 - 2.17 1.78 - 2.30 1.97 - 2.09 1.86 - 2.31 1.88 - 2.20 1.81 - 2.10 1.83 - 2.17 1.75 - 2.24
1.00 + 0.05 2.27 + 0.23 1.00 + 0.03 1.80 + 0.06 - - 0.99 + 0.06 1.07 + 0.08 1.05 + 0.06 1.04 + 0.07 0.96 + 0.07 1.02 + 0.05
0.91 - 1.06 1.94 - 2.65 0.97 - 1.05 1.74 - 1.91 - - 0.94 - 1.07 0.98 - 1.17 1.00 - 1.14 0.94 - 1.12 0.88 - 1.04 0.95 - 1.07
1.00 + 0.04 2.04 + 0.10 - - 1.00 + 0.02 0.99 + 0.05 1.13 + 0.03 1.11 + 0.03 1.21 + 0.06 1.33 + 0.07 1.47 + 0.04 1.40 + 0.04
0.95 - 1.05 1.81 - 2.16 - - 0.97 - 1.03 0.91 - 1.04 1.10 - 1.17 1.06 - 1.15 1.13 - 1.28 1.24 - 1.41 1.41 - 1.51 1.34 - 1.44
1.00 + 0.06 1.89 + 0.11 - - 1.90 + 0.08 2.00 + 0.08 1.83 + 0.15 1.75 + 0.06 1.97 + 0.12 1.87 + 0.06 1.73 + 0.08 1.64 + 0.15
0.92 - 1.07 1.73 - 2.08 - - 1.80 - 1.99 1.91 - 2.09 1.60 - 2.00 1.71 - 1.86 1.84 - 2.16 1.79 - 1.92 1.64 - 1.85 1.44 - 1.84
1.00 + 0.06 1.98 + 0.16 1.08 + 0.07 1.82 + 0.15 - - 1.07 + 0.06 1.04 + 0.07 1.06 + 0.06 1.10 + 0.07 1.03 + 0.03 0.96 + 0.10
0.93 - 1.11 1.78 - 2.17 1.01 - 1.16 1.67 - 2.07 - - 1.01 - 1.17 0.97 - 1.15 0.96 - 1.12 0.99 - 1.16 1.00 - 1.07 0.82 - 1.09
1.00 + 0.14 2.75 + 0.17 - - 1.36 + 0.12 1.12 + 0.07 1.21 + 0.09 1.20 + 0.04 1.36 + 0.12 1.43 + 0.02 1.62 + 0.03 1.61 + 0.07
0.80 - 1.18 2.51 - 2.98 - - 1.18 - 1.47 1.04 - 1.22 1.12 - 1.32 1.13 - 1.24 1.22 - 1.50 1.40 - 1.46 1.59 - 1.65 1.55 - 1.72
1.00 + 0.07 2.73 + 0.17 - - 2.87 + 0.14 2.90 + 0.19 2.80 + 0.27 2.94 + 0.11 2.91 + 0.13 2.87 + 0.04 2.80 + 0.13 2.48 + 0.20
0.90 - 1.12 2.43 - 2.98 - - 2.70 - 3.02 2.75 - 3.22 2.61 - 3.26 2.82 - 3.12 2.73 - 3.02 2.84 - 2.92 2.71 - 3.01 2.21 - 2.69
1.00 + 0.08 2.89 + 0.18 1.11 + 0.13 2.62 + 0.27 - - 1.13 + 0.07 1.22 + 0.05 1.27 + 0.03 1.32 + 0.10 1.31 + 0.04 1.18 + 0.09
0.83 - 1.13 2.66 - 3.30 0.96 - 1.26 2.37 - 3.03 - - 1.06 - 1.25 1.17 - 1.30 1.24 - 1.31 1.20 - 1.44 1.25 - 1.36 1.06 - 1.28
1.00 + 0.07 1.79 + 0.13 - - 1.10 + 0.06 1.12 + 0.04 1.11 + 0.08 1.03 + 0.06 1.03 + 0.03 1.09 + 0.03 1.13 + 0.06 1.14 + 0.08
0.91 - 1.15 1.54 - 1.99 - - 1.02 - 1.16 1.07 - 1.18 1.03 - 1.23 0.96 - 1.10 0.99 - 1.06 1.05 - 1.13 1.05 - 1.20 1.07 - 1.25
1.00 + 0.05 2.15 + 0.06 - - 2.03 + 0.13 2.01 + 0.10 2.11 + 0.12 2.11 + 0.08 2.23 + 0.05 2.13 + 0.13 2.14 + 0.15 2.00 + 0.03
0.90 - 1.10 2.03 - 2.23 - - 1.87 - 2.22 1.91 - 2.18 2.01 - 2.24 1.99 - 2.19 2.16 - 2.28 1.98 - 2.27 1.96 - 2.34 0.96 - 2.02
1.00 + 0.12 1.91 + 0.07 0.84 + 0.09 1.48 + 0.08 - - 0.90 + 0.03 0.93 + 0.08 0.89 + 0.03 1.02 + 0.10 0.94 + 0.06 0.98 + 0.05
0.88 - 1.28 1.77 - 1.98 0.72 - 0.96 1.35 - 1.56 - - 0.86 - 0.93 0.84 - 1.02 0.87 - 0.94 0.90 - 1.15 0.83 - 0.98 0.93 - 1.04
1.00 + 0.04 1.90 + 0.14 - - 1.16 + 0.07 1.09 + 0.07 0.99 + 0.05 1.06 + 0.03 1.03 + 0.06 1.07 + 0.05 1.18 + 0.04 1.18 + 0.05
0.94 - 1.07 1.65 - 2.06 - - 1.09 - 1.24 1.02 - 1.19 0.93 - 1.04 1.01 - 1.09 0.95 - 1.09 1.00 - 1.14 1.13 - 1.24 1.12 - 1.25
1.00 + 0.05 2.16 + 0.19 - - 2.04 + 0.14 2.01 + 0.08 2.12 + 0.11 2.08 + 0.08 2.10 + 0.14 2.05 + 0.16 1.87 + 0.07 1.89 + 0.10
0.91 - 1.06 1.91 - 2.45 - - 1.91 - 2.22 1.92 - 2.11 2.00 - 2.25 1.99 - 2.17 1.96 - 2.29 1.92 - 2.24 1.81 - 1.98 1.81 - 2.03
1.00 + 0.05 2.10 + 0.10 1.05 + 0.04 1.88 + 0.09 - - 1.11 + 0.09 1.07 + 0.04 1.04 + 0.02 1.04 + 0.07 0.99 + 0.05 0.95 + 0.03
0.92 - 1.07 1.96 - 2.26 1.00 - 1.12 1.76 - 2.01 - - 0.99 - 1.22 1.02 - 1.11 1.03 - 1.06 0.97 - 1.10 0.93 - 1.05 0.93 - 1.00
1.00 + 0.06 2.30 + 0.23 - - 1.29 + 0.06 1.16 + 0.02 1.03 + 0.07 1.03 + 0.08 1.07 + 0.04 1.01 + 0.06 1.16 + 0.07 1.15 + 0.05
0.89 - 1.07 2.04 - 2.67 - - 1.20 - 1.35 1.12 - 1.18 0.95 - 1.12 0.91 - 1.12 1.02 - 1.12 0.95 - 1.08 1.06 - 1.26 1.09 - 1.21
1.00 + 0.03 2.19 + 0.28 - - 2.17 + 0.10 2.01 + 0.13 2.26 + 0.11 2.22 + 0.11 2.17 + 0.09 2.13 + 0.09 2.05 + 0.12 1.93 + 0.17
0.94 - 1.04 1.87 - 2.74 - - 2.02 - 2.25 1.85 - 2.19 2.16 - 2.45 2.11 - 2.40 2.09 - 2.32 2.02 - 2.27 1.92 - 2.20 1.70 - 2.11
1.00 + 0.07 2.09 + 0.13 0.96 + 0.04 1.98 + 0.09 - - 1.03 + 0.05 1.05 + 0.05 1.08 + 0.11 1.13 + 0.05 1.02 + 0.04 1.01 + 0.03
0.90 - 1.12 1.92 - 2.26 0.91 - 1.01 1.88 - 2.07 - - 0.97 - 1.08 0.98 - 1.09 0.99 - 1.25 1.06 - 1.20 0.95 - 1.05 0.96 - 1.04
1.00 + 0.06 1.96 + 0.10 - - 1.10 + 0.07 1.05 + 0.06 1.02 + 0.06 1.10 + 0.05 1.02 + 0.07 1.02 + 0.04 1.01 + 0.05 1.00 + 0.06
0.94 - 1.09 1.86 - 2.17 - - 1.03 - 1.19 1.00 - 1.13 0.93 - 1.10 0.96 - 1.07 0.94 - 1.11 0.98 - 1.06 0.97 - 1.08 0.95 - 1.09
1.00 + 0.08 2.14 + 0.12 - - 2.23 + 0.10 2.20 + 0.05 2.12 + 0.04 2.10 + 0.08 2.06 + 0.12 2.09 + 0.08 1.99 + 0.09 1.78 + 0.09
0.90 - 1.16 2.05 - 2.45 - - 2.07 - 2.33 2.14 - 2.28 2.09 - 2.19 2.00 - 2.16 1.91 - 2.18 1.99 - 2.17 1.88 - 2.10 1.68 - 1.89
1.00 + 0.03 1.92 + 0.12 0.91 + 0.08 1.87 + 0.14 - - 0.90 + 0.03 0.90 + 0.05 0.87 + 0.04 0.89 + 0.02 0.89 + 0.05 0.85 + 0.03
0.94 - 1.04 1.74 - 2.09 0.84 - 1.01 1.71 - 2.03 - - 0.86 - 0.94 0.83 - 0.96 0.82 - 0.93 0.87 - 0.92 0.83 - 0.96 0.82 - 0.89
Composite 11
Composite 11 with Estradiol
Composite 11 with Hydroxytamoxifen
Composite 9
Composite 9 with Estradiol
Composite 9 with Hydroxytamoxifen
Composite 10
Composite 10 with Estradiol
Composite 10 with Hydroxytamoxifen
Composite 7
Composite 7 with Estradiol
Composite 7 with Hydroxytamoxifen
Composite 8
Composite 8 with Estradiol
Composite 8 with Hydroxytamoxifen
Composite 5
Composite 5 with Estradiol
Composite 5 with Hydroxytamoxifen
Composite 6
Composite 6 with Estradiol
Composite 6 with Hydroxytamoxifen
Composite 3
Composite 3 with Estradiol
Composite 3 with Hydroxytamoxifen
Composite 4
Composite 4 with Estradiol
Composite 4 with Hydroxytamoxifen
Composite 1
Composite 1 with Estradiol (E2)
Composite 1 with Hydroxytamoxifen (Tam)
Composite 2 with Estradiol
Composite 2
Composite 2 with Hydroxytamoxifen
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Table 7. T47D Proliferation Index Data Summary (Mean with SD and Range) 
Neg Ctl Pos Ctr Tam Tam + E2 1/4000 1/3000 1/2000 1/1500 1/1000 1/500 1/200 1/100
1.00 + 0.07 1.77 + 0.09 - - 1.09 + 0.08 1.07 + 0.07 1.05 + 0.04 1.08 + 0.03 1.15 + 0.06 1.17 + 0.04 1.26 + 0.08 1.39 + 0.06
0.91 - 1.11 1.61 - 1.87 - - 0.99 - 1.18 0.98 - 1.14 1.01 - 1.11 1.05 - 1.13 1.08 - 1.23 1.13 - 1.24 1.18 - 1.36 1.34 - 1.48
1.00 + 0.17 1.66 + 0.31 - - 2.13 + 0.15 2.18 + 0.08 2.03 + 0.12 2.09 + 0.06 2.04 + 0.10 2.01 + 0.13 1.59 + 0.13 1.50 + 0.08
0.81 - 1.18 1.21 - 2.02 - - 2.03 - 2.39 2.07 - 2.27 1.86 - 2.16 2.03 - 2.17 1.93 - 2.19 1.81 - 2.12 1.43 - 1.80 1.42 - 1.60
1.00 + 0.17 1.87 + 0.23 1.43 + 0.08 1.57 + 0.10 - - 1.16 + 0.17 1.10 + 0.08 1.01 + 0.09 1.02 + 0.07 1.10 + 0.04 1.19 + 0.11
0.83 - 1.27 1.55 - 2.20 1.28 - 1.48 1.46 - 1.67 - - 0.93 - 1.36 1.04 - 1.24 0.95 - 1.15 0.92 - 1.08 1.05 - 1.15 1.00 - 1.30
1.00 + 0.12 1.69 + 0.09 - - 1.10 + 0.06 0.96 + 0.12 1.02 + 0.07 1.07 + 0.12 1.24 + 0.09 1.16 + 0.03 1.24 + 0.05 1.32 + 0.07
0.78 - 1.14 1.48 - 1.77 - - 1.03 - 1.16 0.84 - 1.15 0.92 - 1.09 0.93 - 1.19 1.15 - 1.37 1.12 - 1.19 1.20 - 1.31 1.23 - 1.41
1.00 + 0.05 1.62 + 0.08 - - 1.70 + 0.11 1.75 + 0.08 1.63 + 0.09 1.68 + 0.11 1.71 + 0.02 1.70 + 0.11 1.85 + 0.11 1.80 + 0.06
0.90 - 1.06 1.50 - 1.77 - - 1.60 - 1.87 1.67 - 1.85 1.56 - 1.77 1.60 - 1.87 1.69 - 1.75 1.52 - 1.80 1.76 - 2.03 1.73 - 1.89
1.00 + 0.06 1.70 + 0.17 1.15 + 0.05 1.43 + 0.05 - - 1.13 + 0.10 1.14 + 0.05 1.20 + 0.06 1.21 + 0.05 1.20 + 0.03 1.23 + 0.04
0.92 - 1.10 1.47 - 2.15 1.08 - 1.20 1.37 - 1.48 - - 1.01 - 1.25 1.08 - 1.22 1.12 - 1.27 1.13 - 1.25 1.16 - 1.22 1.19 - 1.28
1.00 + 0.08 1.51 + 0.09 - - 1.16 + 0.06 1.11 + 0.04 1.09 + 0.06 1.03 + 0.05 1.03 + 0.08 1.07 + 0.04 1.13 + 0.03 1.19 + 0.09
0.90 - 1.10 1.37 - 1.64 - - 1.06 - 1.22 1.07 - 1.18 1.02 - 1.17 0.97 - 1.09 0.98 - 1.17 1.02 - 1.12 1.09 - 1.18 1.08 - 1.32
1.00 + 0.11 1.46 + 0.13 - - 1.58 + 0.08 1.61 + 0.12 1.55 + 0.17 1.51 + 0.14 1.53 + 0.08 1.60 + 0.09 1.61 + 0.09 1.61 + 0.11
0.86 - 1.23 1.27 - 1.70 - - 1.47 - 1.66 1.46 - 1.77 1.36 - 1.81 1.36 - 1.72 1.43 - 1.65  1.52 - 1.74 1.54 - 1.76 1.52 - 1.78
1.00 + 0.11 1.56 + 0.15 1.16 + 0.05 1.52 + 0.04 - - 1.03 + 0.05 1.09 + 0.12 1.08 + 0.14 1.10 + 0.12 1.11 + 0.06 1.19 + 0.11
0.82 - 1.20 1.39 - 1.92 1.09 - 1.20 1.48 - 1.57 - - 0.97 - 1.11 1.00 - 1.30 0.96 - 1.30 0.98 - 1.27 1.03 - 1.20 1.09 - 1.33
1.00 + 0.06 1.61 + 0.06 - - 1.20 + 0.11 1.23 + 0.06 1.16 + 0.05 1.15 + 0.10 1.29 + 0.11 1.41 + 0.09 1.58 + 0.08 1.61 + 0.07
0.89 - 1.10 1.52 - 1.68 - - 1.08 - 1.36 1.15 - 1.29 1.08 - 1.21 1.05 - 1.30 1.13 - 1.39 1.27 - 1.50 1.49 - 1.70 1.51 - 1.70
1.00 + 0.06 1.76 + 0.14 - - 1.67 + 0.05 1.67 + 0.02 1.90 + 0.09 1.84 + 0.15 2.00 + 0.06 1.93 + 0.09 2.08 + 0.08 1.99 + 0.09
0.92 - 1.10 1.56 - 1.95 - - 1.63 - 1.75 1.64 - 1.69 1.78 - 2.00 1.71 - 2.08 1.94 - 2.09 1.81 - 2.02 1.94 - 2.14 1.91 - 2.10
1.00 + 0.06 1.80 + 0.10 1.17 + 0.07 1.45 + 0.05 - - 1.16 + 0.04 1.17 + 0.05 1.28 + 0.03 1.27 + 0.06 1.29 + 0.09 1.23 + 0.04
0.95 - 1.14 1.62 - 1.96 1.08 - 1.27 1.38 - 1.49 - - 1.12 - 1.23 1.10 - 1.23 1.23 - 1.32 1.19 - 1.33 1.22 - 1.44 1.19 - 1.29
1.00 + 0.05 1.56 + 0.07 - - 1.19 + 0.04 1.10 + 0.08 1.06 + 0.09 1.05 + 0.05 1.14 + 0.04 1.11 + 0.09 1.18 + 0.11 1.22 + 0.11
0.91 - 1.08 1.46 - 1.72 - - 1.16 - 1.25 1.00 - 1.19 1.00 - 1.21 0.97 - 1.08 1.08 - 1.18 0.99 - 1.19 1.09 - 1.36 1.15 - 1.42
1.00 + 0.09 1.54 + 0.13 - - 1.55 + 0.04 1.57 + 0.07 1.51 + 0.09 1.57 + 0.10 1.58 + 0.15 1.64 + 0.08 1.55 + 0.10 1.49 + 0.03
0.85 - 1.14 1.33 - 1.72 - - 1.50 - 1.62 1.48 - 1.66 1.42 - 1.66 1.41 - 1.64 1.44 - 1.81 1.53 - 1.76 1.43 - 1.67 1.45 - 1.54
1.00 + 0.10 1.72 + 0.17 1.11 + 0.10 1.50 + 0.16 - - 1.08 + 0.10 1.07 + 0.05 1.07 + 0.09 1.12 + 0.05 1.14 + 0.05 1.14 + 0.12
0.90 - 1.24 1.50 - 2.05 1.02 - 1.28 1.32 - 1.70 - - 0.94 - 1.20 0.99 - 1.11 0.98 - 1.21 1.07 - 1.19 1.05 - 1.21 0.99 - 1.28
1.00 + 0.04 1.48 + 0.07 - - 1.00 + 0.06 0.99 + 0.05 1.02 + 0.05 1.02 + 0.05 1.05 + 0.02 1.23 + 0.02 1.32 + 0.07 1.37 + 0.07
0.94 - 1.07 1.33 - 1.58 - - 0.91 - 1.07 0.91 - 1.03 0.94 - 1.08 0.96 - 1.08 1.02 - 1.06 1.21 - 1.25 1.23 - 1.39 1.29 - 1.48
1.00 + 0.06 1.54 + 0.09 - - 1.59 + 0.13 1.54 + 0.05 1.57 + 0.07 1.52 + 0.09 1.54 + 0.13 1.62 + 0.11 1.53 + 0.07 1.56 + 0.09
0.90 - 1.09 1.39 - 1.69 - - 1.42 - 1.73 1.46 - 1.61 1.50 - 1.66 1.42 - 1.63 1.40 - 1.75 1.50 - 1.74 1.43 - 1.60 1.47 - 1.71
1.00 + 0.05 1.58 + 0.12 0.97 + 0.02 1.27 + 0.08 - - 1.05 + 0.03 1.08 + 0.04 1.09 + 0.02 1.10 + 0.04 1.15 + 0.04 1.13 + 0.04
0.93 - 1.11 1.40 - 1.76 0.94 - 1.00 1.18 - 1.40 - - 1.02 - 1.09 1.02 - 1.11 1.07 - 1.13 1.06 - 1.15 1.09 - 1.20 1.09 - 1.19
1.00 + 0.08 1.61 + 0.12 - - 1.12 + 0.07 1.05 + 0.11 1.05 + 0.01 1.04 + 0.06 1.13 + 0.06 1.17 + 0.08 1.34 + 0.09 1.38 + 0.06
0.89 - 1.12 1.46 - 1.76 - - 1.06 - 1.21 0.96 - 1.19 1.03 - 1.06 0.96 - 1.11 1.09 - 1.23 1.06 - 1.25 1.23 - 1.45 1.30 - 1.45
1.00 + 0.06 1.77 + 0.11 - - 1.93 + 0.10 1.69 + 0.11 1.78 + 0.07 1.91 + 0.07 1.96 + 0.09 1.96 + 0.09 2.00 + 0.08 1.92 + 0.13
0.92 - 1.08 1.59 - 1.90 - - 1.85 - 2.08 1.60 - 1.87 1.71 - 1.90 1.81 - 1.98 1.87 - 2.11 1.85 - 2.06 1.86 - 2.06 1.75 - 2.09
1.00 + 0.05 1.76 + 0.10 1.19 + 0.20 1.73 + 0.43 - - 1.19 + 0.05 1.28 + 0.07 1.29 + 0.08 1.29 + 0.04 1.36 + 0.10 1.25 + 0.07
0.92 - 1.08 1.64 - 1.97 0.97 - 1.50 1.45 - 2.46 - - 1.10 - 1.23 1.21 - 1.40 1.17 - 1.36 1.24 - 1.32 1.22 - 1.48 1.18 - 1.35
1.00 + 0.03 1.83 + 0.14 - - 1.00 + 0.03 1.05 + 0.11 1.11 + 0.04 1.08 + 0.10 1.13 + 0.07 1.11 + 0.06 1.25 + 0.06 1.35 + 0.06
0.94 - 1.04 1.51 - 2.02 - - 0.96 - 1.03 0.96 - 1.22 1.04 - 1.15 0.97 - 1.22 1.06 - 1.22 1.01 - 1.16 1.18 - 1.34 1.30 - 1.44
1.00 + 0.08 1.83 + 0.11 - - 1.73 + 0.09 1.81 + 0.08 1.86 + 0.07 1.93 + 0.05 1.97 + 0.09 1.92 + 0.06 1.96 + 0.09 1.99 + 0.07
0.90 - 1.15 1.63 - 1.98 - - 1.63 - 1.84 1.70 - 1.93 1.75 - 1.93 1.89 - 2.02 1.83 - 2.06 1.83 - 1.98 1.80 - 2.04 1.90 - 2.10
1.00 + 0.07 1.93 + 0.21 1.01 + 0.07 1.29 + 0.05 - - 1.07 + 0.03 1.15 + 0.04 1.12 + 0.03 1.17 + 0.04 1.24 + 0.09 1.31 + 0.17
0.87 - 1.12 1.72 - 2.39 0.93 - 1.12 1.25 - 1.36 - - 1.03 - 1.12 1.11 - 1.20 1.07 - 1.16 1.12 - 1.22 1.14 - 1.36 1.12 - 1.53
1.00 + 0.07 1.56 + 0.13 - - 1.03 + 0.03 1.04 + 0.04 1.10 + 0.10 1.08 + 0.03 1.07 + 0.03 1.13 + 0.02 1.19 + 0.03 1.24 + 0.07
0.92 - 1.12 1.41 - 1.89 - - 1.00 - 1.08 0.99 - 1.08 0.96 - 1.21 1.05 - 1.12 1.05 - 1.13 1.11 - 1.15 1.14 - 1.23 1.15 - 1.33
1.00 + 0.08 1.64 + 0.14 - - 1.59 + 0.05 1.61 + 0.10 1.69 + 0.05 1.70 + 0.12 1.73 + 0.06 1.74 + 0.09 1.70 + 0.13 1.68 + 0.09
0.91 - 1.13 1.52 - 2.00 - - 1.52 - 1.66 1.47 - 1.75 1.65 - 1.78 1.49 - 1.78 1.65 - 1.78 1.59 - 1.82 1.54 - 1.90 1.57 - 1.80
1.00 + 0.05 1.63 + 0.08 1.13 + 0.05 1.50 + 0.12 - - 1.12 + 0.03 1.12 + 0.05 1.13 + 0.03 1.17 + 0.10 1.08 + 0.03 1.07 + 0.01
0.94 - 1.13 1.52 - 1.77 1.06 - 1.18 1.35 - 1.63 - - 1.09 - 1.17 1.05 - 1.16 1.08 - 1.16 1.03 - 1.30 1.04 - 1.12 1.06 - 1.09
1.00 + 0.09 1.57 + 0.12 - - 1.00 + 0.06 0.95 + 0.06 1.01 + 0.09 0.99 + 0.08 1.04 + 0.08 1.07 + 0.07 1.18 + 0.20 1.22 + 0.12
0.89 - 1.16 1.39 - 1.78 - - 0.93 - 1.08 0.85 - 0.99 0.88 - 1.11 0.87 - 1.08 0.94 - 1.16 0.97 - 1.15 0.92 - 1.41 1.10 - 1.41
1.00 + 0.07 1.62 + 0.13 - - 1.58 + 0.09 1.56 + 0.10 1.51 + 0.04 1.64 + 0.07 1.59 + 0.06 1.69 + 0.10 1.74 + 0.08 1.69 + 0.08
0.90 - 1.10 1.44 - 1.80 - - 1.47 - 1.67 1.45 - 1.68 1.44 - 1.54 1.53 - 1.72 1.54 - 1.69 1.56 - 1.80 1.66 - 1.88 1.60 - 1.79
1.00 + 0.16 1.56 + 0.16 1.12 + 0.14 1.49 + 0.20 - - 0.99 + 0.06 1.10 + 0.05 1.00 + 0.07 1.14 + 0.11 1.16 + 0.09 1.16 + 0.10
0.83 - 1.35 1.24 - 1.79 1.02 - 1.35 1.17 - 1.71 - - 0.91 - 1.07 1.02 - 1.14 0.89 - 1.07 1.02 - 1.33 1.04 - 1.25 1.08 - 1.28
1.00 + 0.07 1.44 + 0.09 - - 1.12 + 0.16 1.04 + 0.06 1.01 + 0.09 1.10 + 0.09 1.06 + 0.08 1.08 + 0.07 1.03 + 0.03 1.05 + 0.06
0.91 - 1.12 1.32 - 1.56 - - 0.96 - 1.37 0.97 - 1.13 0.91 - 1.11 1.03 - 1.25 1.02 - 1.20 1.01 - 1.20 1.00 - 1.07 1.00 - 1.15
1.00 + 0.09 1.50 + 0.14 - - 1.59 + 0.06 1.51 + 0.10 1.45 + 0.11 1.59 + 0.20 1.49 + 0.08 1.56 + 0.09 1.34 + 0.37 1.44 + 0.06
0.86 - 1.13 1.31 - 1.71 - - 1.50 - 1.65 1.42 - 1.68 1.32 - 1.60 1.43 - 1.89 1.42 - 1.62 1.44 - 1.70 0.70 - 1.60 1.37 - 1.52
1.00 + 0.08 1.61 + 0.10 1.04 + 0.07 1.50 + 0.11 - - 1.10 + 0.09 1.11 + 0.05 1.17 + 0.07 1.16 + 0.04 1.09 + 0.02 1.08 + 0.04
0.89 - 1.13 1.50 - 1.85 0.93 - 1.12 1.41 - 1.69 - - 0.98 - 1.19 1.04 - 1.16 1.07 - 1.24 1.12 - 1.21 1.07 - 1.11 1.02 - 1.12
Composite 11
Composite 11 with Estradiol
Composite 11 with Hydroxytamoxifen
Composite 9
Composite 9 with Estradiol
Composite 9 with Hydroxytamoxifen
Composite 10
Composite 10 with Estradiol
Composite 10 with Hydroxytamoxifen
Composite 7
Composite 7 with Estradiol
Composite 7 with Hydroxytamoxifen
Composite 8
Composite 8 with Estradiol
Composite 8 with Hydroxytamoxifen
Composite 5
Composite 5 with Estradiol
Composite 5 with Hydroxytamoxifen
Composite 6
Composite 6 with Estradiol
Composite 6 with Hydroxytamoxifen
Composite 3
Composite 3 with Estradiol
Composite 3 with Hydroxytamoxifen
Composite 4
Composite 4 with Estradiol
Composite 4 with Hydroxytamoxifen
Composite 1
Composite 1 with Estradiol
Composite 1 with Hydroxytamoxifen
Composite 2
Composite 2 with Estradiol
Composite 2 with Hydroxytamoxifen
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from Ford City (Composites 4 and 6).  Gender does not appear to be a factor in either case.  The 
graphs for BT-20, MCF-7 and T47D analyses are shown in Appendices A, B and C, respectively. 
 
Table 8. Summary of the Estrogen Response Profile (ERP) for Cell Proliferation Assays by Composite 
 1 2 3 4 5 6 7 8 9 10 11 
BT20 - - - - - - - - - - - 
MCF7 - -/+ - -/+ -/+ -/+ -/+ - -/+ -/+ - 
T47D -/+ -/+ - + -/+ + -/+ -/+ -/+ -/+ - 
Key: 
-          No Response 
-/+      Weak (sub-estrogenic) Response 
+         Estrogenic Response 
++      Strong Response 
 
 
2.3.3 Estrogenicity Index 
Table 9, MCF-7 Estrogenicity Index Data Summary (Mean with SD and Range), displays the 
results of the mean EI with standard deviations and ranges for all eleven composites in each 
dilution range for the MCF-7 analysis.  Table 10, T47D Estrogenicity Index Data Summary 
(Mean with SD and Range), displays the same results for the T47D analysis. 
Results for average EI of MCF-7 and T47D cell lines were plotted for location and 
gender by analyses and then for analyses by composite.  Refer to Figures 9-25 for various plots 
of average EI versus dilution. Figures 9-14 show the cell lines plotted for location and gender by 
analyses.  These figures clearly show that extracts from fish caught in Ford City exhibit higher 
estrogenic responses in both genders and in both MCF-7 and T47D analyses.  In Figures 15-25, 
cell lines were plotted by composite.  The T47D estrogenic responses were higher in all dilutions 
for Composites 3, 4, 5 and 11.  The T47D cells appear to  
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Table 9. MCF-7 Estrogenicity Index Data Summary (Mean with SD and Range) 
 
 
Table 10. T47D Estrogenicity Index Data Summary (Mean with SD and Range) 
 
  
1/4000 1/3000 1/2000 1/1500 1/1000 1/500 1/200 1/100
0.16 + 0.05 0.14 + 0.04 0.05 + 0.06 0.02 + 0.08 0.09 + 0.09 0.15 + 0.05 0.11 + 0.08 0.23 + 0.11
0.12 - 0.24 0.10 - 0.18 -0.06 - 0.10 -0.08 - 0.14 0.00 - 0.24 0.08 - 0.21 0.05 - 0.25 0.10 - 0.38
0.11 + 0.07 0.03 + 0.03 0.08 + 0.05 0.12 + 0.05 0.10 + 0.05 0.11 + 0.05 0.18 + 0.05 0.23 + 0.04
0.07 - 0.24 -0.03 - 0.05 0.03 - 0.15 0.07 - 0.17 0.04 - 0.16 0.04 - 0.16 0.14 - 0.26 0.17 - 0.26
0.10 + 0.08 0.00 + 0.08 -0.01 + 0.05 0.00 + 0.04 0.00 + 0.04 0.03 + 0.04 0.06 + 0.05 0.07 + 0.05
-0.01 - 0.21 -0.06 - 0.13 -0.05 - 0.08 -0.04 - 0.04 -0.07 - 0.04 -0.03 - 0.07 0.01 - 0.13 0.00 - 0.13
0.18 + 0.07 0.22 + 0.08 0.23 + 0.05 0.22 + 0.10 0.39 + 0.12 0.47 + 0.11 0.48 + 0.11 0.41 + 0.07
0.07 - 0.24 0.15 - 0.31 0.15 - 0.28 0.11 - 0.33 0.22 - 0.49 0.34 - 0.60 0.34 - 0.63 0.30 - 0.49
0.00 + 0.07 0.03 + 0.07 0.03 + 0.06 -0.02 + 0.04 -0.02 + 0.02 0.01 + 0.04 0.12 + 0.03 0.14 + 0.05
-0.09 - 0.10 -0.04 - 0.13 -0.04 - 0.11 -0.07 - 0.04 -0.05 - 0.01 -0.03 - 0.07 0.09 - 0.16 0.07 - 0.21
0.00 + 0.02 -0.02 + 0.05 0.12 + 0.02 0.10 + 0.03 0.20 + 0.06 0.31 + 0.07 0.45 + 0.04 0.39 + 0.04
-0.03 - 0.03 -0.09 - 0.04 0.10 - 0.16 0.06 - 0.14 0.13 - 0.27 0.23 - 0.39 0.39 - 0.49 0.33 - 0.42
0.20 + 0.07 0.07 + 0.05 0.12 + 0.05 0.12 + 0.03 0.21 + 0.07 0.24 + 0.01 0.35 + 0.02 0.35 + 0.04
0.10 - 0.27 0.02 - 0.13 0.07 - 0.18 0.07 - 0.14 0.13 - 0.29 0.23 - 0.26 0.34 - 0.37 0.31 - 0.41
0.12 + 0.08 0.15 + 0.06 0.14 + 0.09 0.03 + 0.08 0.04 + 0.04 0.11 + 0.04 0.17 + 0.08 0.18 + 0.10
0.03 - 0.20 0.09 - 0.23 0.04 - 0.29 -0.05 - 0.13 -0.01 - 0.08 0.06 - 0.16 0.06 - 0.25 0.09 - 0.32
0.18 + 0.07 0.10 + 0.09 -0.02 + 0.05 0.07 + 0.04 0.03 + 0.07 0.08 + 0.06 0.20 + 0.05 0.20 + 0.05
0.10 - 0.27 0.02 - 0.21 -0.08 - 0.04 0.01 - 0.10 -0.06 - 0.10 0.00 - 0.16 0.14 - 0.27 0.13 - 0.28
0.22 + 0.05 0.12 + 0.02 0.02 + 0.05 0.02 + 0.06 0.05 + 0.03 0.01 + 0.05 0.12 + 0.06 0.12 + 0.04
0.15 - 0.27 0.09 - 0.14 -0.04 - 0.09 -0.07 - 0.09 0.02 - 0.09 -0.04 - 0.06 0.05 - 0.20 0.07 - 0.16
0.10 + 0.07 0.06 + 0.06 0.02 + 0.07 0.01 + 0.05 0.02 + 0.07 0.02 + 0.04 0.01 + 0.04 0.00 + 0.05
0.03 - 0.20 0.00 - 0.14 -0.07 - 0.10 -0.04 - 0.07 -0.06 - 0.11 -0.02 - 0.06 -0.03 - 0.08 -0.05 - 0.09
Composite 7
Composite 8
Composite 9
Composite 10
Composite 11
Composite 1
Composite 2
Composite 3
Composite 4
Composite 5
Composite 6
1/4000 1/3000 1/2000 1/1500 1/1000 1/500 1/200 1/100
0.13 + 0.11 0.10 + 0.10 0.08 + 0.06 0.12 + 0.04 0.22 + 0.08 0.24 + 0.06 0.36 + 0.11 0.54 + 0.08
-0.02 - 0.25 -0.02 - 0.20 0.02 - 0.16 0.06 - 0.18 0.11 - 0.32 0.18 - 0.34 0.25 - 0.51 0.48 - 0.67
0.14 + 0.08 -0.06 + 0.17 0.03 + 0.10 0.10 + 0.17 0.35 + 0.14 0.23 + 0.04 0.35 + 0.08 0.46 + 0.10
0.04 - 0.24 -0.24 - 0.21 -0.12 - 0.13 -0.11 - 0.27 0.22 - 0.53 0.18 - 0.27 0.28 - 0.45 0.34 - 0.60
0.31 + 0.12 0.22 + 0.08 0.18 + 0.12 0.06 + 0.10 0.07 + 0.16 0.14 + 0.09 0.25 + 0.07 0.38 + 0.18
0.12 - 0.42 0.15 - 0.35 0.03 - 0.33 -0.06 - 0.18 -0.03 - 0.34 0.04 - 0.23 0.17 - 0.35 0.16 - 0.62
0.33 + 0.18 0.37 + 0.11 0.26 + 0.08 0.24 + 0.17 0.47 + 0.18 0.68 + 0.14 0.96 + 0.13 1.00 + 0.11
0.13 - 0.59 0.25 - 0.48 0.13 - 0.35 0.08 - 0.49 0.21 - 0.63 0.45 - 0.82 0.81 - 1.15 0.83 - 1.15
0.35 + 0.07 0.18 + 0.14 0.11 + 0.16 0.09 + 0.09 0.24 + 0.07 0.20 + 0.15 0.32 + 0.19 0.40 + 0.20
0.28 - 0.44 0.01 - 0.33 0.00 - 0.37 -0.05 - 0.15 0.15 - 0.33 -0.03 - 0.33 0.17 - 0.64 0.26 - 0.75
0.00 + 0.13 -0.03 + 0.10 0.03 + 0.11 0.03 + 0.10 0.10 + 0.04 0.48 + 0.04 0.66 + 0.14 0.78 + 0.15
-0.19 - 0.14 -0.18 - 0.06 -0.11 - 0.16 -0.08 - 0.17 0.04 - 0.13 0.43 - 0.52 0.47 - 0.81 0.60 - 0.99
0.20 + 0.11 0.09 + 0.17 0.08 + 0.02 0.06 + 0.09 0.22 + 0.09 0.28 + 0.14 0.55 + 0.14 0.63 + 0.10
0.09 - 0.35 -0.06 - 0.32 0.06 - 0.10 -0.07 - 0.18 0.15 - 0.37 0.09 - 0.41 0.37 - 0.73 0.50 - 0.73
-0.01 + 0.03 0.06 + 0.13 0.13 + 0.05 0.10 + 0.12 0.15 + 0.08 0.13 + 0.07 0.30 + 0.07 0.42 + 0.07
-0.04 - 0.04 -0.05 - 0.26 0.05 - 0.19 -0.04 - 0.27 0.08 - 0.27 0.01 - 0.19 0.22 - 0.40 0.37 - 0.53
0.06 + 0.05 0.07 + 0.07 0.18 + 0.17 0.14 + 0.05 0.13 + 0.06 0.23 + 0.03 0.34 + 0.06 0.43 + 0.13
0.00 - 0.13 -0.01 - 0.14 -0.07 - 0.38 0.09 - 0.22 0.09 - 0.23 0.20 - 0.27 0.25 - 0.40 0.27 - 0.60
0.01 + 0.11 -0.09 + 0.10 0.02 + 0.16 -0.02 + 0.13 0.06 + 0.15 0.12 + 0.13 0.31 + 0.34 0.39 + 0.20
-0.12 - 0.14 -0.26 - -0.02 -0.21 - 0.19 -0.23 - 0.14 -0.10 - 0.27 -0.05 - 0.26 -0.14 - 0.72 0.18 - 0.72
0.27 + 0.37 0.08 + 0.14 0.03 + 0.19 0.23 + 0.21 0.14 + 0.18 0.18 + 0.17 0.06 + 0.06 0.12 + 0.13
-0.08 - 0.83 -0.07 - 0.29 -0.21 - 0.24 0.06 - 0.58 0.04 - 0.47 0.02 - 0.46 0.00 - 0.15 0.01 - 0.34
Composite 7
Composite 8
Composite 9
Composite 10
Composite 11
Composite 1
Composite 2
Composite 3
Composite 4
Composite 5
Composite 6
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show a stronger response in general than the MCF-7 cell line, which seems to imply that more of 
the estrogenic potential from these samples may be due to an ERβ response.  However, because 
T47D have some content of alpha receptors, this could be a flawed assumption.  T47D cell lines 
are primarily ERβ, but also exhibit some ERα response.  This makes it difficult to determine the 
specific class of chemical that may be causing the estrogenic response in this case.  If the T47D 
would have had a much greater response than the MCF-7, then the EI could have been 
contributed to chemicals only exhibiting ERβ receptor mechanisms.  If the T47D response would 
have been much lower than the MCF-7 results, the EI could then have been contributed to 
chemicals only exhibiting ERα receptor mechanism.  H owever, in this experiment the graphs 
trend quite well with each other, and this relationship was statistically verified by the Spearman’s 
Rank Correlation for the overall analyses.  Therefore, it cannot be determined that one class of 
chemicals is playing a more prominent role in the overall analysis.   
2.3.4 Statistical Results 
Statistical analysis of the calculated EI yielded a significant difference (p < 0 .05) in MCF-7 
estrogenicity when tested by location only, with samples from fish captured at Ford City having 
the higher mean EI.  There were no significant differences when testing for differences in gender 
or weight class.  A  model including all three covariates did not produce significant results.  
Statistical analysis for estrogenicity in T47D cells did not show any significant results. 
It was suspected that extracts from the fish captured in the Freeport area would have 
higher estrogenicity levels than the ones from Ford City because of the higher number of CSOs 
in the Freeport area and because the sampling location at Freeport is in closer vicinity to CSOs  
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Figure 9. All MCF-7 Composites by Location 
 
Figure 10. All T47D Composites by Location 
 
Figure 11. MCF-7 Composites by Locations; Males Only 
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Figure 12. T47D Composites by Location; Males Only 
 
Figure 13. MCF-7 Composites by Location; Females Only 
 
Figure 14. T47D Composites by Location; Females Only 
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Figure 15. Comparison of Average Estrogenicity Index for MCF-7 and T47D Analyses for Composite 1 
 
Figure 16. Comparison of Average Estrogenicity Index for MCF-7 and T47D Analyses for Composite 2 
 
Figure 17. Comparison of Average Estrogenicity Index for MCF-7 and T47D Analyses for Composite 3 
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Figure 18. Comparison of Average Estrogenicity Index for MCF-7 and T47D Analyses for Composite 4 
 
Figure 19. Comparison of Average Estrogenicity Index for MCF-7 and T47D Analyses for Composite 5 
 
Figure 20. Comparison of Average Estrogenicity Index for MCF-7 and T47D Analyses for Composite 6 
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Figure 21. Comparison of Average Estrogenicity Index for MCF-7 and T47D Analyses for Composite 7 
 
Figure 22. Comparison of Average Estrogenicity Index for MCF-7 and T47D Analyses for Composite 8 
 
Figure 23. Comparison of Average Estrogenicity Index for MCF-7 and T47D Analyses for Composite 9 
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Figure 24. Comparison of Average Estrogenicity Index for MCF-7 and T47D Analyses for Composite 10 
 
Figure 25. Comparison of Average Estrogenicity Index for MCF-7 and T47D Analyses for Composite 11 
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Figure 26. Correlation Plot of Estrogenicity Index for MCF-7 Versus T47D Analyses for All Composites 
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and WWTP effluent discharges than the Ford City sample location.  However, this was not found 
to be the case.  Although not significantly different from the Freeport location after adjusting for 
the covariates of gender and weight, samples from fish captured at Ford City had the higher 
mean Estrogenicity Index (e.g. 0.259 at dilution 1/100 vs. 0.171 for Freeport).  This suggests that 
estrogenicity studies cannot be simply designed.  There are multiple factors that have an effect 
on the outcome of the study, not merely CSO density.  It would have been helpful to collect data 
on the amount of flow contributing from each WWTP and CSO outfall, rather than just the 
proximity.  This is difficult because not even the PA DEP collects flow data for CSOs at this 
time.  P revious studies have collected data on t he amounts of total organic nitrogen in these 
areas. Higher nitrogen in the water is a sign that the water has not been processed by a WWTP 
because most WWTP processes will convert organic nitrogen and ammonia into nitrate before it 
leaves as WWTP effluent [19]. In 2003, the United States Geological Survey (USGS) sampled 
Allegheny River surface water in Kittanning (approximately four miles north of Ford City) and 
determined the total nitrogen content to be 0.67 mg/L [152].  Also in 2003, Three Rivers Second 
Nature Project, a group directed by artists and researchers in Allegheny County, PA in 
association with Carnegie Mellon University, sampled Buffalo Creek near the area where the 
creek enters into the Allegheny River and determined the total nitrogen content to be 0.30 mg/L 
[153].  Even though these studies were performed a few years before the current sampling in this 
study, and the sample locations are not exactly the same, the assessments of the areas are useful 
to show that although both areas have low total nitrogen values, the general area near Ford City 
had a total nitrogen value twice as high as that of Freeport.  This data helps to explain why our 
original theory was incorrect.  It is general knowledge that rural areas tend to have higher 
volumes of agricultural runoff and higher usage of septic tanks/outhouses.  T hese two 
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confounding factors may explain why the initial assumption in this study was incorrect and could 
be contributing to xenoestrogenic pollution in the area, rather than CSO density alone. 
Spearman Rank Correlation testing was performed to determine the relationship between 
MCF-7 and T47D analyses.  Figure 26, Correlation Plot of Estrogenicity Index for MCF-7 
Versus T47D Analyses for All Composites, is a plot of the correlation. There is a strong 
correlation between MCF-7 and T47D results, ρ = 0.5056, p < 0.0001.  With a correlation this 
strong, it is safe to say that both the MCF-7 and T47D cell line analyses are equally valid in 
assessing for the estrogenicity of extracts from fish caught in surface waters. 
2.4 PUBLIC HEALTH SIGNIFICANCE 
Estrogenicity in fish extracts can imply environmental pollution by xenoestrogens.  S ome 
examples of such xenoestrogens are pharmaceuticals (e.g. contraceptives or hormone 
replacement therapies), phytoestrogens (dietary xenoestrogens found in some plant products such 
as soy beans and flax seeds), plasticizers such as Bisphenol A, and hygiene product preservatives 
(e.g. parabens).  As determined from this study, the correlation between the MCF-7 and T47D 
analyses results implies that there is probably an equal or mixed amount of ERα and ERβ 
receptor positive chemicals acting to cause the increase in estrogenic potential.  Pharmaceutical 
products for hormone therapy are more likely to be the cause of ERα pollutants than 
phytoestrogens.  Pharmaceutical products have a high potential to reach the water supply when 
excreted into human urine and feces, or are disposed of directly down household drains [19].  
WWTPs are only partially efficient at removing pharmaceuticals and there is a lot of household 
water that is disposed of into community surface waters without the benefit of prior treatment 
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[20].  A lthough this research is not strong evidence that pharmaceutical products are causing 
estrogenic problems in the Ford City and Freeport area surface waters, it leads to stimulating 
results which support future hypothesis generating research. 
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3.0  ANALYSIS OF SURFACE WATER BY HIGH-PERFORMANCE LIQUID 
CHROMATOGRAPHY-MASS SPECTROMETRY 
Fish flesh and fat samples in the Greater Pittsburgh Area have been shown to exhibit estrogenic 
potential, as determined from research in Chapter 2 of this dissertation and previous Center for 
Healthy Environments and Communities (CHEC) studies [148, 149].  I t can be inferred that 
Pittsburgh area surface waters would be the source of such estrogenicity in fish.  A problem with 
screening fish extracts for estrogenic potential via the E-Screen Assay (or any similar cell 
proliferation assay) is that the analysis alone does nothing to discover which chemical, or 
combination of chemicals, is present in a s ample to cause the estrogenic effect.  T herefore, 
research efforts are needed to develop better techniques (e.g. more cost and time efficient 
analytical methods, as well as lower detection limits) to be used in conjunction with cell 
proliferation assays [154].  A  method for analyzing several xenoestrogens in a s urface water 
matrix was developed utilizing available literature and an attempt was made to quantify levels of 
Bisphenol A (BPA) and parabens in six locations along the Allegheny and Monongahela Rivers. 
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3.1 BACKGROUND 
BPA has been thoroughly studied in surface water systems across the world.  B PA has been 
detected in Taiwan surface waters at ranges between 0.037 µg/L (limit of detection) to 4.23 µg/L 
in 59% of samples tested [37].  Surface waters analyzed in Spain and other Mediterranean areas 
discovered BPA in the µg/L range for all samples collected.  United States waters ranged 
between <1.0 to 8.0 µg/L for BPA concentrations [38, 39].  BPA in German waters ranged from 
0.0005 to 0.776 µg/L, and a surface water sample from the Czech Republic was 28 ng/L [39-43, 
57, 155]. Japanese levels varied from <0.005 to 1.9 µg/L, while in China, BPA levels ranged 
from 0.03 to 0.083 µg/L [39, 45-51].  I n the Netherlands, concentrations were found to be 
between <0.012 and 1 µg/L [39, 52, 53].  BPA was detected in 51% of surface waters sampled in 
Portugal in the range of 0.07- 4.0 µg/L [55].  BPA was detected in sewage treatment plant 
influents and effluents in the United Kingdom and Spain, with ranges of 884.7-1105.2 ng/L and 
13.3-19.2 ng/L, respectively [56].  In Germany, Wastewater Treatment Plant (WWTP) effluents 
have BPA concentrations in the 18-33 ng/L ranges [57]. 
Less is known about the transport and fate of parabens in the environment, but it is 
generally believed that they do not persist for long periods of time.  A ny potential endocrine 
disrupting effects will most likely come from direct exposure from market products containing 
parabens.  Wastewater treatment processes have been shown to adequately reduce paraben 
concentrations.  Canosa et. al. showed influent concentrations of methyl paraben in two sets of 
samples were reduced from 2.92 ng /mL to less than detectable in the effluent [108].  E thyl, 
propyl and butyl parabens were reduced to non-detectable as well, with benzyl paraben not being 
present in the influent [108].  With these removal efficiencies, it is not expected that parabens 
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would be present in surface waters [108].  However, this was not found to be the case in Spanish 
research studies.  In a 2009 Spanish study, methyl paraben was detected in tap and surface water 
at 0.040 ng/mL and 0.037 ng/mL, respectively, however ethyl, propyl, butyl and benzyl parabens 
were all below the limits of quantification or non-detectable [118].  In a 2010 study of the same 
area (Northwest Spain), all parabens were present in levels ranging from 0.8 – 105 ng/L, with 
methyl paraben at 54 ng/L, ethyl paraben at 29 ng/L, and derivations of propyl paraben as the 
high and low values [119].  These two studies imply that there may be some seasonal effects on 
the transport and fate of this family of chemicals.  M ethyl paraben is also being detected in 
Spanish tap water in concentrations of 17 ng/L [120]. 
3.2 OBJECTIVES 
The objectives of this study were as follows: 
• To develop a method for analyzing xenoestrogens, particularly BPA and parabens, 
utilizing available literature. 
• To determine if concentrations of xenoestrogens are detectable in Greater Pittsburgh Area 
surface waters. 
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3.3 MATERIAL AND METHODS 
3.3.1 Sample Locations 
Six sample locations were chosen for this study to match the locations where fish were sampled, 
as described in Chapter 4 of this dissertation.  Table 11, Surface Water Sampling Information, 
lists the coordinates of the sample points, as well as general information about sampling.  Figure 
27, Map of Surface Water Sample Locations, is a map of the sample locations with reference to 
the lock and dam system.  A ll surface water locations from this chapter and fish sampling 
locations from Chapters 2 and 4 are in the same vicinity of one another.  The Kittanning location 
was the only fish sampling point that was not sampled for surface water, due to logistical 
concerns. 
Ford City, Pennsylvania is located in Armstrong County on t he Allegheny River 
approximately 40 miles northeast of the city of Pittsburgh and approximately four miles south of 
Kittanning.  Ford City has one permitted WWTP and three permitted Combined Sewer 
Overflows (CSOs), as determined by the Pennsylvania Department of Environmental Protection 
(PA DEP) data file searches.  The sample point is the confluence of the Crooked Creek with the 
Allegheny River.  Water samples were taken near Ford City downstream of the area’s WWTP 
and CSO outfalls, between Allegheny Lock and Dam No 6 and 7, in the Lock and Dam 6 Pool 
[150]. 
Freeport, Pennsylvania is located in Armstrong County on t he Allegheny River 
approximately 28 miles northeast of Pittsburgh.  Freeport has one permitted WWTP and a total 
of five permitted CSOs, as determined by PA DEP data file searches.  Two of the CSOs and the 
WWTP discharge into Buffalo Creek, less than 0.5 miles from where the creek flows into the 
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Allegheny River.  The other three CSOs discharge directly into the Allegheny River, with the 
nearest discharge approximately 0.6 miles up-river of the Freeport sample point.  A ll of the 
Freeport discharges are within one mile of the sample point, and the sample point is between 
Allegheny River Lock and Dam No 4 and 5, in the Lock and Dam 4 Pool [150]. 
Springdale and Harmarville sampling locations are both upstream of all Allegheny 
County Sanitary Authority (ALCOSAN) CSOs and Sanitary Sewer Overflows (SSOs).  
Springdale is located in Allegheny County on the Allegheny River approximately 18 miles 
northeast of Pittsburgh. The sample point is located between Allegheny River Lock and Dam No 
4 and the C.W. Bill Young Lock and Dam, in the C.W. Bill Young Lock and Dam Pool [150].  
Harmarville is located in Allegheny County on the Allegheny River northeast of Pittsburgh.  The 
sample point is located between the Allegheny River Lock and Dam No 2 a nd the C.W. Bill 
Young Lock and Dam, in the Lock and Dam 2 Pool [150]. 
Braddock is located in Allegheny County on the Monongahela River southeast of 
Pittsburgh. The Braddock sample location has eleven CSOs within one mile of it; five are 
upstream and six are downstream.  This sample site is located between the Monongahela River 
Lock and Dam No 3 and the Braddock Lock and Dam, within the Braddock Lock and Dam Pool 
[150]. 
Monessen is located in Westmoreland County on t he Monongahela River south of 
Pittsburgh. There are a total of seventeen CSOs in the area, as determined by PA DEP data file 
searches. Six of the CSOs are upstream of the sample site and eleven downstream, all within 
approximately 2.5 miles on either side of the sample location.  The Monessen sample location is 
upstream of the Monongahela River Lock and Dam No 3, in the Lock and Dam 3 Pool [150]. 
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Figure 27. Map of Surface Water Sample Locations 
3.3.2 Surface Water Sampling Methods 
Sampling techniques were available for a wide variety of analytes and exposure pathways, but 
few exist specifically for suspected xenoestrogens.  A written sampling plan was utilized, with 
specific sample locations, frequency, sample size and sample quantities predetermined so as to 
minimize bias [156, 157].  Sample contamination was avoided at all costs by employing good 
sampling techniques and minimizing the use of hygiene products during sample collection and 
preparation.  This is especially important when analyzing for parabens because they are common 
hygiene product ingredients and could easily damage the integrity of the analysis. 
Surface water samples were taken during the summer months.  Amber glass sample jars 
were conditioned with environmental grade water, kept on i ce, and in darkness to prevent 
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degradation.  Grab samples were obtained using a 1.7L water sampler.  Bottom, middle and top 
aliquots were composited into one liter samples. Top aliquots were all taken at one meter below 
the surface; middle and bottom sample depths are listed in Table 11, Surface Water Sampling 
Information.  R iver conditions, such as temperature, depth, and Total Dissolved Solids (TDS), 
and GPS coordinates were noted for each sample.  Samples were stored for no more than six 
days, in darkness at 4OC, until solid phase extraction could be performed.  Solid phase extraction 
was performed as described in the next section.  
 
 
Table 11. Surface Water Sampling Information 
Sample    
Location 
Sample      
ID 
Sample                    
Date 
Sample             
Time 
Depth of           
river (m) 
Depth of                           
bottom           
aliquot 
(m) 
Ford City FC01 8/12/2009 1125 6.5 5.5 
Freeport FP01 8/12/2009 1306 13.5 12.2 
Springdale SP01 8/12/2009 1450 13.2 12.2 
Harmarville HV02 8/12/2009 1625 7.2 6.2 
Braddock BD01 8/13/2009 1102 4.8 3.6 
Monessen MN02 8/13/2009 1405 3.7 2.7 
      Sample    
Location 
Depth of 
middle  
aliquot 
(m) 
Latitude Longitude Temp. (C)  
Ford City 4.5 N: 40.74939 W: 79.57368 23.1  
Freeport 6.5 N: 40.66216 W: 79.69544 22.2  
Springdale 4.1 N: 40.53582 W: 79.79764 23.2  
Harmarville 3 N: 40.52304 W: 79.85004 23.1  
Braddock 2.6 N: 40.39621 W: 79.87112 24.9  
Monessen 1.75 N: 40.16156 W: 79.86620 25.3  
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3.3.3 Solid Phase Extraction 
C18 Oasis HLB 5cc 200 mg LP glass cartridges were purchased from Waters Corporation.  The 
columns were washed with 100% HPLC grade acetonitrile (Fisher Scientific), then conditioned 
with 1% acetonitrile.  Acetonitrile was also added to all samples, reagents and blanks to make 
them 1% v/v.  Only water that was both deionized and distilled was used for rinsing and standard 
preparation. Use of plastics were minimized in the laboratory environment, but could not be 
completely avoided. All glassware was triple rinsed with deionized and distilled water, then with 
acetonitrile.  The volume extracted varied per sample due to solids in the river; exact extraction 
volumes are listed in Table 12, Solid Phase Extraction Volumes.  Some samples needed to be 
filtered with Whatman filters (934-AH purchased from Fisher Scientific; cat. no. 1827 047).  
One blank, one quality control check, one duplicate sample and one sample with methyl paraben 
added were used to determine the accuracy and precision of the method.  One liter of extracted 
sample was re-extracted in order to test if there was breakthrough of the columns.  All samples 
were eluted with 5 mL of 100% acetonitrile, and the flask was then rinsed with 5 mL of 
acetonitrile to make a 10 mL sample stored in amber glass vials.  The vials were then stored at 
4OC until delivered to the laboratory for analysis. 
Table 12. Solid Phase Extraction Volumes 
Sample Location Sample  ID Filtered (Y/N) Extraction Volume (mL) 
Ford City FC01A No 130 
Ford City Duplicate FC01B Yes 500 
Freeport FP01 No 1000 
Springdale SP01 Yes 400 
Harmarville HV02 No 900 
Braddock BD01 No 750 
Monessen MN02 No 1000 
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3.3.4 Analytical Method for Surface Water Analysis 
Samples were analyzed using High Performance Liquid Chromatography-Mass Spectrometry 
(HPLC-MS) on triple quadrupole mass spectrometer (TSQ Discovery Max).  The HPLC biphasic 
gradient (over 15 minutes) conditions were as follows: C-8 Hypersil gold column, 5 µ, 100 x 4.6 
mm (Thermo Fisher) and H2O : acetonitrile as mobile phase. Five microliters (5 µL) of sample 
were injected using the HPLC autosampler (Surveyor Plus), and the needle was washed in 
between each sample with 100 mL methanol to prevent cross contamination.  All solutions were 
HPLC grade and the water was pre-treated trough C-18 columns (Thermo Fisher) to remove 
contaminating estrogenic chemicals prior to using it for the mobile phase gradient. The vial trays 
were kept chilled throughout the runs. The ions were assessed using multiple reaction monitoring 
of the product ions following argon gas collision fragmentation. The transitions monitored were: 
151.04/92.1, 165.06/92.07, 170.07/92.13, 193.1/92.09 and 227.13/211.9 for methyl paraben, 
ethyl paraben, propyl paraben, butyl paraben and BPA; tube lens 66, 70,  50, 80 and 80; using 
collision energy at 23, 23, 24, 24 a nd 25 respectively and collision gas (argon) pressure at 1.5 
psi.  Electrospray ionization was chosen in the –ve ion mode with activated divert valve to 
monitor only the chromatogram within the expected retention time frame. Using neat standards 
(Sigma-Aldrich), the parent/product masses and the retention time for the parabens and BPA 
were assessed and the limitation of the detection using this method was 0.1-0.3 part per billion 
(µg/L) for the analytical vial. Solid phase extraction was performed in the laboratory and then 
concentration of the sample onto the ion chromatograph column allowed for sample 
concentrations as low as 0.2 ppt to be detectable.   
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The data was analyzed using Xcalibr software package (Thermo) and the results were 
expressed and calculated as total ion current of the area under the curve and were plotted against 
a standard curve with external neat standards. 
3.4 RESULTS AND DISCUSSION 
All samples were analyzed for the following chemicals: methyl paraben, ethyl paraben, propyl 
paraben, butyl paraben, BPA, simazine, atrazine, propazine, and cyanazine.  T he result of the 
quality control check completed for methyl paraben to test accuracy was satisfactory, being 
within 20% of the expected concentration.   Methyl paraben was added to a second sample 
collected from Springdale, and it was determined that there was less than a 50% recovery from 
the solid phase extraction.  This was confirmed by a second extraction of water performed on the 
Springdale sample, which continued to show carryover of methyl paraben, in a concentration 
nearly equal to the original sample, implying that not all methyl paraben is extracted by one pass 
through the C18 column.  It is determined that the solid phase extraction process used in this 
method has a less than 50% recovery rate for methyl paraben in the river water matrix possibly 
because there was not enough C18 media for the unknown concentrations of chemicals or 
possibly due to clogging of the C18 media from solids in the sample.  These results are different 
from the quality control check because it was a deionized water matrix, which would not cause 
clogging of the C18 media like the surface water matrix could.  A duplicate sample analyses was 
attempted on samples collected from Ford City, however it was not a true duplicate sample 
because the analyses were not performed exactly the same way.  Solid phase extraction volumes 
were different due to the turbidity and suspended solids in the sample.  Before performing the 
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duplicate extraction, it was decided that filtration would be necessary to extract an adequate 
volume for analysis, thus slightly altering the true nature of a duplicate sample.  The results of 
this duplicate sample were variable.  Methyl and propyl parabens were reproducible within 25% 
of each other.  Propazine and cyanazine were not detected in either sample.  Atrazine was precise 
with a 4% difference between samples.  H owever, ethyl paraben, butyl paraben and simazine 
were found to have low level positive results in one sample, but were not detected in the other.  
The BPA results had the most variation, with the first sample having a significant positive result 
of 15.4 ppt  and the duplicate sample only having a small positive result (1.2 ppt).   These 
discrepancies are likely attributed to the difference in volumes filtered for the sample, allowing 
for error in calculation caused by the extraction process.  It may be possible that the 
discrepancies may be due to laboratory contamination, although this is less likely for these 
analytes than for the analytes that did not have discrepancies.  It is also possible that some of the 
BPA was removed during the filtration process, because it is suspected that BPA will adsorb 
onto solids because of its high sediment adsorption coefficient [33]. 
Results were compared to a methanol blank and any values below this blank are 
determined to be non-detectable as well.  Methyl paraben was detected in all water samples at 
concentrations above the methanol blank value ranging from 2.2 -17.3 ppt.  Ethyl paraben was 
detected in only one sample, and the results were less than the methanol blank values, therefore, 
we can conclude that ethyl paraben was not detectable in the rivers of Pittsburgh.  P ropyl 
paraben was detected in one sample above the methanol blank values at the Ford City Location 
(confirmed by the duplicate sample analysis) at concentrations of 9.2 and 12.0 ppt.  B utyl 
paraben was only detected in the duplicate analysis of Ford City, at the very low concentration of 
0.2 ppt.  BPA was detected in five out of six sample locations with concentrations ranging from 
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0.6-15.4 ppt. Simazine was detected in all six sample locations in the range of 0.4 -2.7 ppt. 
Atrazine was detected in all samples with concentrations ranging from 1.0-5.3 ppt.  P ropazine 
and cyanazine were not detected in any sample.  Table 13, Results of Surface Water Samples 
(ng/L or ppt), lists the exact concentrations for all of these analytes.   
 
Table 13. Results of Surface Water Samples (ng/L or ppt) 
Sample  
Location 
Methyl 
Paraben 
Ethyl 
Paraben 
Propyl 
Paraben 
Butyl 
Paraben 
Bisphenol 
A 
Ford City 12.3 nd 9.2 nd 15.4 
Ford City 
Duplicate 
16.0 nd 12.0 0.2 1.2 
Freeport 6.0 nd nd nd 0.6 
Springdale 10.0 nd nd nd 2.0 
Harmarville 2.2 nd nd nd nd 
Braddock 17.3 nd nd nd 0.8 
Monessen 13.0 nd nd nd 0.6 
Sample  
Location 
Simazine Atrazine Propazine Cyanazine  
Ford City nd 3.8 nd nd  
Ford City 
Duplicate 
0.4 4.0 nd nd  
Freeport 1.0 4.0 nd nd  
Springdale 2.5 5.0 nd nd  
Harmarville 1.1 4.4 nd nd  
Braddock 2.7 5.3 nd nd  
Monessen 2.0 1.0 nd nd  
*’nd’ = not detectable 
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3.5 PUBLIC HEALTH SIGNIFICANCE 
The concentrations of BPA found in Pittsburgh rivers were fairly low compared to the range of 
0.0005 – 8 µg/L reported in published literature from around the world [37-43, 45-53, 55, 57, 
155]. The results were very similar to value of 28 ng/L reported for the Czech Republic [57].  
The concentrations of parabens were also similar to published literature ranging from 0.8 – 105 
ng/L [119].  While this research was obviously a pilot experiment with only six sample locations 
studied, it can be inferred that the rivers in the Greater Pittsburgh Area do show positive levels of 
suspected xenoestrogens in the surface water media. 
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4.0  ANALYSES OF EXTRACTS FROM FISH BRAIN TISSUE FOR 
XENOESTROGENS AND ESTROGENIC POTENTIAL 
In order to further investigate the presence of xenoestrogens in the Greater Pittsburgh Area, fish 
brain tissue was selected for analysis because it has a high lipid content and would therefore be 
likely to have a higher potential to bioconcentrate chemicals in that area.   
The method utilized in Chapter 3 to study xenoestrogens in a surface water matrix was 
further developed to allow for the analysis of parabens and Bisphenol A (BPA) in a tissue 
matrix.    B ecause methods of solid phase extraction are not available for tissue samples, 
derivatization by dansyl chloride was necessary for the analysis via High Performance Liquid 
Chromatography-Mass Spectrometry (HPLC-MS).  Dansyl chloride derivatization enhances the 
specificity of the determination of xenoestrogens. Dansyl chloride easily reacts with phenolic 
hydroxyl and amino groups, which tend to be present in most suspected Endocrine Disrupting 
Chemicals (EDCs).  Interference from other compounds decreases when detection is specified 
for the dansyl derivatives [62].  Derivatization with dansyl chloride has been used previously 
with liquid chromatography methods to allow for greater sensitivity and selectivity of 
alkylphenols [68].  Fish were sampled from similar locations to the surface water study described 
in Chapter 3 so that observed Bioconcentration Factors (BCFs) could be calculated.   
MCF-7 cell proliferation assays are becoming a co mmon practice for determining the 
estrogenicity of a s ample.  Previous research has studied the total estrogenicity of fish 
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compounds by performing MCF-7 cell line analysis to determine cell proliferation rates after 
exposure to the fish serum [148, 149].  However, these methods do nothing to help determine 
which chemicals are causing the increases in estrogenicity of the fish.  Little, if any, research has 
been published linking MCF-7 proliferation results to specific environmental xenoestrogen 
exposures.  In this study, extracts from fish brain tissues were analyzed for estrogenicity in an 
attempt to correlate the results of the HPLC-MS analysis to the estrogenicity of the samples. 
4.1 OBJECTIVES 
The objectives of this study were as follows: 
• To develop a method for analyzing xenoestrogens, particularly BPA and parabens, in a 
tissue matrix. 
• To determine if concentrations of xenoestrogens were detectable in extracts from fish 
brain tissue sampled in the Greater Pittsburgh Area. 
• To determine the estrogenicity of the extracts from fish brain tissues via 
Bromodeoxyuridine (BrdU) Analysis using MCF-7 human breast cancer cells. 
• To determine if there are relationships between fish characteristics and the results of 
either of these analyses (HPLC-MS and/or BrdU). 
• To determine if there is a correlation between the detected xenoestrogens and 
estrogenicity, if applicable. 
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4.2 MATERIAL AND METHODS 
4.2.1 Sampling Locations 
A total of seven sampling sites were selected for this study.  The Center for Healthy 
Environments and Communities (CHEC) and Allegheny River Stewardship Project (ARSP) 
researchers collected samples from Freeport, Fort City, and Springdale locations based on 
investigation from previous studies from those same locations described in Chapter 2 of this 
dissertation [148, 149].  CHEC then paired with researchers from the United States Geological 
Survey (USGS) who were taking fish samples in the area to extend this research to the other four 
locations, (Kittanning, Harmarville, Braddock, and Monessen) which also overlapped with 
previous CHEC research locations. 
Six of the seven sampling locations are the same as listed in Chapter 3 for surface water 
analysis via HPLC-MS.  F ish from Kittanning, Pennsylvania were available from USGS and 
were determined to be valuable to this study. 
Kittanning, Pennsylvania is located on t he Allegheny River approximately 44 miles 
northeast of Pittsburgh.  T he sampling site is located downstream from one Combined Sewer 
Overflow (CSO), as determined by the Pennsylvania Department of Environmental Protection 
(PA DEP) data file searches, and is upstream from the Allegheny River Lock and Dam No 7, in 
the Lock and Dam 7 Pool [150].  
Refer to Chapter 3 for descriptions of CSO outfalls and lock and dam pool information 
for all other sample locations.  Figure 28, M ap of Seven Fish Sample Locations with Nearby 
Sewage Outfalls, shows the seven locations of fish sampling, the relative locations of WWTPs 
and CSO overflows and barriers of fish movement offered by lock and dam systems. Although 
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fish are generally free to move within a specific lock and dam system, the fish sampled from 
these seven locations are independent of one another.  Lock and dam facilities exist along the 
Allegheny and Monongahela Rivers between each sample location, making it unlikely that the 
fish would travel across dams to reach the other locations [150]. 
 
 
Figure 28. Map of Seven Fish Sample Locations with Nearby Sewage Outfalls 
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4.2.2 Sampling Methods 
The methods for sampling and dissecting fish were described in Chapter 2 of  this dissertation.  
All of the same regulations and protocols were followed for this study as well. 
4.2.3 Sample Extraction and Preparation for HPLC-MS Analysis 
Samples were placed in a p olypropylene round bottom tube (Falcon-352063) and 2 mL of 
Environmental Grade Water Optima LC/MS (Fisher-W6-4) were added.  U sing Tissue Tearor 
(Biospec Products-985370), the tissues were homogenized in the polypropylene tubes.  E ach 
homogenized tissue was then divided into two 1 mL aliquots, stored in disposable culture tubes 
(Fisher-14-958-G).   Ne xt, two mL of ethyl acetate was added to each tube, and tubes were 
mixed at high speed for 20 seconds.  Samples were then placed in the centrifuge at 3000 RPM 
for three minutes.  The solvent phase of the mixture was transferred to a new culture tube and 
vacuum dried using Speed Vac Plus (Savant-SC110A) and Refrigerated Vapor Trap (Savant-
RVT100) in the Gel Dryer Vacuum System.  Two mL of hexane was added to the aqueous phase 
of the centrifuged sample, mixed for 20 seconds at maximum speed and centrifuged again at 
3000 RPM for three minutes.  The solvent phase was then transferred to a new tube and vacuum 
dried as described above.  A fter drying, all samples were stored at -20oC and protected from 
light.  Each sample was then extracted into four tubes, two from the ethyl acetate solvent phase 
and two from the hexane solvent phase.  Three hundred µL of methanol was then added to each 
tube and all were vortexed.  One hundred twenty µL was extracted for straight analysis, 120 µL 
for was extracted for dBPA present analyses, and the remaining 60 µL was derivatized as 
described in the next section.   
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4.2.4 Derivatization for HPLC-MS Analysis 
The background concentrations of BPA and parabens in the mobile phase generated measurable 
signals because of the concentration effect of the C-8 column. In an effort to increase the 
sensitivity of the assay, a method that relies on chemical derivatization of OH-containing 
compounds was adopted. The samples were extracted as described above from fish brains. 
Environmental-grade water used for the extraction contained 100 ppt of 16d (deuterium) BPA as 
an internal quality control.  F ollowing vacuum desiccation of the organic phase, the samples 
were resuspended in 100 µL sodium bicarbonate (0.1 M in water). Dansyl chloride (Sigma-
Aldrich) was added (100 mL, 1 mg/mL) in acetone, briefly mixed with vortexing and incubated 
in a water bath for 10 minutes at 60oC. The samples were then cooled and extracted with 1.5 µL 
ethyl acetate.  The organic phase was separated by centrifugation and dried under vacuum. The 
derivatized samples were resuspended in 100 mL methanol and moved to HPLC screw top vials. 
4.2.5 Analytical Method for HPLC-MS Analysis 
The newly derivatized ions were assayed via HPLC-MS on a triple quadrupole mass 
spectrometer (TSQ Discovery Max) using electrospray ionization in the positive ion mode. The 
new m/z for the dansylated (DS) compounds were: 386.14, 399.93, 4 14.08, 428.08, 440.25, 
440.25, 454.26, 522.3, 530.3, 695.29, 709.31 f or DS-MP, DS-EP, DS-PP, DS-BP, DS-octyl 
phenol, DS-tert-octyl phenol, DS-nonyl phenol, DS-estriol, DS-ethynyl estradiol, DS-BPA and 
DS-16d-BPA respectively.  The prominent product ions after argon gas collision were 171.1.1, 
171.06, 171.06, 170.97, 170.97, 170.97, 171.06, 170.95, 170.1 and 170 and the collision energy 
used was 27, 25, 28,  27, 29, 29, 34,  34, 37, 36 respectively. The samples were resolved on C-8 
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reverse phase column (C-8 Hypersil gold) using mobile phase gradient for 30 minutes with 0.1% 
formic acid (A) and 100% acetonitrile (D). The gradient for this HPLC method was: 0 min 99% 
A 1% D, 3 min 60% A  40% D, 22 min 100% D, hold 100% D for 3 minutes, 29 min 99% A 1% 
D and 2 minutes hold for the last condition. The injection volume was 5 µL and the needle was 
washed between the samples in 100% methanol.  This method was unsuccessful for DS-octyl 
phenol, DS-tert-octyl phenol, and DS-nonyl phenol due to interferences at the peak retention 
time and/or background contamination.  These problems did not occur for BPA or parabens. 
The data was analyzed using Xcalibr software package (Thermo) and the results were 
expressed and calculated as total ion current of the area under the curve and were plotted against 
a standard curve with external neat standards. With the derivatized compounds, DS-16d-BPA 
was used as internal calibrator or quality control for the extraction and loading of the samples.  
The limitation of the detection using this method was 0.1-0.3 part per billion (µg/L) in the 
sample vial. 
4.2.6 Analytical Method for Bromodeoxyuridine (BrdU) Analysis 
Fish brain samples were weighed and their masses were recorded before liquid phase extraction 
with environmental grade water and ethyl acetate occurred, as described above.  The solvent 
phase was then extracted and dried.  One hundred µL of methanol was added.  Five µL of the 
brain extract in methanol was added to MCF-7 breast cancer cells and left to sit for one day.  
Bromodeoxyuridine (BrdU) was added to the cell cultures.  BrdU works by substituting the ‘T’ 
in DNA synthesis with a ‘U’ attached to bromine.  U-Br on the newly synthesized DNA can then 
be detected with an antibody.  Media was removed from the cell plate after an incubation period.  
This leaves the cells attached to the plate.  D NA was then extracted out of the cells and 
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dissolved.  The protein was removed and the DNA precipitated.  DNA was reconstituted in TE 
Buffer. 
4.2.7 MCF-7 DNA Isolation 
Cells were collected with 100 µL lysis solution.  One µL RNase A was added to the lysate, then 
inverted 25 times and incubated for five minutes at 37oC.  Samples were cooled to room 
temperature in order to precipitate the protein by using ice for one minute.  Next, 33 µL of 
protein precipitate was added to the solution, vortexed vigorously at high speed for 20 seconds, 
and then centrifuged at 13,000-16,000 xg for 1 minute.  This was repeated until a tight pellet was 
formed.  The supernate was poured into clean 1.5 m L eppendorf tubes containing 150 µL of 
100% isopropanol (2-propanol) used to precipitate the DNA.  It was then mixed by inverting 50 
times and centrifuged at 13,000-16,000 xg for one minute or until the DNA was visible.  Again, 
the supernate was poured off and drained.  One hundred microliters (100 µL) of 70% ethanol 
was added, inverted several times, then centrifuged for one minute.  The ethanol was poured off 
and dried.  Fifty µL TE Buffer was added. 
SSC Buffer was added to the sample during membrane preparation.  D NA adheres to 
membrane and is dot-blotted on a Nitro-cellulous membrane using a western blot.  T he 
membrane was soaked in water and treated with UV light, then fixed with an anti-BrdU 
antibody.  A  second anti-body was added to detect the first, and light is emitted based on the 
intensity of the signal. 
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4.2.8 BPA and BrdU Data Comparisons and Corrections 
Raw BrdU data was analyzed alongside of a known estradiol standard (3 ppb), as well as a 
known ethinyl estradiol standard (3 ppb), in order to compare results from the samples to 
determine their relative estrogenicity. 
There is, however, the potential for error in pipetting to the initial cell plate during BrdU 
analysis, extraction of the DNA, and blot loading.  An internal control check was performed to 
verify that equal amounts of DNA were loaded on to the blot.  MCF-7 proliferation data were 
divided by the internal control check to correct for errors within DNA synthesis. 
The fish extracts prepared for either analysis (HPLC-MS and MCF-7 cell proliferation 
assay) were not originally corrected for sample size.  The whole brain sample was used during 
extraction, and therefore concentrations were different for each sample.  To correct for this, the 
BrdU results corrected for DNA synthesis were also corrected for the weight of the fish brain 
sample.  BPA vial concentrations in ng/L were back calculated based upon the weight of the fish 
brain sample for reporting results in pg/gram of fish brain. 
4.2.9 Statistical Methods for BPA Analysis 
Preliminary data analyses utilized BPA concentrations rather than BCF calculations because 
BPA concentrations were available for all fish (non-detectable results were considered to be zero 
for statistical purposes) and BCF concentrations were not available for all fish.  BCFs could not 
be calculated in locations where surface water concentrations were non-detectable (Harmarville) 
nor could they be calculated for the Kittanning location because surface water samples were not 
collected.  B CF is calculated from the BPA concentrations, so statistical results should be 
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similar.  The preliminary statistics will provide information on which effects may be significant 
when creating the Subject Specific Random Effects Model to be used with the BPA data.  To 
examine relationships between BPA concentration and certain fish characteristics, three 
nonparametric tests were utilized.  Spearman’s Rank Correlation was utilized for the continuous 
variables of weight and length.  The Kruskal-Wallis test (the nonparametric alternative to one-
way ANOVA) was utilized for the categorical variables species and location, and Wilcoxon 
Mann-Whitney was used for gender. 
Univariate analysis of the BPA statistics showed that location and species may 
significantly influence BPA concentration in fish brain.  A Subject Specific Random Effects 
Model was utilized to determine if these relationships would hold true after adjusting for 
additional covariates.   BPA concentrations were utilized rather than the BCF because they were 
available for all 58 fish, as BCF was only able to be calculated in five of the seven locations.  
The covariates considered for entry into the model were species, gender, weight, length 
and location.  All fish had complete information on species and location. One Freeport sample 
was missing information on gender.  Gender, weight and length data were not available from the 
Braddock, Harmarville, Kittanning and Monessen locations.  A  version of step-wise model 
selection was utilized to determine the optimal model for the data [158]. Because of collinearity 
errors, two models were selected.  The incomplete information on gender, weight and length, as 
well as small sample sizes caused collinearity issues and was prohibitive of the full investigation 
of effects from all factors. 
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4.2.10 Statistical Methods for BrdU Analysis 
Preliminary data analyses utilized average BrdU corrected analysis results rather than individual 
repeated results because univariate analysis is not adequate for repeated measures statistics. The 
preliminary statistics will provide information on which effects may be significant when creating 
the Subject Specific Random Effects Model to be used with the BrdU data.  To examine 
relationships between BrdU analysis results and certain fish characteristics, three nonparametric 
tests were utilized.  Spearman’s Rank Correlation was utilized for the continuous variables of 
weight and length.  The Kruskal-Wallis test (the nonparametric alternative to one-way ANOVA) 
was utilized for the categorical variables species and location, and Wilcoxon Mann-Whitney was 
used for gender. 
Univariate analysis of the Average BrdU statistics showed that length and species may 
significantly influence BrdU analysis results.  A  Subject Specific Random Effects Model was 
utilized to determine if these relationships would hold true after adjusting for additional 
covariates.   A verage BrdU statistics were utilized rather than the individual analysis for each 
fish because univariate analysis does not account for repeated measured analytical results.   
The covariates considered for entry into the model were species, gender, weight, length 
and location.  All fish had complete information on species and location. One Freeport sample 
was missing information on gender.  Gender, weight and length data were not available from the 
Braddock, Harmarville, Kittanning and Monessen locations.  Collinearity errors were a concern 
for this model, as it was for the BPA models. However, adjustments for these errors did not 
reveal any new findings and were therefore excluded from this summary.   A  version of step-
wise model selection was utilized to determine the optimal model for the data [158]. 
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Spearman’s Rank Correlation testing will also be utilized to determine if there is a 
relationship between the concentration of BPA and the average BrdU analysis results. 
4.3 RESULTS 
4.3.1 Analytical Results 
Fifty eight fish were sampled from the rivers in the Greater Pittsburgh Area.  All fish were tested 
for methyl, ethyl, propyl and butyl paraben, as well as BPA.  All samples were non-detectable 
for methyl, ethyl, propyl and butyl parabens.  BPA was detected in 44 of the 58 samples, with a 
range from non-detectable up to 120 pg/gram of fish brain (or ppt by weight) and an average of 
16.4 pg/gram fish brain.  dBPA was found positive in all samples at the correct retention time to 
validate the accuracy of BPA detection.  Table 14, Individual Fish Data and Analytical Results 
for BPA, contains all individual fish concentrations of Bisphenol A, as well as fish 
characteristics for all samples. 
4.3.2 Bioconcentration Factors (BCFs) 
Bioconcentrations factors (BCFs) were calculated for fish using the analytical results from the 
surface water study described in Chapter 3 of this dissertation.  BCFs were calculated as a ratio 
of the final BPA concentration in pg/gram of fish brain (or ppt by weight) to the surface water 
concentration in ng/L (or ppt).  BCFs could not be calculated for the Harmarville location  
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Table 14. Individual Fish Data and Analytical Results for BPA 
Fish Species Gender Location Weight (g) Length (cm) BPA (pg/g) 
1 Shad Male Freeport 200 30.3 2.0 
2 Alewife Male Ford City 150 25.5 3.0 
3 Shad Male Freeport 160 26.8 15.7 
4 Alewife Male Ford City 250 30.0 13.0 
5 Shad Male Freeport 175 25.1 11.5 
6 Alewife Female Ford City 350 31.9 4.4 
7 Shad Female Ford City 203 28.4 4.1 
8 Small Mouth Bass  Freeport 530 34.5 7.1 
9 Shad Male Freeport 150 27.5 4.0 
10 Shad Male Freeport 550 37.4 3.8 
11 Alewife Male Ford City 175 26.5 7.5 
12 Small Mouth Bass Male Springdale 107 21.6 2.5 
13 Small Mouth Bass Male Freeport 125 22.4 3.3 
14 Small Mouth Bass Male Freeport 400 35.1 nd 
15 Alewife Male Ford City 165 26.5 3.7 
16 Small Mouth Bass Male Freeport 200 26.5 15.0 
17 Alewife Male Ford City 275 31.4 nd 
18 Small Mouth Bass Male Springdale 205 25.9 8.2 
19 Shad Female Freeport 250 30.7 nd 
20 Shad Male Freeport 200 29.3 3.1 
21 Shad Female Freeport 225 29.8 66.7 
22 Alewife Male Ford City 175 26.3 nd 
23 Alewife Male Ford City 230 28.4 2.9 
24 Small Mouth Bass Male Ford City 100 22.5 3.7 
25 Shad Male Freeport 650 37.9 nd 
26 Shad Male Ford City 167 26.6 nd 
27 Small Mouth Bass Male Ford City 150 26.5 22.1 
28 Alewife Male Ford City 200 27.0 6.9 
29 Small Mouth Bass Male Springdale 395 31.9 1.3 
30 Small Mouth Bass Male Springdale 150 23.5 7.5 
31 Small Mouth Bass Male Freeport 135 24.0 5.9 
32 Small Mouth Bass Male Ford City 190 25.2 27.3 
33 Small Mouth Bass Male Freeport 190 19.9 nd 
34 Small Mouth Bass Male Springdale 435 33.4 nd 
35 Small Mouth Bass Male Springdale 400 32.0 nd 
36 Alewife Male Ford City 197 27.5 nd 
37 Small Mouth Bass Female Ford City 317 29.5 23.5 
38 Small Mouth Bass Male Springdale 222 26.7 20.0 
39 Small Mouth Bass Male Ford City 375 31.2 25.0 
40 Small Mouth Bass  Monessen   8.9 
41 Small Mouth Bass  Monessen   22.5 
42 Small Mouth Bass  Monessen   85.7 
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Table 14 Continued 
Fish Species Gender Location Weight (g) Length (cm) BPA (pg/g) 
43 Small Mouth Bass  Monessen   32.0 
44 Small Mouth Bass  Braddock   11.5 
45 Alewife Male FordCity 300 31.7 7.5 
46 Shad Male Freeport 180 27.3 nd 
47 Alewife Male Freeport 200 28.4 nd 
48 Alewife Male Freeport 160 26.4 nd 
49 Alewife Female Freeport 320 31.9 40.0 
50 Shad Male Freeport 140 24.4 nd 
51 Shad Female Freeport 600 42.9 3.0 
52 Shad Female Freeport 450 35.7 0.1 
53 Small Mouth Bass  Kittanning   6.9 
54 Small Mouth Bass  Kittanning   9.0 
55 Small Mouth Bass  Kittanning   0.3 
56 Small Mouth Bass  Harmarville   120.0 
57 Small Mouth Bass  Harmarville   60.0 
58 Small Mouth Bass  Harmarville   3.6 
“nd” = not detectable 
 
because surface water results were non-detectable.  BCFs could also not be calculated for the 
Kittanning sample location because this location was not analyzed as part of the surface water 
study.  Table 15, Bioconcentration Factors (BCF) for BPA Using Individual Surface Water 
Results, shows the ranges of BCFs by location and species.  In order to calculate BCFs for all 
locations and to determine what may be more representative BCFs for the entire Pittsburgh area, 
BCFs were also calculated using an average of all of the surface water results from Chapter 3.  
The average value used for calculations was 2.9 ppt, which included all six positive results from 
the seven analyses total (Ford City had two positive results).  T he non-detectable result from 
Harmarville was assumed to be zero for averaging purposes.  These calculations are included in 
Table 16, Bioconcentration Factors (BCF) for BPA Using Average Surface Water Results From 
All Locations.  Calculations performed using the average of the surface water results determined 
BCFs to be much lower than the localized calculations.  This implies that the general Pittsburgh 
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area does not have a regional problem with bioconcentration effects of BPA in fish tissue, but 
that specific communities within the Greater Pittsburgh Area may have a higher risk than others, 
influenced by what industry is in the vicinity. 
Table 15. Bioconcentration Factors (BCF) for BPA Using Individual Surface Water Results 
Location Number of 
Samples 
Number of 
Positive 
Results 
Mean 
Concentration 
(pg/g or ppt 
by weight) 
BCF for 
Shad 
BCF for 
Alewife 
BCF for 
Small 
Mouth 
Bass 
Freeport 22 14 12.9 0.2-111.1 66.7 5.6-25.0 
Ford City 18 14 11.0 3.4 2.4-10.9 3.1-22.7 
Braddock 1 1 11.5 N/A(a) N/A(a) 14.4 
Monessen 4 4 37.3 N/A(a) N/A(a) 14.8-142.9 
Springdale 7 5 7.9 N/A(a) N/A(a) 0.7-10.0 
Total 52 38 7.9-37.3 0.2-111.1 2.4-66.7 0.7-142.9 
(a) Species not sampled at this location. 
 
 
 
Table 16. Bioconcentration Factors (BCF) for BPA Using Average Surface Water Results From All Locations 
Location Number 
of 
Samples 
Number 
of Positive 
Results 
Mean 
Concentration 
(pg/g or ppt 
by weight) 
BCF for 
Shad 
BCF for 
Alewife 
BCF for 
Small 
Mouth 
Bass 
Freeport 22 14 12.9 0.05-23.0 13.8 1.1-5.2 
Ford City 18 14 11.0 1.4 1.0-4.5 1.3-9.4 
Braddock 1 1 11.5 N/A(a) N/A(a) 4.0 
Monessen 4 4 37.3 N/A(a) N/A(a) 0.7-3.1 
Springdale 7 5 7.9 N/A(a) N/A(a) 0.5-6.9 
Harmarville 3 3 61.2 N/A(a) N/A(a) 1.2-41.4 
Kittanning 3 3 5.4 N/A(a) N/A(a) 0.1-3.1 
Total 58 44 5.4-61.2 0.05-23.0 1.0-13.8 0.1-41.4 
(a) Species not sampled at this location. 
 
 
4.3.3 Statistical Results for BPA Analysis 
Univariate statistical analysis determined that there were no significant correlations between 
BPA concentration and length or weight.  There was also not a significant relationship between 
gender and BPA.  A significant relationship between species and BPA concentration was found 
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(p = 0.03) and a borderline significant relationship was found between BPA concentration and 
location (p = 0.06).  Table 17, Relationships Between BPA and Fish Characteristics from 
Preliminary Univariate Analysis, contains p-values and test methods utilized for univariate 
analysis of BPA concentrations. These results were further investigated utilizing Subject Specific 
Random Effects statistical models. 
 
Table 17. Relationships Between BPA and Fish Characteristics from Preliminary Univariate Analysis 
Characteristic p-value Test 
Length 0.4629 Spearman’s Rank Correlation 
Weight 0.8419 Spearman’s Rank Correlation 
Species 0.0314 Kruskal-Wallis 
Gender 0.1873 Wilcoxon Mann Whitney 
Location 0.0613 Kruskal-Wallis 
 
After model selection, location and gender were initially found to be significant 
predictors of BPA concentration when using all seven sample locations as determined using the 
Subject Specific Random Effects Model.  However, the location and gender factors could not be 
placed into a model together because of collinearity errors, so they were placed into separate 
models.  Although species was not found to be a significant predictor during the step-wise model 
selection process, species was selected to remain in both models because of results from the 
univariate analysis.   
Table 18, The BPA Location Model, lists the results of the location model statistics.  
Harmarville was found to produce significantly higher results than all of the other locations.  
This is particularly interesting because Harmarville was the only surface water sample to 
produce non-detectable results.   
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As described, gender was also found to be a significant predictor of BPA concentration.  
Table 19, The BPA Gender Model, lists the results of the gender model statistics.  Males were 
found to have a significantly lower BPA concentration than females from these locations. 
 
Table 18. The BPA Location Model 
Parameter   
Parameter 
Estimate 95% Confidence Limits 
Standard 
Error Pr > ChiSq 
Location 
(baseline=’Braddock’; 
n=1) 
Ford City 8 1.269692    -34.5712 37.11059 18.28651 0.945 
Freeport 2 -697427 -35.6994 35.55991 18.17873 0.997 
Harmarville 3 49.66 10.80591 88.51409 19.82388 0.012 
Kittanning 3 -.143333 -4.99742 32.71076 19.82388 0.757 
Monessen 4 25.735 -1.88531 63.35531 19.19439 0.180 
Springdale 7 -.891428 -1.86333 30.08047 18.35335 0.748 
Species 
(baseline=’Alewife’; 
n=14) 
Shad 5 2.126917 -2.94078 17.19462 7.687743 0.782 
Sm Mouth 
Bass 9 6.179099 -.034173 20.39237 7.251802 0.394 
 
 
Table 19. The BPA Gender Model 
Parameter   
Parameter 
Estimate 95% Confidence Limits 
Standard 
Error Pr > ChiSq 
Gender 
(baseline=’Female’; n=8) Male 8 -13.5959    -0.70724    -0.484558 4.648728     0.003     
Species 
(baseline=’Alewife’; 
n=14) 
Shad 5 -1.3366 -0.802331     7.129131 4.31933     0.757     
Sm Mouth 
Bass 9 4.525412    -0.558123     12.60895 4.124328 0.273     
 
 
 The significant results are different from the univariate analysis.  This is because the 
Subject Specific Random Effects Model adjusts for other covariates while the univariate analysis 
only considers one factor at a t ime.  After adjusting for gender and location, species no longer 
showed a significant effect on BPA concentrations. The effect that was seen in the univariate 
analysis may actually have been caused by gender or location, not species. 
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Table 20. BrdU Analyses Results 
Fish 1st  BrdU 
Raw 
Analysis 
2nd BrdU 
Raw 
Analysis 
Average 
BrdU Raw 
Analysis 
1st  BrdU 
Corrected 
Analysis 
2nd  BrdU 
Corrected 
Analysis 
Average 
BrdU 
Corrected 
Analysis 
1 0.402 0.310 0.333 10.55 12.73 11.64 
2 1.683 1.029 1.192 189.02 69.55 129.29 
3 0.553 1.375 1.169 14.64 42.97 28.80 
4 0.771 0.500 0.568 8.19 7.30 7.75 
5 0.696 0.662 0.671 19.01 14.77 16.89 
6 1.009 0.837 0.880 58.06 43.69 50.87 
7 0.552 1.082 0.949 15.97 30.12 23.04 
8 1.607 2.073 1.957 61.94 90.60 76.27 
9 1.509 1.698 1.651 35.70 38.70 37.20 
10 0.949 0.000 0.237 21.32 0.00 10.66 
11 0.279 0.468 0.421 21.32 29.36 25.34 
12 1.255 -0.073 0.259 61.35 -9.71 25.82 
13 1.031 1.091 1.076 32.38 37.72 35.05 
14 1.268 1.316 1.304 25.40 18.90 22.15 
15 1.794 1.989 1.940 103.13 105.81 104.47 
16 1.777 1.877 1.852 176.74 184.06 180.40 
17 1.548 1.499 1.512 60.76 63.41 62.09 
18 1.829 1.352 1.471 105.24 97.09 101.16 
19 -0.043 0.310 0.222 -2.37 17.94 7.78 
20 0.750 1.047 0.973 14.88 21.99 18.44 
21 1.210 1.769 1.629 110.89 124.42 117.65 
22 1.524 1.171 1.260 145.94 127.20 136.57 
23 1.450 1.411 1.421 47.80 50.21 49.00 
24 1.189 0.747 0.857 67.04 35.77 51.41 
25 0.000 0.064 0.048 0.00 1.65 0.82 
26 0.249 0.886 0.727 14.74 54.55 34.64 
27 1.333 1.490 1.451 33.28 52.33 42.80 
28 0.726 1.280 1.141 78.58 108.35 93.47 
29 1.014 1.673 1.508 20.39 27.61 24.00 
30 1.370 1.806 1.697 61.54 66.20 63.87 
31 0.453 0.458 0.457 14.91 17.50 16.20 
32 1.176 1.218 1.207 34.41 33.72 34.07 
33 1.675 1.093 1.238 111.49 84.04 97.77 
34 0.442 0.837 0.738 11.61 19.63 15.62 
35 0.853 0.691 0.732 28.38 25.05 26.71 
36 0.632 0.170 0.285 26.83 6.27 16.55 
37 0.414 0.604 0.556 10.64 16.80 13.72 
38 1.078 0.760 0.839 38.37 26.58 32.47 
39 1.155 0.690 0.806 31.92 18.10 25.01 
40 0.804 1.478 1.309 26.23 71.31 48.77 
41 1.280 1.522 1.462 94.32 94.67 94.49 
42 0.555 0.557 0.557 83.78 95.88 89.83 
43 0.795 0.434 0.525 28.67 23.54 26.10 
44 0.959 0.774 0.821 72.13 47.38 59.75 
45 1.632 1.446 1.492 168.32 125.07 146.70 
46 1.323 1.054 1.122 132.52 80.27 106.40 
47 0.306 1.756 1.393 12.05 48.06 30.06 
48 1.025 0.457 0.599 21.22 14.57 17.90 
49 1.292 1.090 1.140 109.08 306.53 207.80 
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Table 20 Continued 
Fish 1st  BrdU 
Raw 
Analysis 
2nd BrdU 
Raw 
Analysis 
Average 
BrdU Raw 
Analysis 
1st  BrdU 
Corrected 
Analysis 
2nd  BrdU 
Corrected 
Analysis 
Average 
BrdU 
Corrected 
Analysis 
50 1.277 1.978 1.803 47.52 61.22 54.37 
51 0.400 2.247 1.785 6.96 40.63 23.80 
52 1.176 1.974 1.774 51.96 50.86 51.41 
53 0.980 0.881 0.905 22.33 39.32 30.83 
54 1.921 0.653 0.970 140.83 34.51 87.67 
55 1.077 1.386 1.309 59.63 73.11 66.37 
56 0.664 1.881 1.577 300.76 325.39 313.08 
57 2.114 2.137 2.131 253.27 94.68 173.97 
58 2.006 2.275 2.208 28.30 53.37 40.83 
 
4.3.4 Descriptive Results of Raw BrdU Data 
Raw BrdU data was analyzed alongside of a known estradiol standard (3 ppb) as well as a known 
ethinyl estradiol standard (3 ppb), in order to compare results from the samples to determine their 
relative estrogenicity. Table 20, BrdU Analyses Results, lists all the results from the BrdU 
analyses, including the average raw results from the two BrdU analyses.  Figure 29, Graph of 
Average Raw BrdU Data Compared to Estradiol Control, is a g raph of the average raw data 
plotted as a fold increase over the untreated MCF-7 control cells.  T he estradiol and ethinyl 
estradiol standards had a very similar response, therefore only one was included on the graph for 
comparison purposes.  Two of the three Harmarville samples were greater than the estradiol 
control, exhibiting a very strong estrogenic response from this area. 
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Figure 29. Graph of Average Raw BrdU Data Compared to Estradiol Control 
 
4.3.5 Statistical Results for BrdU Analysis 
Univariate statistical analysis showed no significant correlations between average BrdU analysis 
results and any of the fish characteristics.  There were borderline significant relationships for 
length (p = 0.06) and species (p = 0.07).  Table 21, Relationships Between Average BrdU 
Analysis Results and Fish Characteristics from Preliminary Univariate Analysis, lists all p-values 
and test methods utilized for univariate analysis of BrdU data. These results will be further 
investigated utilizing the Subject Specific Random Effects Model. 
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Table 21. Relationships Between Average BrdU Analysis Results and Fish Characteristics from Preliminary 
Univariate Analysis 
 
Characteristic p-value Test 
Length 0.0550 Spearman’s Rank Correlation 
Weight 0.1308 Spearman’s Rank Correlation 
Species 0.0715 Kruskal-Wallis 
Gender 0.9770 Wilcoxon Mann Whitney 
Location 0.3761 Kruskal-Wallis 
 
After model selection, location and species were found to be significant predictors of 
BrdU analysis results.  Although length was not found to be a significant predictor during the 
step-wise model selection process, it was selected to remain in the model because of results from 
the univariate analysis in order to be consistent with methods employed for BPA analyses.  
However, the length factor caused collinearity errors and could not be incorporated into the 
BrdU analysis model.  Table 22, The BrdU Model, contains BrdU model statistics.  Shad 
exhibited significantly lower estrogenicity when compared to the alewife.  Harmarville was 
found to produce significantly higher results than all of the other locations.  This is particularly 
interesting because Harmaville was also the significant location for BPA concentration and 
produced strong estrogenic potential for raw BrdU analytical comparisons. 
 
Table 22. The BrdU Model 
Parameter   
Parameter 
Estimate 95% Confidence Limits 
Standard 
Error Pr > ChiSq 
Location 
(baseline=’Braddock’; 
n=2) 
Ford City 6 -17.11418    -117.0978     82.86944 51.01299     0.737     
Freeport 4 3.853815    -95.54053     103.2482 50.71233      0.939     
Harmarville 6 116.2051    7.815732     224.5945 55.30173      0.036      
Kittanning 6 1.870021    -106.5194     110.2594 55.30173      0.973     
Monessen 8 5.044485    -99.90309     109.9921 53.54567      0.925     
Springdale 14 -18.37425    -118.7233     81.97482 51.19945     0.720     
Species 
(baseline=’Alewife’; 
n=28) 
Shad 30 -54.43011    -96.46374 -12.3964 21.44613 0.011 
Sm Mouth 
Bass 58 -29.85474       -69.50482 9.795345 20.23 0.140 
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The significant results of the Subject Specific Random Effects Model are different from 
the univariate analysis.  This happens because the model adjusts for other covariates while the 
univariate analysis only considers one factor at a time.  The discrepancy is also likely because it 
was necessary to use the average BrdU analysis results, rather than the individual repeated 
measures for the univariate analysis.  The model allows for the use of repeated measures, thus 
increasing the data set and providing more statistical power. Refer to Table 20, BrdU Analyses 
Results, for a listing of the individual corrected results utilized from the repeated measures 
analyses. 
4.3.6 Correlation between BPA and BrdU Results 
BPA concentration and average BrdU analysis results were tested using the Spearman’s Rank 
Correlation test.  BPA concentration and average BrdU analysis results were significantly 
correlated (r = 0.2793, p = 0.0337).  S ee Figure 30, Graph of Average Corrected BrdU Data 
Compared to BPA Concentration, for a graph of the correlation. 
4.4 CONCLUSIONS AND PUBLIC HEALTH SIGNIFICANCE 
The statistical methods employed in this chapter discovered that location and gender have 
predictor effects on BPA concentration.  Males had lower BPA concentrations than females.  The 
Harmarville location had significantly higher BPA concentrations than all six other sampling 
sites.  This is interesting because it was the one site that had non-detectable surface water BPA 
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Figure 30. Graph of Average Corrected BrdU Data Compared to BPA Concentration 
 
results in Chapter 3.  T hat is probably most easily explained by the fact that only one surface 
water sample was obtained and analyzed.  M ore accurate readings would have been available 
with a larger study.  The statistical methods for BrdU analysis showed that location and species 
had predictor effects on estrogenicity of the samples.  S had exhibited significantly lower 
estrogenicity when compared to the alewife.  It was determined that this was not due to the size 
(as determined by weight or length measurements) of the fish.   
The Harmarville sample site was of particular interest in all facets of this study.  This 
location had higher results for raw BrdU analysis results, as well as significantly higher results 
for both BPA concentration and MCF-7 cell proliferation when compared to all six other sample 
sites during the statistical analyses of corrected results.  It is interesting that the sample results 
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produced with the highest BPA concentrations also provided the greatest estrogenic response, 
leading to the conclusion that BPA may be associated with the increased MCF-7 cell 
proliferation.  This correlation is statistically supported by the results of the Spearman’s Rank 
Correlation, which described a significant relationship between BPA concentration and average 
BrdU analysis results.   
Upon further investigation of the sample location, it was determined that there are epoxy 
paint manufacturing facilities located near the Harmarville sample site (both upstream and 
downstream).  There is also a plastic bottling facility located less than two miles downstream of 
the sample location and within the same lock and dam pool. There is a good likelihood that fish 
exposed downstream could travel and be caught at an upstream location.  These plants do not  
have direct permitted discharges into the Allegheny River according to the United States 
Environmental Protection Agency’s (EPA) public database.  They do, however, have discharges 
into tributaries that flow into the Allegheny River [159].  T he proximity to manufacturing 
facilities which utilize BPA in their products could account for the significantly higher results 
found at the Harmarville location. 
BPA has an Octanol-Water Partition Coefficient (Kow) of 3.32, i ndicating that its 
lipophilicity will allow it to  bioconcentrate in exposed fatty tissues [33].  Exposed fish will 
bioconcentrate BPA via oral and gill exposure routes and therefore have the potential to cause 
the bioaccumulation of BPA throughout the food chain.  This concept has not been generally 
accepted as it is believed that BPA will be conjugated in the gastrointestinal tract quickly enough 
not to allow for bioconcentration [33].  In our research, we tested fish brains; not as a pathway to 
human exposure, but to study the bioconcentration properties of BPA. Brain tissue has a high 
lipid content, and would therefore be likely to have a higher potential to bioconcentrate 
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chemicals than fish flesh.  Analytical methods for testing fish tissue have been available since the 
1990s, however, they have mostly focused on the edible tissues of fish, leaning towards a method 
to quantify exposure [63].  We have proven that BPA can be bioconcentrated in the brain tissue 
of fish. 
Although there are no specific criteria for determining if a chemical is likely to 
bioaccumulate in the environment, the EPA generally uses a BCF factor of >1000 as determining 
a chemical to be a persistent environmental hazard [160]. None of the BCFs calculated in this 
study are anywhere near that range, and are at least a factor of 10 lower than that.  This would 
lead to the conclusion that BPA is not a strongly persistent chemical.  However, the European 
Union considers that any chemical with a BCF >100 has the potential to bioaccumulate in the 
environment and is therefore a danger to the environment [161, 162].   
BPA has a l og Kow equal to 3.32, i ndicating that it will bioconcentrate [27].  
Experimental studies have calculated the expected BCF for BPA to be 68 [161].  Using the log 
Kow of 3.32 and a general BCF equation derived for a variety of fish species and chemicals, the 
calculated (or expected) BCF for BPA is exactly 100 from octanol-water partitioning alone, 
indicating that BCFs lower than this are not really bioconcentrating [163].  The observed BCFs 
reported in this chapter are comparable to both expected values.   
Expected values for parabens should be theoretically similar to BPA but because the log 
Kow values for parabens are slightly lower than BPA, it is  expected that they would have a 
weaker ability to bioconcentrate in the fish tissue.  Log Kow values reported for parabens increase 
with increasing chain length: below 3 f or methyl and ethyl paraben, just around 3 f or propyl 
paraben, and are greater than 3 for butyl paraben [104, 105, 107, 108].  However, they might still 
be expected to bioconcentrate if the chemicals had been detectable in the surface water.  In our 
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study, only methyl paraben was found at consistent concentrations across all locations. This 
analyte has the lowest log Kow, and therefore the least likelihood to be bioconcentrated.  It is not 
surprising that we were unable to detect parabens in extracts from brain tissue of the fish from 
these locations after analyzing the surface water locations also. 
Environmental concentrations of BPA found in this study (maximum of 120 pg/g and 
average 16 pg/g) may be at biologically relevant concentrations.  Median estradiol values in the 
human body range from 100 – 1000 pmol/L (50 – 250 pg/mL) for the average woman of child-
bearing age [164, 165].  Assuming that the density of human blood and fish brains are relatively 
similar, these concentrations are within the same magnitude of each other.  BPA is known in 
vitro to be approximately 10,000 t imes weaker than estradiol [13]. However, this study 
determined that fish with the highest levels of BPA (from Harmarville) also exhibited significant 
estrogenic effects in the BrdU assay, at levels equivalent to the estradiol controls.  This suggests 
a few possibilities that cannot be determined from this study: BPA may not be the only 
contributor to the estrogenicity of the fish extract, BPA may have an additive/synergistic effects 
in combination with unknown chemicals present in the sample, or BPA is more potent than 
originally thought.  
Usually bioconcentration studies are employed to determine exposure pathways to 
humans.  However, this is not the case with a study on fish brains because they are rarely a food 
source by the general American public, although some local anglers and foreigners do consume 
the whole fish.  Fish brains were selected for this study because they are high in fat content, and 
therefore would be a good site for lipophilic chemicals to choose concentration.  Although this 
study may not be illustrating an exposure pathway to humans, it could be modeling what is 
happening in the human body.  It is impossible to test if BPA is bioaccumulating in the brains of 
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human subjects because of ethical issues, but there may be a true public health need to 
investigate the idea further.  There is evidence of higher prevalence rates in psychological and 
learning disorders, like autism, in children, which may or may not be due to an environmental 
concern [166].  EDCs or xenoestrogens, such as BPA, may be to blame for their methods of 
endocrine disruption or simply because of their toxic ability to bioaccumulate in areas of the 
brain affecting the learning centers. 
It is possible for BPA to be concentrating in the brains of fish by one of two different 
mechanisms: directly entering the bloodstream then crossing the blood-brain barrier or by axonal 
transport. All vertebrates are known to have a blood-brain barrier which helps to keep toxic 
agents out of the brain [167].   Axonal transport is the normal physiological process for the 
transport of dissolved chemicals along nerve axons, thus circumventing the protection of the 
blood-brain barrier [168-170].  It is unknown at this time which mechanism is causing the BPA 
to enter the brains of fish.  BPA has already been found in human blood and proven to cross the 
maternal-fetal placental barrier [13, 87].  If it is determined that BPA is crossing the blood-brain 
barrier, it could have grave public health consequences.  Current research in neuroendocrinology 
is focusing efforts on the effects of estrogens and xenoestrogens on the brain and other central 
nervous system functions.  Certain areas of the brain, particularly the hypothalamus and pituitary 
gland, control synthesis and secretion of molecules which regulate endocrine function of the 
body.  For example, the pituitary gland secretes Luteinizing Hormone (LH) and Follicle-
Stimulating Hormone (FSH), which directly target the testes and ovaries [171].  I nterference 
with the normal function of this delicate hormonal balance could prove detrimental at some 
stages of development.  Estrogen is known to play a large role in the areas of cognition and 
memory and is suspected to be have the ability to mitigate conditions such as Alzheimer’s and 
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Parkinson’s [172].  Studies have found BPA to have antagonistic effects on spine synapses for 
both estradiol in female monkeys and testosterone in male rats [173].  It is unclear at this time 
what effect BPA may have on the natural levels of estrogen in the human brain. 
There is a need to continue the study the bioconcentration and bioaccumulation properties 
of BPA and parabens.  The paraben data from this study is weak because ethyl, propyl and butyl 
parabens were not consistently detected in surface water samples from Chapter 3.  It is not 
sufficient to say that parabens do not  bioconcentrate in fish tissue when we cannot be sure if 
parabens were present in the water source to begin with.  More research needs to be completed to 
correlate the results of chemical analyses with MCF-7 cell proliferation assays for estrogenic 
potential, to continue to determine causal relationships.  Further investigation should be made to 
determine what public health effect on humans, if any, is resulting from BPA bioconcentrating in 
areas around epoxy paint and plastic manufacturing plants.  Clearly, more research is needed to 
determine the effects of BPA on the human brain. 
 
 113 
5.0  OPINION OF POLICY AND REGULATIONS REGARDING PARABENS AND 
BISPHENOL A 
With regard to any new research developments, regulation and policy should be reviewed to 
determine whether or not there are adequate protective margins being employed by the 
government to safeguard the public from an established hazard.  Parabens and Bisphenol A 
(BPA), as well as other Endocrine Disrupting Compounds (EDCs), have been a topic of political 
debate for the last few years. 
5.1 POLICY AND REGULATION REGARDING PARABENS 
5.1.1 Summary of Regulatory Actions for Parabens 
The European Commission (EEC) placed restrictions on parabens for the use of preservatives: 
products are not to exceed 0.4% w/w for one ester and 0.8% for mixtures of esters.  This 
restriction is not applicable if the use of parabens in the product was for something other than as 
a preservative [136, 137].  Dietary administration studies in vivo calculated No-Observed-
Adverse-Effect-Level (NOAEL) for methyl and ethyl paraben at 1000 mg/kg bw/day and a 
Lowest-Observed-Adverse-Effect-Level (LOAEL) of 10 m g/kg bw/day for propyl paraben 
[139]. Toxicological data has led the EU Scientific Committee on Food to establish an 
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Acceptable Daily Intake (ADI) for total parabens at 10 mg/kg bw/day [139].  The 2005 opinion 
that methyl and ethyl parabens can be safely used up to maximum concentrations of 0.4% w/w 
remains unchanged, but more data was requested for propyl, butyl and isobutyl parabens [139].  
In the United States, the FDA has limited the use of heptyl paraben to a maximum level 
of 12 ppm in fermented malt beverages and 20 ppm in noncarbonated soft drinks and fruit-based 
beverages [141].  No other paraben derivatives have restricted uses in the United States. 
5.1.2 Pros and Cons of Using Parabens 
Parabens are used as preservatives in many hygiene products. They are very effective at reducing 
bacterial growth and therefore extending the shelf-life of products.  P arabens are relatively 
inexpensive, easy to use in both water and oil based products and are generally well tolerated.  
Parabens are also used as food preservatives because of their antifungal properties, and are 
therefore present in edible coatings on produce to extend the shelf life of agricultural products 
[110, 111].   
Parabens were found to be estrogenic during in vitro testing [127].  Darbre et. al. reported 
parabens accumulated in human breast tumours, although this study is considered to be 
controversial [132].  Spanish researchers detected the formation of three new halogenated 
transformation products (for each parent paraben) when parabens were exposed to chlorinated 
tap water, making a total of five by-products for each parent paraben.  They were identified as 
bromo- and bromochloro-parabens, because of the traces of bromine also found in tap water 
[117].  This formation takes place within minutes, allowing dermal and possibly ingestion routes 
of exposure to be realistic while bathing.  Formation of brominated by-products occurred when 
bromine was present in the tap water in only minimal amounts.  This research group also found 
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the presence of di-chlorinated forms of methyl and propyl parabens in raw sewage for the first 
time [117].  These by-products could be instrumental in the process of determining any dangers 
of using parabens, possibly more so that the endocrine disrupting potential of the parent parabens 
themselves. 
5.1.3 Alternatives to the Use of Parabens 
There are a number of alternatives to parabens.  Mikrokil PCC may be used for skin care and 
hair care products; Cosmocil CQ can be used in contact lens solutions; and Biovert is a new 
preservative that mimics the natural enzyme, lacto peroxidase, found in tears, saliva and breast 
milk [174]. The addition of diazolidinyl urea to sodium benzoate and potassium sorbate can be a 
combination that offers a promising alternative to parabens, as well [175].  S odium 
Hydroxymethylglycinate is a potential alternative to parabens, however research as to the safety 
and effectiveness is still being performed [176]. Other alternatives include certain essential oils 
for use in oil-based products (will not effectively preserve water-based products), potassium 
sorbate (for mold and yeast only, not bacteria), and vitamins [176]. 
5.1.4 Recommendations for Parabens 
In the work reported here, only methyl paraben was detected in all surface water samples, propyl 
and butyl parabens were only detected in one location, and ethyl was not detected in any. 
Paraben concentrations were not found in significant amounts at any location.  Parabens were not 
detected in extracts from fish brain tissue in any sample, and therefore could not be determined 
to bioconcentrate in the environment from this study. Consequently, only environmental 
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exposure to methyl paraben seems possible in the Greater Pittsburgh Area water supply and this 
compound remains unregulated at this time. 
Therefore, it is my opinion that the current regulatory stance on parabens remains 
adequate for unregulated environmental usage and disposal/discharge.  However, it would be 
prudent to continue further investigation into the effects of discharges near locations where 
parabens and paraben-containing products are manufactured, as this was not accounted for in our 
study of the Greater Pittsburgh Area.  M anufacturing locations for parabens could lead to 
localized public health consequences specific to those areas, as it has been indicated in previous 
literature reviews suggesting that parabens do have the potential to cause endocrine disruption.   
5.2 POLICY AND REGULATIONS REGARDING BISPHENOL A 
5.2.1 Summary of Regulatory Actions for BPA 
Although BPA remains a hot topic for debate among regulatory agencies, little action has been 
taken to remove BPA from the market.  The maximum tolerated dose of BPA was determined to 
be 1000 mg/kg bw/day and the EPA calculated reference dose is 50 µg/kg/day, while a NOAEL 
has yet to be found because adverse responses have always been detected in even the lowest 
administered doses [13].  In 2008, the National Toxicology Program reported a subpanel critique 
of the data available on BPA exposure and potential low-dose health effects.  They concluded 
that there is credible evidence available to show that low doses of BPA  can  cause specific 
effects, but that the low dose effects of BPA have not been established as reproducible findings 
[95].  In the United States, though, most withdraws have been market driven, meaning that 
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companies have voluntarily phased out BPA-containing products in order to promote positive 
customer relations [96].  Some local and state governments have started to propose regulations 
and enforce them, but as of yet, nothing has been legislated on a federal government level.   
Canadian government officials have chosen to withdraw products containing BPA from 
their market.  Prior to this decision, the Canadian governments respected limits for BPA of 0.1 
mg/L for drinking water resulting from contact with BPA containing packaging [97].  A 
Provisional Tolerable Daily Uptake (PTDU) for BPA from food was established to be 25 µg/kg 
bw/day [97].  T he European Scientific Committee on Food set its tolerable daily intake to 50 
µg/kg bw/day in 2006 and exposure to BPA from migration out of food packaging was set at 0.6 
mg/kg [97].  
The current opinion of the United States government is that BPA is safe to use and the 
benefits far outweigh the risks.  The U.S. Food and Drug Administration (FDA) and the National 
Toxicological Program believe that current research provides some concern as to the public 
health effects of BPA on the brain and behavior of infants and children, however the FDA is not 
recommending the discontinuation of the use of BPA at this time [177].  T he EPA has 
considered addressing environmental concerns about BPA in its Bisphenol A Action Plan started 
in early 2010, but resulted in deferring to the FDA as the primary regulator because the majority 
of human exposure to BPA comes directly from food packaging, not drinking water [12, 178]. 
5.2.2 Pros and Cons of Using BPA 
BPA is used in the manufacturing of epoxy resins and polycarbonate plastics, which are used for 
food packaging, metal can linings, and dental filings, among other things.  Polycarbonate plastic 
is selected for use because of its high durability, resistance to shattering, transparency, light 
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weight and resistance to heat [179]. The manufacturing of polycarbonate plastics is a large 
worldwide industry, creating many jobs with a huge socioeconomic impact.  P ublic health 
improvements since the development of BPA-containing materials have been significant and 
have included the reduction of food contamination from metal cans, the extension of the shelf 
life of canned goods and an alternative to mercury amalgam dental composite fillings [12, 180]. 
BPA is known to exhibit estrogenic and antiandrogenic properties [13].  BPA is known to 
mimic estrogen at low doses and impedes the binding of testosterone and thyroid hormone to 
their associated receptors at higher doses [25].  This classifies BPA as an endocrine disruptor.  
BPA is also known to bind to persistent organic pollutants, such as dioxin and polychlorinated 
biphenyls (PCBs) causing longer exposures to BPA and increasing the environmental risk [25]. 
5.2.3 Alternatives to the Use of BPA 
There are alternative products on t he market available for use.  Some alternatives to BPA-
containing polycarbonate plastics are High Density Polyethylene (HDPE) plastics, polypropylene 
plastics, and Polyethylene Terephthalate (PET) plastics. All of which are considered non-
carcinogenic and have not been established to have endocrine disrupting potential at this time 
[181]. Other less attractive alternatives are glass, aluminum and stainless steel containers, which 
tend to be heavy and cumbersome, plus glass is easily damaged.  A n alternative to the BPA-
containing epoxy resins used for metal can liners is Oleoresin, a mixture of oil and resin found in 
various plants.  However, Oleoresin cannot be used in combination with acidic foods [181, 182].  
Products made with paperboard combined with aluminum and Low Density Polyethylene 
(LDPE) are also available alternatives [181]. 
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5.2.4 Recommendations for BPA 
The research generated by this dissertation supports earlier reports suggesting that BPA will be 
present in United States surface water media and that it will bioconcentrate to low degrees in the 
environment [27, 38, 39].  As discussed in Chapter 4, our observed BCFs were within the ranges 
established by experimental studies reported in the literature (BCF = 68) and calculated/expected 
values based on the log Kow of 3.32 (BCF = 100) [161, 163].  However, the  EPA generally uses 
a BCF factor of > 1000 as determining a chemical to be a persistent environmental hazard [160]. 
The European Union considers that any chemical with a BCF > 100 has the potential to 
bioaccumulate in the environment and is therefore a danger to the environment [161, 162].  Of 
the BCFs calculated in this study most were below 100, with only two species at two locations 
reaching above 100, leading to the conclusion that BPA is not a strongly persistent chemical in 
the Greater Pittsburgh Area river system and water supply. 
However, this new research has suggested that BPA is capable of crossing the blood-
brain barrier in fish.  There remains a difficult public health dilemma then to answer the question 
as to whether this occurrence could happen in humans as well.  It is known that humans are 
exposed to BPA through oral exposure routes from food packaging, and that BPA has been 
positively detected in blood serum and found to cross the maternal-fetal placental barrier [13, 
87].  Determining if BPA is concentrating in human brain tissue will be an insurmountable 
ethical task that can only be overcome by relying on in vivo animal and in situ environmental 
studies such as this one.  T here could also be profound public health implications if this 
phenomenon lurks unnoticed. 
Therefore, because of this new question, paired with the known fact that BPA is an 
endocrine disruptor that exhibits both estrogenic and antiandrogenic effects, it is recommended 
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that stricter regulations be enforced on BPA until such time when research questions about BPA 
can be answered [13].  Unfortunately, it would be difficult to remove BPA from the market 
entirely.  Movements could be made to ban the use of BPA-containing materials in all instances 
where the risk to public health from BPA exposure is less than the benefit to public health from 
using BPA-containing materials. For example, because there are adequate alternatives for 
plastics, BPA could be banned from use for the manufacturing of plastic bottles, electronic 
equipment, epoxy paint and the like in the luxury market economy.  However, because the use of 
BPA-containing materials for medical equipment and dental fillings may have greater public 
health benefits than the risk from BPA exposure, it may not be necessary to remove this source 
of exposure at this time.  An adequate alternative for metal can linings to be used with acidic 
foods has not really been established either, so it would not be realistic to remove this exposure 
from the market at this time.  Although the EPA deferred to the FDA as the primary regulator for 
BPA, mostly due to exposure coming directly from food ingestion, it would not hurt to enforce 
environmental regulatory limits on di scharges from manufacturing plants that are producing 
BPA-containing plastics and epoxy resins. 
Removing part of the exposure to BPA by enforcing regulations on industry could reduce 
environmental levels of BPA, and therefore reduce the risk of endocrine disruption, although 
admittedly it would not likely reduce exposure by a significant amount.  While research studies 
and regulators are considering BPA to be a safe chemical and environmental levels are to be of 
no concern, it is easy to overlook that a known phenomena of EDCs is their ability to have 
additive or synergistic effects when present with other EDCs [13, 15].  While we may not be able 
to remove all exposure to BPA from the market at this time, any reduction in exposure could 
have profound effects by removing unknown hazards associated with the mixture of BPA with 
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other chemicals, hazards of which have yet to be discovered and adequately studied.  T hese 
precautionary regulatory actions are necessary and well established by sound science in the case 
of BPA. 
5.3 CONCLUSIONS 
In summary, this dissertation and the research it describes supported all previous available 
reports leading to the conclusion that parabens are safe to remain on the market and not a 
significant environmental concern. In particular, there does not seem to be any need for concern 
over paraben levels detected in the Greater Pittsburgh Area river system and water supply.  The 
BPA portion of this dissertation research, however, was in agreement with previous literature as 
to the bioconcentration tendencies of BPA; but new implications regarding the public health 
consequences stemming from the effect of BPA on brain tissue may require some re-evaluation 
of concern as to the significance of BPA transport and fate in the environment around Pittsburgh 
and elsewhere. 
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APPENDIX A: ERP MEAN AND 95% CONFIDENCE INTERVAL PLOTS FOR BT-20 
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APPENDIX B: ERP MEAN AND 95% CONFIDENCE INTERVAL PLOTS FOR MCF-7  
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APPENDIX C: ERP MEAN AND 95% CONFIDENCE INTERVAL PLOTS FOR T47D 
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